data_1c17_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1c17 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.58 0.229 . . . . 1.0 111.275 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.7 -29.48 0.77 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.367 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -71.01 -62.85 1.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.081 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.59 -17.94 64.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 109.953 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.61 -71.78 0.17 Allowed 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.525 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.17 -21.96 60.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.661 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.27 -44.85 28.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.26 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' B' ' 10' ' ' TYR . 0.7 OUTLIER -75.04 -40.04 60.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.976 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.437 HD21 ' HA ' ' A' ' 73' ' ' TYR . 6.8 tt -56.11 -59.11 5.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.551 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.578 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 14.8 m-85 -56.2 -54.15 48.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.201 0.524 . . . . 0.0 110.119 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 57.2 ttp -54.46 -20.14 7.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.166 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -70.57 -54.2 13.03 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.032 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.577 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -62.91 -19.19 63.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.786 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.69 -39.18 11.98 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.529 0.68 . . . . 0.0 109.49 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 46.0 t -74.89 -37.06 41.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.146 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.603 ' O ' ' HG2' ' A' ' 65' ' ' MET . 57.8 mtm -70.24 -62.52 1.36 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.419 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.577 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 40.6 mtm -63.1 -51.49 66.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.397 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' CG2' ' A' ' 22' ' ' ILE . . . -54.6 -37.08 60.07 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.583 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 24.7 tp -79.6 -38.47 33.86 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.579 ' HB1' ' CB ' ' A' ' 65' ' ' MET . . . -85.64 -35.94 20.63 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.514 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.572 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -62.57 -43.71 98.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.521 ' CD1' ' N ' ' A' ' 23' ' ' GLY . 2.6 pp -65.26 -40.53 88.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.521 ' N ' ' CD1' ' A' ' 22' ' ' ILE . . . -60.98 -29.35 70.58 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 119.859 -1.162 . . . . 0.0 110.22 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 58' ' ' GLY . . . -73.21 -56.62 4.84 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.005 -0.598 . . . . 0.0 110.07 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.53 -54.4 18.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.227 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.12 -56.4 8.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.747 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -47.97 -54.08 12.79 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.898 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 24' ' ' ALA . 68.2 mt -49.86 -34.38 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.66 -34.36 28.33 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.356 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mm -77.17 -62.06 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.0 0.429 . . . . 0.0 110.42 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 54' ' ' PHE . 0.5 OUTLIER -60.95 -43.13 99.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.781 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.98 -50.42 67.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.882 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.33 -51.97 24.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.786 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -58.78 -42.18 88.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.594 0.235 . . . . 0.0 111.402 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CZ ' ' HD2' ' A' ' 50' ' ' ARG . 59.9 t80 -58.68 -47.36 84.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.786 0.327 . . . . 0.0 110.889 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.1 tp -55.25 -44.3 75.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.0 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.28 -31.46 67.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.99 24.17 27.83 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.656 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.27 31.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.297 . . . . 0.0 111.333 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.32 -34.29 21.89 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.908 0.385 . . . . 0.0 111.078 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -67.85 -47.3 69.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.117 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -58.17 163.55 4.4 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.079 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.475 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 52.0 Cg_exo -53.16 161.3 3.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.553 2.169 . . . . 0.0 111.98 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.56 30.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.84 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.0 tp -97.73 -60.66 1.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.481 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 1.7 mp -76.27 -54.63 1.91 Allowed Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.91 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 28.9 Cg_endo -63.26 -32.51 73.25 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.862 1.708 . . . . 0.0 112.358 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.14 -34.38 74.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.405 ' O ' ' CG ' ' A' ' 52' ' ' GLN . 0.3 OUTLIER -75.33 -42.13 55.14 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.359 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.496 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -73.45 -35.89 65.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.911 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.454 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 53.6 m -59.37 -46.57 88.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.592 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.496 ' HA ' HG12 ' A' ' 55' ' ' ILE . 15.3 pt20 -61.78 -45.14 95.14 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.269 0.557 . . . . 0.0 109.836 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.25 -36.96 21.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.502 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 8.8 m-85 -77.66 -69.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.056 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' A' ' 52' ' ' GLN . 28.9 pt -44.55 -33.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.8 t -76.83 -46.05 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 49.3 ttm -50.61 -29.54 11.15 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -84.59 -33.63 18.67 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.2 tp -73.07 -7.51 51.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.199 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.499 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 65.0 t -109.56 -1.33 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.877 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 38.6 t70 -81.47 -23.5 37.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.912 0.387 . . . . 0.0 110.609 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.572 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -88.7 -42.08 12.19 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.559 0.695 . . . . 0.0 110.026 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.567 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.4 mm -47.11 -34.42 4.28 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.799 -1.091 . . . . 0.0 113.613 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 63' ' ' ILE . 3.6 Cg_exo -78.37 -54.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.936 1.757 . . . . 0.0 111.616 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.603 ' HG2' ' O ' ' A' ' 16' ' ' MET . 2.0 tpt -52.85 -37.36 60.14 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.506 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 75.5 mt -66.22 -54.46 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.638 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.32 -31.4 61.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.2 t -75.7 -43.98 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.891 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.69 -35.73 91.43 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.439 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -67.25 -38.12 84.66 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.762 -0.719 . . . . 0.0 109.703 178.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 75' ' ' MET . . . -64.91 -60.77 6.48 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.271 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.45 HD22 ' CZ ' ' B' ' 73' ' ' TYR . 58.4 mt -52.2 -34.51 45.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.494 0.664 . . . . 0.0 109.624 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.578 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 10.7 t80 -71.18 -47.05 59.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.48 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 70' ' ' LEU . 93.2 t -62.31 -26.28 39.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.852 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 71' ' ' GLY . 89.3 mtp -63.73 -49.97 70.96 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.453 ' CG ' ' HE1' ' A' ' 10' ' ' TYR . 2.4 t80 -53.03 -35.88 59.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.24 -32.64 68.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.058 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.13 -32.74 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.973 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.087 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.571 0.224 . . . . 1.0 111.221 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.68 -29.45 0.76 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.371 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.11 -62.84 1.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.53 -17.88 64.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 109.98 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.74 -71.66 0.17 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.508 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 23.4 ptp -59.23 -21.98 60.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.624 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.17 -44.92 28.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.281 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' C' ' 10' ' ' TYR . 0.7 OUTLIER -75.05 -39.98 60.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.964 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' B' ' 73' ' ' TYR . 6.8 tt -56.15 -59.13 5.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . 0.581 ' CE2' ' CE2' ' B' ' 73' ' ' TYR . 15.0 m-85 -56.13 -54.21 47.77 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.207 0.527 . . . . 0.0 110.146 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' MET . . . . . . . . . . . . . 57.2 ttp -54.44 -20.1 6.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.124 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' B' ' 16' ' ' MET . . . -70.57 -54.22 12.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.055 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.579 ' O ' ' HG3' ' B' ' 17' ' ' MET . . . -62.94 -19.17 64.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.794 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.67 -39.26 11.95 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.396 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' B' ' 19' ' ' LEU . 46.3 t -74.85 -37.1 41.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.167 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.598 ' O ' ' HG2' ' B' ' 65' ' ' MET . 57.6 mtm -70.16 -62.57 1.34 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.44 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' MET . . . . . 0.579 ' HG3' ' O ' ' B' ' 13' ' ' ALA . 40.6 mtm -63.1 -51.42 66.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.412 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.457 ' O ' ' CG2' ' B' ' 22' ' ' ILE . . . -54.69 -37.02 60.3 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.582 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.452 ' CB ' ' O ' ' B' ' 15' ' ' VAL . 24.5 tp -79.61 -38.45 33.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.577 ' HB1' ' CB ' ' B' ' 65' ' ' MET . . . -85.65 -35.97 20.6 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.484 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.578 ' HA ' ' CB ' ' B' ' 62' ' ' ALA . . . -62.53 -43.68 98.23 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.515 ' CD1' ' N ' ' B' ' 23' ' ' GLY . 2.6 pp -65.28 -40.54 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.515 ' N ' ' CD1' ' B' ' 22' ' ' ILE . . . -60.97 -29.28 70.37 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.237 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' B' ' 58' ' ' GLY . . . -73.31 -56.59 4.86 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.023 -0.589 . . . . 0.0 110.01 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.56 -54.37 18.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.187 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.14 -56.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.727 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 31' ' ' LEU . . . -47.99 -54.01 13.04 Favored Glycine 0 CA--C 1.508 -0.388 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.895 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 24' ' ' ALA . 68.5 mt -49.93 -34.27 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.285 0.564 . . . . 0.0 109.489 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.434 ' HA2' ' HG ' ' A' ' 31' ' ' LEU . . . -80.67 -34.42 28.13 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.356 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.15 -62.07 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.027 0.441 . . . . 0.0 110.454 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' B' ' 54' ' ' PHE . 0.5 OUTLIER -60.91 -43.2 98.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.811 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.94 -50.46 67.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.844 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.28 -52.03 24.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.789 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.8 -42.12 88.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.558 0.218 . . . . 0.0 111.409 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' PHE . . . . . 0.491 ' CZ ' ' HD2' ' B' ' 50' ' ' ARG . 59.9 t80 -58.68 -47.42 84.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.93 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.413 HD23 ' CD1' ' A' ' 35' ' ' PHE . 64.2 tp -55.2 -44.26 75.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.035 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.38 -31.39 67.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.99 24.17 27.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.704 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.25 31.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.75 0.31 . . . . 0.0 111.305 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.38 -34.27 21.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.911 0.386 . . . . 0.0 111.093 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' B' ' 41' ' ' ARG . 0.3 OUTLIER -67.79 -47.29 69.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.186 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -58.14 163.56 4.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.124 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . 0.475 ' O ' ' CG ' ' B' ' 47' ' ' PRO . 51.8 Cg_exo -53.18 161.29 3.73 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.518 2.145 . . . . 0.0 112.041 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.55 30.9 1.88 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.807 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.74 -60.57 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.391 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.481 ' N ' ' HD2' ' B' ' 47' ' ' PRO . 1.7 mp -76.37 -54.6 1.86 Allowed Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.857 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' B' ' 46' ' ' ILE . 28.8 Cg_endo -63.26 -32.57 73.16 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.888 1.725 . . . . 0.0 112.34 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.08 -34.48 74.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' B' ' 52' ' ' GLN . 0.3 OUTLIER -75.28 -42.09 55.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.425 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.491 ' HD2' ' CZ ' ' B' ' 35' ' ' PHE . 0.0 OUTLIER -73.48 -35.92 65.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.908 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.453 ' HA ' ' CD2' ' B' ' 35' ' ' PHE . 54.2 m -59.31 -46.61 88.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.607 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.503 ' HA ' HG12 ' B' ' 55' ' ' ILE . 15.4 pt20 -61.73 -45.19 95.01 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.203 0.525 . . . . 0.0 109.793 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.3 -36.91 22.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.452 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' B' ' 31' ' ' LEU . 8.7 m-85 -77.64 -69.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.071 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.503 HG12 ' HA ' ' B' ' 52' ' ' GLN . 29.0 pt -44.65 -33.92 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.743 0.306 . . . . 0.0 110.901 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 91.2 t -76.72 -46.18 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 49.3 ttm -50.6 -29.47 10.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' B' ' 24' ' ' ALA . . . -84.61 -33.64 18.61 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 45.4 tp -73.1 -7.51 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 110.183 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.499 ' O ' ' HD3' ' B' ' 64' ' ' PRO . 65.0 t -109.54 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.884 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' B' ' 24' ' ' ALA . 38.6 t70 -81.38 -23.59 37.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.912 0.387 . . . . 0.0 110.58 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.578 ' CB ' ' HA ' ' B' ' 21' ' ' ALA . . . -88.66 -42.11 12.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.54 0.686 . . . . 0.0 110.001 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.562 ' N ' ' CD ' ' B' ' 64' ' ' PRO . 2.4 mm -47.16 -34.42 4.37 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.527 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' B' ' 63' ' ' ILE . 3.6 Cg_exo -78.36 -54.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.923 1.748 . . . . 0.0 111.623 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' MET . . . . . 0.598 ' HG2' ' O ' ' B' ' 16' ' ' MET . 2.0 tpt -52.83 -37.39 59.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.504 ' HA ' ' HG2' ' B' ' 17' ' ' MET . 75.6 mt -66.22 -54.47 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.596 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.23 -31.49 61.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 56.4 t -75.69 -43.92 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.963 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.79 -35.62 91.16 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.438 ' O ' ' CG2' ' B' ' 74' ' ' VAL . 0.5 OUTLIER -67.33 -38.04 84.25 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.781 -0.71 . . . . 0.0 109.672 178.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.432 ' O ' ' HG3' ' B' ' 75' ' ' MET . . . -65.0 -60.68 6.56 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.26 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.422 HD22 ' CZ ' ' C' ' 73' ' ' TYR . 58.8 mt -52.22 -34.48 45.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.484 0.659 . . . . 0.0 109.63 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.581 ' CE2' ' CE2' ' B' ' 10' ' ' TYR . 10.7 t80 -71.25 -47.0 59.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.484 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' B' ' 70' ' ' LEU . 92.9 t -62.31 -26.33 40.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.813 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' B' ' 71' ' ' GLY . 89.2 mtp -63.65 -50.03 70.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' PHE . . . . . 0.444 ' CG ' ' HE1' ' B' ' 10' ' ' TYR . 2.4 t80 -53.0 -35.94 59.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.5 68.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.126 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.17 -32.75 55.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.974 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.12 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.596 0.236 . . . . 1.0 111.225 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.6 -29.53 0.75 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.407 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.07 -62.82 1.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.04 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.52 -17.93 64.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 0.0 109.925 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.65 -71.79 0.17 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.476 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' MET . . . . . . . . . . . . . 23.3 ptp -59.13 -22.0 60.21 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.638 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.25 -44.86 28.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . 0.442 HD12 ' N ' ' D' ' 11' ' ' MET . 0.7 OUTLIER -75.0 -40.12 60.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.958 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' C' ' 73' ' ' TYR . 6.8 tt -56.08 -59.13 5.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.557 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' TYR . . . . . 0.577 ' CE2' ' CE2' ' C' ' 73' ' ' TYR . 14.9 m-85 -56.15 -54.16 48.48 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 110.147 178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' MET . . . . . . . . . . . . . 57.2 ttp -54.4 -20.2 6.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.152 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' C' ' 16' ' ' MET . . . -70.56 -54.2 13.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.042 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . 0.579 ' O ' ' HG3' ' C' ' 17' ' ' MET . . . -62.9 -19.22 63.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.761 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.67 -39.24 11.96 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.506 0.67 . . . . 0.0 109.454 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' C' ' 19' ' ' LEU . 46.2 t -74.88 -37.03 41.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.168 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' MET . . . . . 0.611 ' O ' ' HG2' ' C' ' 65' ' ' MET . 57.5 mtm -70.28 -62.46 1.38 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.411 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' MET . . . . . 0.579 ' HG3' ' O ' ' C' ' 13' ' ' ALA . 40.7 mtm -63.13 -51.52 66.17 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.376 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.45 ' O ' ' CG2' ' C' ' 22' ' ' ILE . . . -54.58 -37.06 59.94 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.585 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . 0.451 ' CB ' ' O ' ' C' ' 15' ' ' VAL . 24.0 tp -79.64 -38.42 33.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . 0.578 ' HB3' ' CB ' ' C' ' 65' ' ' MET . . . -85.7 -35.94 20.54 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.533 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.58 ' HA ' ' CB ' ' C' ' 62' ' ' ALA . . . -62.53 -43.7 98.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.524 ' CD1' ' N ' ' C' ' 23' ' ' GLY . 2.6 pp -65.33 -40.56 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . 0.524 ' N ' ' CD1' ' C' ' 22' ' ' ILE . . . -60.94 -29.32 70.38 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' C' ' 58' ' ' GLY . . . -73.29 -56.57 4.9 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.045 -0.578 . . . . 0.0 110.069 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.55 -54.38 18.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.259 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 49.1 mm -53.12 -56.42 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.719 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' C' ' 31' ' ' LEU . . . -48.0 -54.06 12.95 Favored Glycine 0 CA--C 1.509 -0.324 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.864 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ILE . . . . . 0.436 HG13 ' O ' ' C' ' 24' ' ' ALA . 68.3 mt -49.81 -34.38 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.299 0.571 . . . . 0.0 109.496 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.69 -34.41 28.08 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.32 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.16 -62.04 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.102 0 CA-C-O 121.009 0.433 . . . . 0.0 110.433 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' LEU . . . . . 0.463 ' CD1' ' CD1' ' C' ' 54' ' ' PHE . 0.5 OUTLIER -60.9 -43.18 98.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.817 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.95 -50.42 67.7 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.855 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.34 -51.99 24.31 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.761 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.81 -42.14 88.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.568 0.223 . . . . 0.0 111.416 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' PHE . . . . . 0.506 ' CZ ' ' HD2' ' C' ' 50' ' ' ARG . 60.0 t80 -58.73 -47.32 85.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.436 HD21 ' CD1' ' B' ' 35' ' ' PHE . 64.1 tp -55.27 -44.3 75.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.023 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.33 -31.37 67.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.97 24.12 28.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.711 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.2 31.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 111.331 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.32 -34.3 21.89 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 120.955 0.407 . . . . 0.0 111.064 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . 0.459 ' HD2' ' N ' ' C' ' 41' ' ' ARG . 0.4 OUTLIER -67.82 -47.3 69.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.116 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -58.14 163.61 4.32 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.115 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' C' ' 47' ' ' PRO . 52.1 Cg_exo -53.22 161.29 3.79 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.566 2.178 . . . . 0.0 111.957 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.51 30.84 1.89 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.86 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 59.0 tp -97.71 -60.61 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.359 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' ILE . . . . . 0.479 ' N ' ' HD2' ' C' ' 47' ' ' PRO . 1.7 mp -76.33 -54.57 1.89 Allowed Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.905 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' C' ' 46' ' ' ILE . 28.9 Cg_endo -63.29 -32.47 72.92 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.848 1.699 . . . . 0.0 112.378 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.17 -34.45 75.05 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' C' ' 52' ' ' GLN . 0.3 OUTLIER -75.22 -42.2 55.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.403 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' ARG . . . . . 0.506 ' HD2' ' CZ ' ' C' ' 35' ' ' PHE . 0.0 OUTLIER -73.36 -36.02 66.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.922 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.453 ' HA ' ' CD2' ' C' ' 35' ' ' PHE . 53.8 m -59.28 -46.6 88.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.558 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . 0.515 ' HA ' HG12 ' C' ' 55' ' ' ILE . 15.3 pt20 -61.8 -45.14 95.12 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.234 0.54 . . . . 0.0 109.824 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.28 -36.95 22.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.488 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' C' ' 31' ' ' LEU . 8.7 m-85 -77.66 -69.58 0.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.051 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' ILE . . . . . 0.515 HG12 ' HA ' ' C' ' 52' ' ' GLN . 29.1 pt -44.5 -34.0 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.779 0.323 . . . . 0.0 110.941 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 89.8 t -76.69 -46.14 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.63 -29.48 11.09 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . 0.525 ' O ' ' HB1' ' C' ' 24' ' ' ALA . . . -84.64 -33.61 18.6 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 45.0 tp -73.11 -7.49 51.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 110.202 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.505 ' O ' ' HD3' ' C' ' 64' ' ' PRO . 64.8 t -109.55 -1.33 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.85 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . 0.433 ' HB3' ' HB1' ' C' ' 24' ' ' ALA . 38.6 t70 -81.48 -23.57 37.32 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.922 0.392 . . . . 0.0 110.601 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' ALA . . . . . 0.58 ' CB ' ' HA ' ' C' ' 21' ' ' ALA . . . -88.6 -42.06 12.27 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.551 0.691 . . . . 0.0 110.089 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' ILE . . . . . 0.576 ' N ' ' CD ' ' C' ' 64' ' ' PRO . 2.4 mm -47.17 -34.45 4.42 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.569 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' C' ' 63' ' ' ILE . 3.6 Cg_exo -78.38 -54.47 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.948 1.766 . . . . 0.0 111.599 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' MET . . . . . 0.611 ' HG2' ' O ' ' C' ' 16' ' ' MET . 2.0 tpt -52.87 -37.37 60.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . 0.52 ' HA ' ' HG2' ' C' ' 17' ' ' MET . 75.4 mt -66.13 -54.47 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.653 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.29 -31.43 61.61 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' VAL . . . . . . . . . . . . . 56.7 t -75.72 -43.98 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.901 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.67 -35.74 91.46 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' LEU . . . . . 0.438 ' O ' ' CG2' ' C' ' 74' ' ' VAL . 0.5 OUTLIER -67.28 -38.03 84.4 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.801 -0.7 . . . . 0.0 109.726 178.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' C' ' 75' ' ' MET . . . -64.96 -60.74 6.51 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.269 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.452 HD22 ' CZ ' ' D' ' 73' ' ' TYR . 58.3 mt -52.19 -34.53 45.78 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.5 0.667 . . . . 0.0 109.648 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.577 ' CE2' ' CE2' ' C' ' 10' ' ' TYR . 10.6 t80 -71.18 -46.96 60.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.537 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' C' ' 70' ' ' LEU . 92.9 t -62.42 -26.22 39.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.819 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' C' ' 71' ' ' GLY . 89.2 mtp -63.71 -50.0 70.89 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' C' ' 76' ' ' PHE . 2.4 t80 -53.03 -35.91 59.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.54 68.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.105 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.19 -32.73 55.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.09 179.937 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.579 0.228 . . . . 1.0 111.261 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.69 -29.41 0.75 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.438 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.08 -62.83 1.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.067 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.59 -17.87 64.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.087 0.47 . . . . 0.0 109.979 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.68 -71.75 0.17 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.473 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.17 -21.98 60.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.622 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.22 -44.91 28.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.272 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . 0.556 HD11 ' N ' ' E' ' 11' ' ' MET . 0.7 OUTLIER -75.02 -40.08 60.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.959 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' D' ' 73' ' ' TYR . 6.8 tt -56.08 -59.09 5.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.568 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.587 ' CE2' ' CE2' ' D' ' 73' ' ' TYR . 14.8 m-85 -56.17 -54.1 49.2 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.166 0.508 . . . . 0.0 110.148 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' MET . . . . . 0.442 ' N ' HD12 ' C' ' 8' ' ' LEU . 57.2 ttp -54.49 -20.19 7.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.128 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' D' ' 16' ' ' MET . . . -70.56 -54.16 13.19 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.075 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . 0.583 ' O ' ' HG3' ' D' ' 17' ' ' MET . . . -62.96 -19.19 64.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.804 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.64 -39.21 11.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.523 0.677 . . . . 0.0 109.49 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' VAL . . . . . 0.456 ' O ' ' CB ' ' D' ' 19' ' ' LEU . 46.2 t -74.86 -37.11 41.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.805 -1.088 . . . . 0.0 109.182 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' MET . . . . . 0.61 ' O ' ' HG2' ' D' ' 65' ' ' MET . 57.7 mtm -70.23 -62.51 1.36 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.425 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' MET . . . . . 0.583 ' HG3' ' O ' ' D' ' 13' ' ' ALA . 40.6 mtm -63.09 -51.49 66.38 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.434 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . 0.452 ' O ' ' CG2' ' D' ' 22' ' ' ILE . . . -54.62 -37.07 60.15 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.557 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . 0.456 ' CB ' ' O ' ' D' ' 15' ' ' VAL . 24.0 tp -79.64 -38.41 33.81 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.574 ' HB3' ' CB ' ' D' ' 65' ' ' MET . . . -85.65 -35.93 20.62 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.536 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . 0.578 ' HA ' ' CB ' ' D' ' 62' ' ' ALA . . . -62.63 -43.69 98.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . 0.521 ' CD1' ' N ' ' D' ' 23' ' ' GLY . 2.6 pp -65.29 -40.59 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . 0.521 ' N ' ' CD1' ' D' ' 22' ' ' ILE . . . -60.94 -29.34 70.44 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.216 177.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' D' ' 58' ' ' GLY . . . -73.17 -56.6 4.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.039 -0.581 . . . . 0.0 110.104 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.57 -54.29 19.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.26 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' ILE . . . . . 0.436 HG21 HD11 ' D' ' 26' ' ' ILE . 49.2 mm -53.23 -56.39 8.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.737 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' D' ' 31' ' ' LEU . . . -47.96 -54.1 12.71 Favored Glycine 0 CA--C 1.508 -0.352 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.902 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' ILE . . . . . 0.443 HG13 ' O ' ' D' ' 24' ' ' ALA . 68.1 mt -49.86 -34.32 9.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . 0.419 ' HA2' ' HG ' ' C' ' 31' ' ' LEU . . . -80.62 -34.5 28.05 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.327 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.14 -62.04 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.987 0.422 . . . . 0.0 110.443 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . 0.523 ' HG ' ' HA2' ' E' ' 29' ' ' GLY . 0.5 OUTLIER -60.93 -43.18 98.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.787 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.99 -50.43 67.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.811 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.29 -51.97 24.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.862 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.8 -42.17 88.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.608 0.242 . . . . 0.0 111.402 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' PHE . . . . . 0.502 ' CZ ' ' HD2' ' D' ' 50' ' ' ARG . 60.0 t80 -58.65 -47.39 84.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.799 0.333 . . . . 0.0 110.931 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.465 HD22 ' CD1' ' C' ' 35' ' ' PHE . 64.4 tp -55.24 -44.23 75.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.31 -31.47 67.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.047 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.92 24.07 28.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.695 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.23 31.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.746 0.308 . . . . 0.0 111.324 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.4 -34.35 21.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.043 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' D' ' 41' ' ' ARG . 0.4 OUTLIER -67.72 -47.29 69.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.172 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' GLN . . . . . 0.401 ' HB3' ' HD2' ' D' ' 43' ' ' PRO . 84.9 mt-30 -58.15 163.6 4.34 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.122 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' PRO . . . . . 0.475 ' O ' ' CG ' ' D' ' 47' ' ' PRO . 52.1 Cg_exo -53.2 161.33 3.73 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.504 2.136 . . . . 0.0 111.998 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.6 30.91 1.89 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.7 -60.67 1.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.366 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' ILE . . . . . 0.472 ' N ' ' HD2' ' D' ' 47' ' ' PRO . 1.7 mp -76.32 -54.58 1.89 Allowed Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.909 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' PRO . . . . . 0.475 ' CG ' ' O ' ' D' ' 43' ' ' PRO . 28.8 Cg_endo -63.16 -32.61 74.22 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 121.873 1.715 . . . . 0.0 112.404 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.11 -34.43 74.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.209 0.528 . . . . 0.0 109.611 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . 0.401 ' O ' ' CG ' ' D' ' 52' ' ' GLN . 0.3 OUTLIER -75.28 -42.14 55.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.384 179.224 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' ARG . . . . . 0.502 ' HD2' ' CZ ' ' D' ' 35' ' ' PHE . 0.0 OUTLIER -73.41 -35.94 65.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.917 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' THR . . . . . 0.443 ' HA ' ' CD2' ' D' ' 35' ' ' PHE . 53.9 m -59.34 -46.55 88.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.595 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . 0.509 ' HA ' HG12 ' D' ' 55' ' ' ILE . 15.3 pt20 -61.86 -45.05 95.45 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.187 0.518 . . . . 0.0 109.8 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.28 -36.98 22.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.429 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.464 ' CD1' ' CD1' ' D' ' 31' ' ' LEU . 8.8 m-85 -77.65 -69.55 0.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.069 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' ILE . . . . . 0.509 HG12 ' HA ' ' D' ' 52' ' ' GLN . 29.0 pt -44.57 -33.96 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.785 0.326 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' VAL . . . . . . . . . . . . . 90.4 t -76.73 -46.17 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.56 -29.55 11.0 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' D' ' 24' ' ' ALA . . . -84.64 -33.58 18.68 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . 0.403 ' HA ' ' CD1' ' D' ' 28' ' ' ILE . 45.1 tp -73.1 -7.53 51.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.188 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . 0.509 ' O ' ' HD3' ' D' ' 64' ' ' PRO . 65.7 t -109.53 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' D' ' 24' ' ' ALA . 38.6 t70 -81.43 -23.54 37.46 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 110.627 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . 0.578 ' CB ' ' HA ' ' D' ' 21' ' ' ALA . . . -88.66 -42.06 12.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.533 0.682 . . . . 0.0 110.045 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' ILE . . . . . 0.575 ' N ' ' CD ' ' D' ' 64' ' ' PRO . 2.4 mm -47.17 -34.47 4.44 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.532 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' D' ' 63' ' ' ILE . 3.6 Cg_exo -78.33 -54.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.021 1.814 . . . . 0.0 111.631 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' D' ' 16' ' ' MET . 2.0 tpt -52.89 -37.36 60.48 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . 0.518 ' HA ' ' HG2' ' D' ' 17' ' ' MET . 75.6 mt -66.14 -54.46 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.658 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.26 -31.43 61.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' VAL . . . . . . . . . . . . . 56.2 t -75.7 -44.0 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.931 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.72 -35.65 91.28 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' LEU . . . . . 0.441 ' O ' ' CG2' ' D' ' 74' ' ' VAL . 0.5 OUTLIER -67.34 -38.02 84.19 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.779 -0.71 . . . . 0.0 109.708 178.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' D' ' 75' ' ' MET . . . -64.97 -60.7 6.55 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.277 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' LEU . . . . . 0.472 HD21 ' CZ ' ' E' ' 73' ' ' TYR . 58.1 mt -52.24 -34.46 46.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.529 0.68 . . . . 0.0 109.675 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' TYR . . . . . 0.587 ' CE2' ' CE2' ' D' ' 10' ' ' TYR . 10.7 t80 -71.22 -46.95 60.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.523 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' D' ' 70' ' ' LEU . 92.9 t -62.4 -26.26 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.791 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' D' ' 71' ' ' GLY . 89.2 mtp -63.64 -50.06 70.79 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' PHE . . . . . 0.444 ' CG ' ' HE1' ' D' ' 10' ' ' TYR . 2.4 t80 -52.99 -35.92 59.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.439 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.32 -32.51 68.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.125 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.16 -32.71 55.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.134 -179.976 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.609 0.242 . . . . 1.0 111.259 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.6 -29.52 0.75 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.421 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -71.11 -62.79 1.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.043 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.57 -17.91 64.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.116 0.484 . . . . 0.0 109.97 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.66 -71.75 0.17 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.512 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.13 -21.99 60.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.3 -44.85 28.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.244 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.551 HD13 ' N ' ' F' ' 11' ' ' MET . 0.7 OUTLIER -75.08 -40.0 60.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.972 179.621 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . 0.435 HD21 ' HA ' ' E' ' 73' ' ' TYR . 6.8 tt -56.13 -59.12 5.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.568 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.588 ' CE2' ' CE2' ' E' ' 73' ' ' TYR . 14.8 m-85 -56.17 -54.03 50.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.139 0.495 . . . . 0.0 110.107 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' MET . . . . . 0.556 ' N ' HD11 ' D' ' 8' ' ' LEU . 56.5 ttp -54.49 -20.23 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.124 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' E' ' 16' ' ' MET . . . -70.54 -54.26 12.87 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.048 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . 0.579 ' O ' ' HG3' ' E' ' 17' ' ' MET . . . -62.87 -19.19 63.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.811 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.72 -39.23 11.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.483 0.658 . . . . 0.0 109.392 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' VAL . . . . . 0.447 ' O ' ' CB ' ' E' ' 19' ' ' LEU . 45.9 t -74.9 -37.06 40.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.163 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' MET . . . . . 0.614 ' O ' ' HG2' ' E' ' 65' ' ' MET . 57.7 mtm -70.23 -62.5 1.36 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.424 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' MET . . . . . 0.579 ' HG3' ' O ' ' E' ' 13' ' ' ALA . 40.5 mtm -63.06 -51.51 66.38 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.471 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' D' ' 19' ' ' LEU . . . -54.63 -37.08 60.21 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.562 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' LEU . . . . . 0.502 HD22 ' HA3' ' F' ' 18' ' ' GLY . 23.8 tp -79.61 -38.37 34.02 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.578 ' HB3' ' CB ' ' E' ' 65' ' ' MET . . . -85.73 -35.89 20.52 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.542 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . 0.575 ' HA ' ' CB ' ' E' ' 62' ' ' ALA . . . -62.63 -43.63 98.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' E' ' 23' ' ' GLY . 2.6 pp -65.29 -40.57 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 23' ' ' GLY . . . . . 0.523 ' N ' ' CD1' ' E' ' 22' ' ' ILE . . . -60.88 -29.41 70.46 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.237 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 24' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' E' ' 58' ' ' GLY . . . -73.2 -56.65 4.81 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.05 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.49 -54.39 18.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.277 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.12 -56.46 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.715 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 27' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' E' ' 31' ' ' LEU . . . -47.92 -54.13 12.53 Favored Glycine 0 CA--C 1.509 -0.329 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.894 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 28' ' ' ILE . . . . . 0.446 HG13 ' O ' ' E' ' 24' ' ' ALA . 68.3 mt -49.85 -34.3 9.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 29' ' ' GLY . . . . . 0.523 ' HA2' ' HG ' ' D' ' 31' ' ' LEU . . . -80.58 -34.54 28.09 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.358 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.13 -62.04 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 121.011 0.434 . . . . 0.0 110.439 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 31' ' ' LEU . . . . . 0.458 ' CD1' ' CD1' ' E' ' 54' ' ' PHE . 0.5 OUTLIER -60.98 -43.15 99.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.765 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.96 -50.45 67.44 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.871 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.31 -51.97 24.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.794 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.83 -42.13 88.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.56 0.219 . . . . 0.0 111.357 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 35' ' ' PHE . . . . . 0.503 ' CZ ' ' HD2' ' E' ' 50' ' ' ARG . 60.0 t80 -58.73 -47.34 84.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.803 0.335 . . . . 0.0 110.891 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . 0.463 HD23 ' CD1' ' D' ' 35' ' ' PHE . 64.5 tp -55.24 -44.26 75.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.046 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -58.32 -31.45 67.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.043 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.98 24.17 27.8 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.673 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.28 31.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.734 0.302 . . . . 0.0 111.322 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.32 -34.33 21.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.984 0.421 . . . . 0.0 111.089 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . 0.459 ' N ' ' HD2' ' E' ' 41' ' ' ARG . 0.4 OUTLIER -67.86 -47.25 69.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.169 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 42' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -58.13 163.59 4.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 43' ' ' PRO . . . . . 0.473 ' O ' ' CG ' ' E' ' 47' ' ' PRO . 52.2 Cg_exo -53.2 161.32 3.74 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.541 2.16 . . . . 0.0 111.963 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.54 30.87 1.89 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.838 0.351 . . . . 0.0 110.864 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.76 -60.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.334 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 46' ' ' ILE . . . . . 0.486 ' N ' ' HD2' ' E' ' 47' ' ' PRO . 1.7 mp -76.26 -54.61 1.91 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.889 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 47' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' E' ' 46' ' ' ILE . 28.9 Cg_endo -63.26 -32.53 73.23 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.815 1.676 . . . . 0.0 112.391 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.15 -34.44 75.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 49' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' E' ' 52' ' ' GLN . 0.3 OUTLIER -75.29 -42.03 55.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.445 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 50' ' ' ARG . . . . . 0.503 ' HD2' ' CZ ' ' E' ' 35' ' ' PHE . 0.0 OUTLIER -73.54 -35.92 65.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.858 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 51' ' ' THR . . . . . 0.449 ' HA ' ' CD2' ' E' ' 35' ' ' PHE . 53.6 m -59.35 -46.56 88.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.601 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . 0.493 ' HA ' HG12 ' E' ' 55' ' ' ILE . 15.4 pt20 -61.76 -45.17 95.07 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.238 0.542 . . . . 0.0 109.796 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.26 -36.96 21.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.486 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 54' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' E' ' 31' ' ' LEU . 8.8 m-85 -77.6 -69.58 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 55' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' E' ' 52' ' ' GLN . 29.0 pt -44.58 -33.97 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.789 0.328 . . . . 0.0 110.883 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 56' ' ' VAL . . . . . . . . . . . . . 91.3 t -76.74 -46.11 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.63 -29.46 11.04 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 58' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' E' ' 24' ' ' ALA . . . -84.64 -33.63 18.53 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 59' ' ' LEU . . . . . . . . . . . . . 45.4 tp -73.08 -7.51 51.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.96 0.409 . . . . 0.0 110.218 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . 0.503 ' O ' ' HD3' ' E' ' 64' ' ' PRO . 64.9 t -109.52 -1.29 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.892 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' E' ' 24' ' ' ALA . 38.6 t70 -81.45 -23.6 37.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.579 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 62' ' ' ALA . . . . . 0.575 ' CB ' ' HA ' ' E' ' 21' ' ' ALA . . . -88.61 -42.13 12.22 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.565 0.697 . . . . 0.0 110.046 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 63' ' ' ILE . . . . . 0.563 ' N ' ' CD ' ' E' ' 64' ' ' PRO . 2.4 mm -47.09 -34.44 4.27 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.611 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 64' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' E' ' 63' ' ' ILE . 3.6 Cg_exo -78.32 -54.54 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.981 1.787 . . . . 0.0 111.624 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 65' ' ' MET . . . . . 0.614 ' HG2' ' O ' ' E' ' 16' ' ' MET . 2.0 tpt -52.8 -37.41 59.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . 0.519 ' HA ' ' HG2' ' E' ' 17' ' ' MET . 75.6 mt -66.22 -54.47 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.608 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.26 -31.46 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 56.5 t -75.66 -43.99 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.93 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.76 -35.6 91.16 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 70' ' ' LEU . . . . . 0.435 ' O ' ' CG2' ' E' ' 74' ' ' VAL . 0.5 OUTLIER -67.33 -38.06 84.3 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.755 -0.723 . . . . 0.0 109.717 178.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 71' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' E' ' 75' ' ' MET . . . -65.0 -60.66 6.59 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.256 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 72' ' ' LEU . . . . . 0.467 HD23 ' CZ ' ' F' ' 73' ' ' TYR . 58.2 mt -52.27 -34.47 46.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.524 0.678 . . . . 0.0 109.645 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 73' ' ' TYR . . . . . 0.588 ' CE2' ' CE2' ' E' ' 10' ' ' TYR . 10.6 t80 -71.2 -47.03 59.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.498 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 74' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' E' ' 70' ' ' LEU . 92.9 t -62.34 -26.2 39.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.804 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 75' ' ' MET . . . . . 0.423 ' HG3' ' O ' ' E' ' 71' ' ' GLY . 89.3 mtp -63.71 -50.04 70.73 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 76' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' E' ' 76' ' ' PHE . 2.4 t80 -53.01 -35.94 59.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.57 68.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.123 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 78' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.16 -32.74 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.996 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.104 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 1' ' ' MET . . . . . 0.428 ' HG3' ' OD1' ' G' ' 3' ' ' ASN . 68.2 mtm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.651 0.262 . . . . 1.0 111.228 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.56 -29.57 0.75 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.05 -62.8 1.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.58 -17.88 64.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.091 0.472 . . . . 0.0 109.967 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.7 -71.71 0.17 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.487 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 6' ' ' MET . . . . . . . . . . . . . 23.1 ptp -59.19 -22.0 60.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.635 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.23 -44.89 28.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.267 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.449 HD11 ' N ' ' G' ' 11' ' ' MET . 0.7 OUTLIER -75.02 -40.06 60.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.954 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' F' ' 73' ' ' TYR . 6.8 tt -56.14 -59.11 5.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.548 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 10' ' ' TYR . . . . . 0.591 ' CE2' ' CE2' ' F' ' 73' ' ' TYR . 14.8 m-85 -56.16 -53.98 50.59 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.175 0.512 . . . . 0.0 110.146 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 11' ' ' MET . . . . . 0.551 ' N ' HD13 ' E' ' 8' ' ' LEU . 56.4 ttp -54.55 -20.22 7.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.085 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 12' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' F' ' 16' ' ' MET . . . -70.53 -54.24 12.95 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.042 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . 0.581 ' O ' ' HG3' ' F' ' 17' ' ' MET . . . -62.95 -19.11 63.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.823 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.67 -39.25 11.95 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.523 0.678 . . . . 0.0 109.455 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 15' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' F' ' 19' ' ' LEU . 46.1 t -74.85 -37.09 41.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.152 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 16' ' ' MET . . . . . 0.603 ' O ' ' HG2' ' F' ' 65' ' ' MET . 57.5 mtm -70.26 -62.54 1.35 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.387 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 17' ' ' MET . . . . . 0.581 ' HG3' ' O ' ' F' ' 13' ' ' ALA . 40.6 mtm -63.08 -51.48 66.49 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.433 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . 0.502 ' HA3' HD22 ' E' ' 19' ' ' LEU . . . -54.66 -37.07 60.3 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.592 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 19' ' ' LEU . . . . . 0.532 HD23 ' HA3' ' G' ' 18' ' ' GLY . 23.6 tp -79.54 -38.4 34.27 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . 0.565 ' HB1' ' CB ' ' F' ' 65' ' ' MET . . . -85.73 -35.91 20.51 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.497 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . 0.574 ' HA ' ' CB ' ' F' ' 62' ' ' ALA . . . -62.57 -43.64 98.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . 0.514 ' CD1' ' N ' ' F' ' 23' ' ' GLY . 2.6 pp -65.29 -40.55 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . 0.514 ' N ' ' CD1' ' F' ' 22' ' ' ILE . . . -60.92 -29.33 70.35 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.257 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 24' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' F' ' 58' ' ' GLY . . . -73.25 -56.63 4.83 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 114.965 -0.618 . . . . 0.0 110.08 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.46 -54.45 17.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.235 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.06 -56.48 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.747 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 27' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' F' ' 31' ' ' LEU . . . -48.03 -54.0 13.19 Favored Glycine 0 CA--C 1.509 -0.324 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.91 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 28' ' ' ILE . . . . . 0.428 HG13 ' O ' ' F' ' 24' ' ' ALA . 68.6 mt -49.87 -34.32 9.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 29' ' ' GLY . . . . . 0.435 ' HA2' ' HG ' ' E' ' 31' ' ' LEU . . . -80.65 -34.43 28.14 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.364 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.15 -62.1 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.993 0.425 . . . . 0.0 110.446 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 31' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' F' ' 54' ' ' PHE . 0.5 OUTLIER -60.89 -43.21 98.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.778 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.97 -50.39 68.11 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.882 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.3 -52.03 24.33 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.806 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.68 -42.24 88.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.619 0.247 . . . . 0.0 111.43 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 35' ' ' PHE . . . . . 0.497 ' CZ ' ' HD2' ' F' ' 50' ' ' ARG . 59.8 t80 -58.66 -47.46 84.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.802 0.334 . . . . 0.0 110.859 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' E' ' 35' ' ' PHE . 64.2 tp -55.25 -44.19 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -58.41 -31.36 67.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.015 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.95 24.12 27.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.719 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.28 31.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.763 0.316 . . . . 0.0 111.357 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.33 -34.3 21.87 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.114 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 41' ' ' ARG . . . . . 0.457 ' N ' ' HD2' ' F' ' 41' ' ' ARG . 0.4 OUTLIER -67.85 -47.29 69.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 42' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -58.1 163.6 4.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 43' ' ' PRO . . . . . 0.465 ' O ' ' CG ' ' F' ' 47' ' ' PRO . 52.3 Cg_exo -53.22 161.36 3.74 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.505 2.137 . . . . 0.0 111.973 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.63 30.93 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.836 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.71 -60.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.089 0.471 . . . . 0.0 111.333 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 46' ' ' ILE . . . . . 0.482 ' N ' ' HD2' ' F' ' 47' ' ' PRO . 1.7 mp -76.34 -54.58 1.88 Allowed Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.857 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 47' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' F' ' 46' ' ' ILE . 28.8 Cg_endo -63.28 -32.49 72.98 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.85 1.7 . . . . 0.0 112.374 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.16 -34.43 75.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.205 0.526 . . . . 0.0 109.594 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 49' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' F' ' 52' ' ' GLN . 0.3 OUTLIER -75.27 -42.1 55.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.438 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 50' ' ' ARG . . . . . 0.497 ' HD2' ' CZ ' ' F' ' 35' ' ' PHE . 0.0 OUTLIER -73.49 -35.96 65.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.857 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 51' ' ' THR . . . . . 0.446 ' HA ' ' CD2' ' F' ' 35' ' ' PHE . 53.4 m -59.36 -46.53 88.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.601 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . 0.501 ' HA ' HG12 ' F' ' 55' ' ' ILE . 15.3 pt20 -61.8 -45.12 95.23 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.247 0.546 . . . . 0.0 109.83 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.31 -36.9 22.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.464 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 54' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' F' ' 31' ' ' LEU . 8.9 m-85 -77.63 -69.57 0.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.095 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 55' ' ' ILE . . . . . 0.501 HG12 ' HA ' ' F' ' 52' ' ' GLN . 29.0 pt -44.62 -33.97 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.76 0.314 . . . . 0.0 110.883 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 56' ' ' VAL . . . . . . . . . . . . . 92.1 t -76.72 -46.15 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 57' ' ' MET . . . . . . . . . . . . . 49.3 ttm -50.58 -29.45 10.84 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 58' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' F' ' 24' ' ' ALA . . . -84.66 -33.61 18.53 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 59' ' ' LEU . . . . . . . . . . . . . 45.5 tp -73.06 -7.55 51.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.964 0.412 . . . . 0.0 110.227 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . 0.506 ' O ' ' HD3' ' F' ' 64' ' ' PRO . 64.5 t -109.48 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.893 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 61' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' F' ' 24' ' ' ALA . 38.6 t70 -81.45 -23.6 37.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.926 0.393 . . . . 0.0 110.552 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 62' ' ' ALA . . . . . 0.574 ' CB ' ' HA ' ' F' ' 21' ' ' ALA . . . -88.63 -42.04 12.27 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.572 0.701 . . . . 0.0 110.099 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 63' ' ' ILE . . . . . 0.574 ' N ' ' CD ' ' F' ' 64' ' ' PRO . 2.4 mm -47.1 -34.52 4.37 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.774 -1.103 . . . . 0.0 113.509 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 64' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' F' ' 63' ' ' ILE . 3.5 Cg_exo -78.34 -54.54 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.994 1.796 . . . . 0.0 111.593 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 65' ' ' MET . . . . . 0.603 ' HG2' ' O ' ' F' ' 16' ' ' MET . 2.0 tpt -52.79 -37.4 59.69 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . 0.516 ' HA ' ' HG2' ' F' ' 17' ' ' MET . 75.7 mt -66.18 -54.46 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.684 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.24 -31.44 61.51 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 68' ' ' VAL . . . . . . . . . . . . . 56.6 t -75.68 -44.04 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.86 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.73 -35.65 91.27 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 70' ' ' LEU . . . . . 0.437 ' O ' ' CG2' ' F' ' 74' ' ' VAL . 0.5 OUTLIER -67.33 -38.05 84.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.696 178.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 71' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' F' ' 75' ' ' MET . . . -64.96 -60.7 6.55 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.278 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 72' ' ' LEU . . . . . 0.454 HD23 ' CZ ' ' G' ' 73' ' ' TYR . 58.2 mt -52.18 -34.52 45.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.514 0.674 . . . . 0.0 109.623 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 73' ' ' TYR . . . . . 0.591 ' CE2' ' CE2' ' F' ' 10' ' ' TYR . 10.7 t80 -71.24 -47.02 59.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.469 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 74' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' F' ' 70' ' ' LEU . 92.8 t -62.33 -26.19 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.807 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 75' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' F' ' 71' ' ' GLY . 89.3 mtp -63.75 -50.0 70.8 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 76' ' ' PHE . . . . . 0.452 ' CG ' ' HE1' ' F' ' 10' ' ' TYR . 2.4 t80 -52.96 -35.98 59.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.23 -32.58 68.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.16 -32.77 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.122 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.6 0.238 . . . . 1.0 111.265 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.67 -29.5 0.77 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.395 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 3' ' ' ASN . . . . . 0.428 ' OD1' ' HG3' ' F' ' 1' ' ' MET . 75.3 m-20 -70.96 -62.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.088 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.54 -17.98 64.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.47 . . . . 0.0 109.97 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.62 -71.78 0.17 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.518 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.11 -22.02 60.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.657 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.2 -44.94 28.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.261 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.416 HD13 ' N ' ' H' ' 11' ' ' MET . 0.7 OUTLIER -75.0 -40.0 60.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.009 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 9' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' G' ' 73' ' ' TYR . 6.8 tt -56.11 -59.2 5.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.528 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 10' ' ' TYR . . . . . 0.58 ' CE2' ' CE2' ' G' ' 73' ' ' TYR . 14.9 m-85 -56.12 -54.06 49.6 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.19 0.519 . . . . 0.0 110.182 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 11' ' ' MET . . . . . 0.449 ' N ' HD11 ' F' ' 8' ' ' LEU . 57.1 ttp -54.48 -20.19 7.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.129 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 12' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' G' ' 16' ' ' MET . . . -70.56 -54.22 12.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.052 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 13' ' ' ALA . . . . . 0.57 ' O ' ' HG3' ' G' ' 17' ' ' MET . . . -62.87 -19.22 63.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.784 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.7 -39.24 11.94 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.491 0.662 . . . . 0.0 109.456 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 15' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' G' ' 19' ' ' LEU . 46.1 t -74.88 -37.03 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.195 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 16' ' ' MET . . . . . 0.609 ' O ' ' HG2' ' G' ' 65' ' ' MET . 57.7 mtm -70.29 -62.54 1.35 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.407 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 17' ' ' MET . . . . . 0.57 ' HG3' ' O ' ' G' ' 13' ' ' ALA . 40.6 mtm -63.05 -51.5 66.44 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.434 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 18' ' ' GLY . . . . . 0.532 ' HA3' HD23 ' F' ' 19' ' ' LEU . . . -54.61 -37.13 60.25 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.591 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 19' ' ' LEU . . . . . 0.505 HD23 ' HA3' ' H' ' 18' ' ' GLY . 23.9 tp -79.55 -38.38 34.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 20' ' ' ALA . . . . . 0.571 ' HB1' ' CB ' ' G' ' 65' ' ' MET . . . -85.72 -35.94 20.51 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.558 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.571 ' HA ' ' CB ' ' G' ' 62' ' ' ALA . . . -62.54 -43.64 98.31 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 22' ' ' ILE . . . . . 0.512 ' CD1' ' N ' ' G' ' 23' ' ' GLY . 2.6 pp -65.36 -40.57 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 23' ' ' GLY . . . . . 0.512 ' N ' ' CD1' ' G' ' 22' ' ' ILE . . . -60.9 -29.35 70.36 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.21 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 24' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' G' ' 58' ' ' GLY . . . -73.26 -56.58 4.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.101 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.49 -54.42 17.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.236 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.12 -56.43 8.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.71 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 27' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' G' ' 31' ' ' LEU . . . -47.95 -54.07 12.75 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.908 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 28' ' ' ILE . . . . . 0.433 HG13 ' O ' ' G' ' 24' ' ' ALA . 68.7 mt -49.87 -34.34 9.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.74 -34.34 28.08 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.297 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.19 -62.04 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 CA-C-O 121.026 0.441 . . . . 0.0 110.454 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 31' ' ' LEU . . . . . 0.454 ' CD1' ' CD1' ' G' ' 54' ' ' PHE . 0.5 OUTLIER -60.91 -43.15 98.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.831 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.95 -50.44 67.46 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.878 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.3 -51.99 24.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.827 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.77 -42.22 88.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.58 0.229 . . . . 0.0 111.406 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 35' ' ' PHE . . . . . 0.504 ' CZ ' ' HD2' ' G' ' 50' ' ' ARG . 59.9 t80 -58.67 -47.41 84.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.736 0.303 . . . . 0.0 110.916 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 36' ' ' LEU . . . . . . . . . . . . . 64.0 tp -55.21 -44.23 75.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.037 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.39 -31.38 67.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.02 24.17 27.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.662 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.27 31.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.75 0.31 . . . . 0.0 111.306 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.34 -34.34 21.85 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.937 0.399 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 41' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' G' ' 41' ' ' ARG . 0.4 OUTLIER -67.8 -47.28 69.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.163 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 42' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -58.15 163.57 4.36 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 43' ' ' PRO . . . . . 0.47 ' O ' ' CG ' ' G' ' 47' ' ' PRO . 52.0 Cg_exo -53.16 161.29 3.69 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.536 2.157 . . . . 0.0 111.982 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.52 30.82 1.89 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 45' ' ' LEU . . . . . . . . . . . . . 58.8 tp -97.67 -60.6 1.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.378 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 46' ' ' ILE . . . . . 0.47 ' N ' ' HD2' ' G' ' 47' ' ' PRO . 1.7 mp -76.36 -54.59 1.87 Allowed Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.891 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 47' ' ' PRO . . . . . 0.47 ' CG ' ' O ' ' G' ' 43' ' ' PRO . 29.0 Cg_endo -63.29 -32.47 72.94 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.8 1.667 . . . . 0.0 112.41 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.12 -34.46 75.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 49' ' ' LEU . . . . . 0.412 ' O ' ' CG ' ' G' ' 52' ' ' GLN . 0.3 OUTLIER -75.31 -42.06 55.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.419 179.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 50' ' ' ARG . . . . . 0.504 ' HD2' ' CZ ' ' G' ' 35' ' ' PHE . 0.0 OUTLIER -73.49 -35.95 65.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.869 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 51' ' ' THR . . . . . 0.453 ' HA ' ' CD2' ' G' ' 35' ' ' PHE . 55.4 m -59.41 -46.52 88.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.557 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 52' ' ' GLN . . . . . 0.5 ' HA ' HG12 ' G' ' 55' ' ' ILE . 15.3 pt20 -61.8 -45.18 94.96 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.268 0.556 . . . . 0.0 109.802 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.23 -36.98 21.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.512 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 54' ' ' PHE . . . . . 0.454 ' CD1' ' CD1' ' G' ' 31' ' ' LEU . 8.9 m-85 -77.58 -69.58 0.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.112 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 55' ' ' ILE . . . . . 0.5 HG12 ' HA ' ' G' ' 52' ' ' GLN . 28.9 pt -44.6 -33.9 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.802 0.335 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 56' ' ' VAL . . . . . . . . . . . . . 91.6 t -76.76 -46.13 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 57' ' ' MET . . . . . . . . . . . . . 49.3 ttm -50.6 -29.52 11.09 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 58' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' G' ' 24' ' ' ALA . . . -84.6 -33.62 18.68 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 59' ' ' LEU . . . . . . . . . . . . . 45.4 tp -73.09 -7.54 51.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.915 0.388 . . . . 0.0 110.191 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 60' ' ' VAL . . . . . 0.505 ' O ' ' HD3' ' G' ' 64' ' ' PRO . 64.8 t -109.52 -1.32 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.894 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 61' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' G' ' 24' ' ' ALA . 38.6 t70 -81.43 -23.55 37.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.972 0.415 . . . . 0.0 110.625 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 62' ' ' ALA . . . . . 0.571 ' CB ' ' HA ' ' G' ' 21' ' ' ALA . . . -88.66 -42.1 12.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.578 0.704 . . . . 0.0 110.043 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 63' ' ' ILE . . . . . 0.57 ' N ' ' CD ' ' G' ' 64' ' ' PRO . 2.4 mm -47.12 -34.42 4.29 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.572 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 64' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' G' ' 63' ' ' ILE . 3.6 Cg_exo -78.35 -54.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.975 1.783 . . . . 0.0 111.629 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 65' ' ' MET . . . . . 0.609 ' HG2' ' O ' ' G' ' 16' ' ' MET . 2.0 tpt -52.86 -37.35 60.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 66' ' ' ILE . . . . . 0.52 ' HA ' ' HG2' ' G' ' 17' ' ' MET . 75.4 mt -66.23 -54.41 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.643 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.44 61.58 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 68' ' ' VAL . . . . . . . . . . . . . 56.2 t -75.68 -43.97 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.9 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.75 -35.66 91.26 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 70' ' ' LEU . . . . . 0.44 ' O ' ' CG2' ' G' ' 74' ' ' VAL . 0.5 OUTLIER -67.3 -38.0 84.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.716 178.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 71' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' G' ' 75' ' ' MET . . . -65.03 -60.7 6.52 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.252 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 72' ' ' LEU . . . . . 0.442 HD23 ' CZ ' ' H' ' 73' ' ' TYR . 58.2 mt -52.19 -34.5 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.521 0.677 . . . . 0.0 109.628 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 73' ' ' TYR . . . . . 0.58 ' CE2' ' CE2' ' G' ' 10' ' ' TYR . 10.7 t80 -71.19 -47.0 60.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.513 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 74' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' G' ' 70' ' ' LEU . 92.7 t -62.4 -26.2 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.784 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 75' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' G' ' 71' ' ' GLY . 89.3 mtp -63.76 -49.97 70.9 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 76' ' ' PHE . . . . . 0.455 ' CG ' ' HE1' ' G' ' 10' ' ' TYR . 2.4 t80 -52.97 -35.95 59.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.33 -32.52 68.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.108 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.13 -32.77 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.966 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.141 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 1' ' ' MET . . . . . 0.468 ' HG3' ' OD1' ' I' ' 3' ' ' ASN . 68.0 mtm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.643 0.259 . . . . 1.0 111.234 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.72 -29.49 0.77 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.362 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.02 -62.85 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.047 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.61 -17.82 64.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.111 0.481 . . . . 0.0 109.978 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.74 -71.77 0.17 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.454 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.12 -22.0 60.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.67 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.22 -44.89 28.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.255 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . 0.405 ' CD1' ' HB3' ' I' ' 10' ' ' TYR . 0.7 OUTLIER -75.02 -40.01 60.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.946 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 9' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' H' ' 73' ' ' TYR . 6.8 tt -56.19 -59.11 5.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.521 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 10' ' ' TYR . . . . . 0.59 ' CE2' ' CE2' ' H' ' 73' ' ' TYR . 14.9 m-85 -56.12 -54.17 48.33 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.225 0.535 . . . . 0.0 110.163 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 11' ' ' MET . . . . . 0.416 ' N ' HD13 ' G' ' 8' ' ' LEU . 57.2 ttp -54.46 -20.13 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.145 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 12' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' H' ' 16' ' ' MET . . . -70.55 -54.26 12.83 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.013 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 13' ' ' ALA . . . . . 0.569 ' O ' ' HG3' ' H' ' 17' ' ' MET . . . -62.92 -19.16 63.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.768 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.68 -39.27 11.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.478 0.656 . . . . 0.0 109.454 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 15' ' ' VAL . . . . . 0.439 ' O ' ' CB ' ' H' ' 19' ' ' LEU . 46.0 t -74.89 -37.03 40.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.163 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 16' ' ' MET . . . . . 0.61 ' O ' ' HG2' ' H' ' 65' ' ' MET . 57.7 mtm -70.24 -62.56 1.34 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.404 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 17' ' ' MET . . . . . 0.569 ' HG3' ' O ' ' H' ' 13' ' ' ALA . 40.6 mtm -63.08 -51.44 66.62 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.436 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 18' ' ' GLY . . . . . 0.505 ' HA3' HD23 ' G' ' 19' ' ' LEU . . . -54.62 -37.1 60.21 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 119.573 -1.299 . . . . 0.0 111.597 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 19' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' H' ' 15' ' ' VAL . 24.5 tp -79.59 -38.4 34.1 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 20' ' ' ALA . . . . . 0.572 ' HB1' ' CB ' ' H' ' 65' ' ' MET . . . -85.68 -35.93 20.58 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.567 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . 0.583 ' HA ' ' CB ' ' H' ' 62' ' ' ALA . . . -62.59 -43.66 98.26 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 22' ' ' ILE . . . . . 0.521 ' CD1' ' N ' ' H' ' 23' ' ' GLY . 2.6 pp -65.34 -40.54 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . 0.521 ' N ' ' CD1' ' H' ' 22' ' ' ILE . . . -60.9 -29.34 70.33 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 24' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' H' ' 58' ' ' GLY . . . -73.29 -56.6 4.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.038 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.53 -54.36 18.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.195 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 26' ' ' ILE . . . . . . . . . . . . . 49.1 mm -53.23 -56.36 8.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.732 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 27' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' H' ' 31' ' ' LEU . . . -47.95 -54.07 12.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.935 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 28' ' ' ILE . . . . . 0.439 HG13 ' O ' ' H' ' 24' ' ' ALA . 68.8 mt -49.91 -34.34 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.73 -34.32 28.17 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.333 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mm -77.19 -62.07 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.974 0.416 . . . . 0.0 110.407 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 31' ' ' LEU . . . . . 0.458 ' CD1' ' CD1' ' H' ' 54' ' ' PHE . 0.5 OUTLIER -60.91 -43.16 98.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.83 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.99 -50.39 68.02 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.888 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.27 -52.01 24.54 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.822 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.82 -42.15 88.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.563 0.221 . . . . 0.0 111.368 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 35' ' ' PHE . . . . . 0.499 ' CZ ' ' HD2' ' H' ' 50' ' ' ARG . 59.9 t80 -58.7 -47.39 84.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.896 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 36' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' G' ' 35' ' ' PHE . 64.2 tp -55.25 -44.25 75.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 37' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -58.39 -31.35 67.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.013 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.02 24.14 28.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.688 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.24 31.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 111.313 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.28 -34.32 21.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.942 0.401 . . . . 0.0 111.112 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 41' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' H' ' 41' ' ' ARG . 0.4 OUTLIER -67.83 -47.29 69.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.15 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 42' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -58.09 163.58 4.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.092 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 43' ' ' PRO . . . . . 0.471 ' O ' ' CG ' ' H' ' 47' ' ' PRO . 52.2 Cg_exo -53.26 161.29 3.85 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.496 2.13 . . . . 0.0 111.968 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.49 30.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.834 0.349 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.68 -60.62 1.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.053 0.454 . . . . 0.0 111.343 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 46' ' ' ILE . . . . . 0.486 ' N ' ' HD2' ' H' ' 47' ' ' PRO . 1.7 mp -76.29 -54.65 1.89 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.908 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 47' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' H' ' 46' ' ' ILE . 29.0 Cg_endo -63.21 -32.55 73.73 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.835 1.69 . . . . 0.0 112.401 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.08 -34.49 74.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 109.594 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 49' ' ' LEU . . . . . 0.403 ' O ' ' CG ' ' H' ' 52' ' ' GLN . 0.3 OUTLIER -75.29 -42.09 55.55 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.423 179.204 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 50' ' ' ARG . . . . . 0.499 ' HD2' ' CZ ' ' H' ' 35' ' ' PHE . 0.0 OUTLIER -73.5 -35.87 65.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.899 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 51' ' ' THR . . . . . 0.445 ' HA ' ' CD2' ' H' ' 35' ' ' PHE . 53.3 m -59.38 -46.58 88.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.548 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 52' ' ' GLN . . . . . 0.512 ' HA ' HG12 ' H' ' 55' ' ' ILE . 15.4 pt20 -61.78 -45.12 95.27 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.233 0.539 . . . . 0.0 109.851 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.3 -36.88 22.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.484 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 54' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' H' ' 31' ' ' LEU . 8.9 m-85 -77.74 -69.54 0.54 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.034 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 55' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' H' ' 52' ' ' GLN . 28.8 pt -44.6 -33.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.81 0.338 . . . . 0.0 110.878 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 56' ' ' VAL . . . . . . . . . . . . . 91.7 t -76.74 -46.1 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.67 -29.43 11.12 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 58' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' H' ' 24' ' ' ALA . . . -84.64 -33.65 18.47 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 59' ' ' LEU . . . . . . . . . . . . . 45.4 tp -73.09 -7.54 51.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.958 0.408 . . . . 0.0 110.194 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 60' ' ' VAL . . . . . 0.505 ' O ' ' HD3' ' H' ' 64' ' ' PRO . 64.8 t -109.53 -1.33 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.873 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 61' ' ' ASP . . . . . 0.449 ' HB3' ' HB2' ' H' ' 24' ' ' ALA . 38.6 t70 -81.46 -23.53 37.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.916 0.389 . . . . 0.0 110.593 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 62' ' ' ALA . . . . . 0.583 ' CB ' ' HA ' ' H' ' 21' ' ' ALA . . . -88.67 -42.07 12.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.589 0.709 . . . . 0.0 110.048 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 63' ' ' ILE . . . . . 0.574 ' N ' ' CD ' ' H' ' 64' ' ' PRO . 2.4 mm -47.18 -34.42 4.41 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.525 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 64' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' H' ' 63' ' ' ILE . 3.6 Cg_exo -78.34 -54.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.968 1.778 . . . . 0.0 111.616 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 65' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' H' ' 16' ' ' MET . 2.0 tpt -52.84 -37.37 60.04 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 66' ' ' ILE . . . . . 0.508 ' HA ' ' HG2' ' H' ' 17' ' ' MET . 75.6 mt -66.18 -54.44 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.646 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.3 -31.39 61.59 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 68' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.64 -44.02 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.894 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.76 -35.66 91.24 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 70' ' ' LEU . . . . . 0.437 ' O ' ' CG2' ' H' ' 74' ' ' VAL . 0.5 OUTLIER -67.31 -38.1 84.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.664 178.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 71' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' H' ' 75' ' ' MET . . . -64.98 -60.73 6.5 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.235 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 72' ' ' LEU . . . . . 0.453 ' CD2' ' CZ ' ' I' ' 73' ' ' TYR . 58.5 mt -52.16 -34.5 45.2 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.508 0.67 . . . . 0.0 109.646 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 73' ' ' TYR . . . . . 0.59 ' CE2' ' CE2' ' H' ' 10' ' ' TYR . 10.7 t80 -71.21 -46.99 60.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.497 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 74' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' H' ' 70' ' ' LEU . 92.6 t -62.41 -26.22 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.822 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 75' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' H' ' 71' ' ' GLY . 89.3 mtp -63.72 -49.93 71.12 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 76' ' ' PHE . . . . . 0.448 ' CG ' ' HE1' ' H' ' 10' ' ' TYR . 2.4 t80 -52.97 -35.99 59.66 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.53 68.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.1 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.18 -32.69 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.114 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.635 0.255 . . . . 1.0 111.284 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.74 -29.42 0.77 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.398 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 3' ' ' ASN . . . . . 0.468 ' OD1' ' HG3' ' H' ' 1' ' ' MET . 75.3 m-20 -71.08 -62.83 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.046 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.57 -17.92 64.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 0.0 109.944 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.73 -71.67 0.17 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.516 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 6' ' ' MET . . . . . . . . . . . . . 23.3 ptp -59.15 -22.0 60.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.688 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.24 -44.84 28.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.274 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 8' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' J' ' 10' ' ' TYR . 0.7 OUTLIER -75.02 -40.09 60.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.962 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 9' ' ' LEU . . . . . 0.45 HD21 ' HA ' ' I' ' 73' ' ' TYR . 6.8 tt -56.06 -59.2 5.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.545 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 10' ' ' TYR . . . . . 0.583 ' CE2' ' CE2' ' I' ' 73' ' ' TYR . 14.9 m-85 -56.1 -54.15 48.56 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.202 0.525 . . . . 0.0 110.192 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 11' ' ' MET . . . . . 0.403 ' CE ' HD21 ' I' ' 8' ' ' LEU . 57.3 ttp -54.44 -20.16 7.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.131 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 12' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' I' ' 16' ' ' MET . . . -70.5 -54.21 13.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 13' ' ' ALA . . . . . 0.581 ' O ' ' HG3' ' I' ' 17' ' ' MET . . . -62.89 -19.24 63.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.723 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.67 -39.26 11.94 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.503 0.668 . . . . 0.0 109.493 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 15' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' I' ' 19' ' ' LEU . 46.1 t -74.89 -37.04 40.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.171 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 16' ' ' MET . . . . . 0.616 ' O ' ' HG2' ' I' ' 65' ' ' MET . 57.8 mtm -70.22 -62.55 1.34 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.451 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 17' ' ' MET . . . . . 0.581 ' HG3' ' O ' ' I' ' 13' ' ' ALA . 40.6 mtm -63.07 -51.47 66.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.409 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 18' ' ' GLY . . . . . 0.455 ' O ' ' CG2' ' I' ' 22' ' ' ILE . . . -54.61 -37.08 60.13 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.614 -1.279 . . . . 0.0 111.622 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 19' ' ' LEU . . . . . 0.446 ' CB ' ' O ' ' I' ' 15' ' ' VAL . 24.5 tp -79.57 -38.48 34.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 20' ' ' ALA . . . . . 0.578 ' HB3' ' CB ' ' I' ' 65' ' ' MET . . . -85.65 -35.97 20.6 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.504 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 21' ' ' ALA . . . . . 0.581 ' HA ' ' CB ' ' I' ' 62' ' ' ALA . . . -62.55 -43.69 98.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 22' ' ' ILE . . . . . 0.524 ' CD1' ' N ' ' I' ' 23' ' ' GLY . 2.6 pp -65.27 -40.58 89.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 23' ' ' GLY . . . . . 0.524 ' N ' ' CD1' ' I' ' 22' ' ' ILE . . . -60.91 -29.38 70.45 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.203 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 24' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' I' ' 58' ' ' GLY . . . -73.22 -56.63 4.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.054 -0.573 . . . . 0.0 110.065 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.49 -54.35 18.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.226 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.23 -56.4 8.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.684 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 27' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' I' ' 31' ' ' LEU . . . -47.95 -54.11 12.66 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.875 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 28' ' ' ILE . . . . . 0.443 HG13 ' O ' ' I' ' 24' ' ' ALA . 68.6 mt -49.83 -34.38 9.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.68 -34.35 28.29 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.345 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.24 -62.05 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.938 0.399 . . . . 0.0 110.389 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 31' ' ' LEU . . . . . 0.456 ' CD1' ' CD1' ' I' ' 54' ' ' PHE . 0.5 OUTLIER -60.92 -43.18 98.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.781 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.99 -50.45 67.41 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.841 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.23 -52.06 24.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.818 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.78 -42.12 88.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.595 0.236 . . . . 0.0 111.429 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 35' ' ' PHE . . . . . 0.501 ' CZ ' ' HD2' ' I' ' 50' ' ' ARG . 60.0 t80 -58.72 -47.41 84.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 36' ' ' LEU . . . . . . . . . . . . . 64.1 tp -55.2 -44.27 75.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 37' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -58.37 -31.4 67.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.061 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.99 24.16 27.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.675 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.25 31.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.762 0.315 . . . . 0.0 111.313 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.3 -34.34 21.91 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.064 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 41' ' ' ARG . . . . . 0.458 ' HD2' ' N ' ' I' ' 41' ' ' ARG . 0.4 OUTLIER -67.81 -47.29 69.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.147 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 42' ' ' GLN . . . . . 0.401 ' HB3' ' HD2' ' I' ' 43' ' ' PRO . 84.8 mt-30 -58.16 163.51 4.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.143 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 43' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' I' ' 47' ' ' PRO . 52.2 Cg_exo -53.2 161.34 3.72 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.507 2.138 . . . . 0.0 111.987 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.55 30.92 1.87 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.78 -60.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.323 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 46' ' ' ILE . . . . . 0.486 ' N ' ' HD2' ' I' ' 47' ' ' PRO . 1.7 mp -76.26 -54.64 1.91 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.891 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 47' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' I' ' 46' ' ' ILE . 29.0 Cg_endo -63.19 -32.58 73.94 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.83 1.686 . . . . 0.0 112.407 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.1 -34.45 74.96 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 49' ' ' LEU . . . . . 0.409 ' O ' ' CG ' ' I' ' 52' ' ' GLN . 0.3 OUTLIER -75.29 -42.09 55.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.416 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 50' ' ' ARG . . . . . 0.501 ' HD2' ' CZ ' ' I' ' 35' ' ' PHE . 0.0 OUTLIER -73.49 -35.89 65.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.93 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 51' ' ' THR . . . . . 0.452 ' HA ' ' CD2' ' I' ' 35' ' ' PHE . 53.6 m -59.39 -46.54 88.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.556 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 52' ' ' GLN . . . . . 0.517 ' HA ' HG12 ' I' ' 55' ' ' ILE . 15.3 pt20 -61.84 -45.14 95.1 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.215 0.531 . . . . 0.0 109.802 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.29 -36.89 22.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.478 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 54' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' I' ' 31' ' ' LEU . 8.7 m-85 -77.67 -69.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.053 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 55' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' I' ' 52' ' ' GLN . 29.0 pt -44.54 -33.94 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.754 0.312 . . . . 0.0 110.932 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 56' ' ' VAL . . . . . . . . . . . . . 91.3 t -76.75 -46.17 30.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.59 -29.47 10.94 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 58' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' I' ' 24' ' ' ALA . . . -84.62 -33.59 18.71 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 59' ' ' LEU . . . . . . . . . . . . . 44.9 tp -73.1 -7.53 51.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.939 0.4 . . . . 0.0 110.178 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 60' ' ' VAL . . . . . 0.492 ' O ' ' HD3' ' I' ' 64' ' ' PRO . 64.7 t -109.54 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.84 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 61' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' I' ' 24' ' ' ALA . 38.6 t70 -81.44 -23.56 37.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.949 0.404 . . . . 0.0 110.61 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 62' ' ' ALA . . . . . 0.581 ' CB ' ' HA ' ' I' ' 21' ' ' ALA . . . -88.69 -42.08 12.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.524 0.678 . . . . 0.0 109.994 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 63' ' ' ILE . . . . . 0.579 ' N ' ' CD ' ' I' ' 64' ' ' PRO . 2.4 mm -47.04 -34.55 4.28 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.548 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 64' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' I' ' 63' ' ' ILE . 3.6 Cg_exo -78.33 -54.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.934 1.756 . . . . 0.0 111.618 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 65' ' ' MET . . . . . 0.616 ' HG2' ' O ' ' I' ' 16' ' ' MET . 2.0 tpt -52.83 -37.36 59.95 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 66' ' ' ILE . . . . . 0.503 ' HA ' ' HG2' ' I' ' 17' ' ' MET . 75.6 mt -66.25 -54.46 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.638 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.26 -31.4 61.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 68' ' ' VAL . . . . . . . . . . . . . 56.6 t -75.73 -44.02 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.888 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.71 -35.67 91.32 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 70' ' ' LEU . . . . . 0.441 ' O ' ' CG2' ' I' ' 74' ' ' VAL . 0.5 OUTLIER -67.24 -38.06 84.59 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.795 -0.702 . . . . 0.0 109.699 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 71' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' I' ' 75' ' ' MET . . . -65.0 -60.69 6.55 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 72' ' ' LEU . . . . . 0.414 ' CD2' ' CZ ' ' J' ' 73' ' ' TYR . 58.6 mt -52.22 -34.5 46.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.503 0.668 . . . . 0.0 109.63 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 73' ' ' TYR . . . . . 0.583 ' CE2' ' CE2' ' I' ' 10' ' ' TYR . 10.6 t80 -71.18 -47.05 59.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.491 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 74' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' I' ' 70' ' ' LEU . 93.0 t -62.35 -26.22 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.83 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 75' ' ' MET . . . . . 0.427 ' HG3' ' O ' ' I' ' 71' ' ' GLY . 89.2 mtp -63.78 -49.91 71.06 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 76' ' ' PHE . . . . . 0.448 ' CG ' ' HE1' ' I' ' 10' ' ' TYR . 2.4 t80 -53.03 -35.92 59.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.33 -32.5 68.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.08 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 78' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.19 -32.78 55.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.101 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.622 0.249 . . . . 1.0 111.273 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.62 -29.45 0.74 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.436 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.12 -62.81 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.07 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.52 -17.97 64.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.164 0.507 . . . . 0.0 109.973 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.65 -71.71 0.17 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.517 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.22 -21.95 60.31 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.624 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.23 -44.94 28.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.225 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 8' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' K' ' 10' ' ' TYR . 0.7 OUTLIER -74.98 -40.08 60.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.958 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 9' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' J' ' 73' ' ' TYR . 6.8 tt -56.13 -59.13 5.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.548 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 10' ' ' TYR . . . . . 0.59 ' CE2' ' CE2' ' J' ' 73' ' ' TYR . 14.8 m-85 -56.15 -54.17 48.28 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 110.114 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 11' ' ' MET . . . . . . . . . . . . . 57.2 ttp -54.42 -20.19 7.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.145 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 12' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' J' ' 16' ' ' MET . . . -70.51 -54.2 13.17 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.066 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 13' ' ' ALA . . . . . 0.567 ' O ' ' HG3' ' J' ' 17' ' ' MET . . . -62.95 -19.13 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.815 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.74 -39.18 11.95 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.505 0.669 . . . . 0.0 109.45 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 15' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' J' ' 19' ' ' LEU . 46.1 t -74.89 -37.08 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.161 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 16' ' ' MET . . . . . 0.61 ' O ' ' HG2' ' J' ' 65' ' ' MET . 57.6 mtm -70.24 -62.52 1.36 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.379 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 17' ' ' MET . . . . . 0.567 ' HG3' ' O ' ' J' ' 13' ' ' ALA . 40.5 mtm -63.11 -51.43 66.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.429 -178.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 18' ' ' GLY . . . . . 0.46 ' O ' ' CG2' ' J' ' 22' ' ' ILE . . . -54.63 -37.08 60.19 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.569 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 19' ' ' LEU . . . . . 0.444 ' CB ' ' O ' ' J' ' 15' ' ' VAL . 24.2 tp -79.63 -38.42 33.81 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 20' ' ' ALA . . . . . 0.578 ' HB2' ' CB ' ' J' ' 65' ' ' MET . . . -85.63 -35.98 20.63 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.478 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 21' ' ' ALA . . . . . 0.574 ' HA ' ' CB ' ' J' ' 62' ' ' ALA . . . -62.55 -43.69 98.19 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 22' ' ' ILE . . . . . 0.518 ' CD1' ' N ' ' J' ' 23' ' ' GLY . 2.6 pp -65.32 -40.51 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . 0.518 ' N ' ' CD1' ' J' ' 22' ' ' ILE . . . -61.0 -29.3 70.52 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 24' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' J' ' 58' ' ' GLY . . . -73.23 -56.66 4.79 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.044 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.52 -54.38 18.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.15 -56.41 8.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.741 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 27' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' J' ' 31' ' ' LEU . . . -47.95 -54.09 12.71 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.89 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 28' ' ' ILE . . . . . 0.445 HG13 ' O ' ' J' ' 24' ' ' ALA . 68.4 mt -49.86 -34.32 9.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.73 -34.32 28.16 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.353 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.19 -62.05 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 120.981 0.419 . . . . 0.0 110.446 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 31' ' ' LEU . . . . . 0.459 ' CD1' ' CD1' ' J' ' 54' ' ' PHE . 0.5 OUTLIER -60.9 -43.17 98.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.837 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.96 -50.47 67.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.861 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.27 -51.99 24.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.845 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 34' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -58.81 -42.11 88.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.586 0.232 . . . . 0.0 111.403 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 35' ' ' PHE . . . . . 0.501 ' CZ ' ' HD2' ' J' ' 50' ' ' ARG . 59.7 t80 -58.69 -47.47 84.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.894 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 36' ' ' LEU . . . . . 0.433 HD21 ' CD1' ' I' ' 35' ' ' PHE . 64.1 tp -55.13 -44.32 74.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.39 -31.35 67.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.045 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.01 24.17 27.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.693 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.25 31.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.768 0.318 . . . . 0.0 111.362 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.3 -34.36 21.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 41' ' ' ARG . . . . . 0.458 ' HD2' ' N ' ' J' ' 41' ' ' ARG . 0.4 OUTLIER -67.8 -47.32 69.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.149 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 42' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -58.1 163.55 4.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 43' ' ' PRO . . . . . 0.477 ' O ' ' CG ' ' J' ' 47' ' ' PRO . 52.1 Cg_exo -53.17 161.36 3.66 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.52 2.147 . . . . 0.0 111.934 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.59 30.86 1.9 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.7 -60.62 1.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.343 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 46' ' ' ILE . . . . . 0.481 ' N ' ' HD2' ' J' ' 47' ' ' PRO . 1.7 mp -76.37 -54.57 1.87 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.891 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 47' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' J' ' 46' ' ' ILE . 29.0 Cg_endo -63.28 -32.48 72.97 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.837 1.692 . . . . 0.0 112.385 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.13 -34.46 75.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 49' ' ' LEU . . . . . 0.403 ' O ' ' CG ' ' J' ' 52' ' ' GLN . 0.3 OUTLIER -75.25 -42.16 55.79 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.378 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 50' ' ' ARG . . . . . 0.501 ' HD2' ' CZ ' ' J' ' 35' ' ' PHE . 0.0 OUTLIER -73.44 -35.88 65.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.969 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 51' ' ' THR . . . . . 0.451 ' HA ' ' CD2' ' J' ' 35' ' ' PHE . 54.1 m -59.35 -46.58 88.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.573 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 52' ' ' GLN . . . . . 0.511 ' HA ' HG12 ' J' ' 55' ' ' ILE . 15.3 pt20 -61.82 -45.13 95.17 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.197 0.523 . . . . 0.0 109.807 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.24 -36.95 21.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.509 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 54' ' ' PHE . . . . . 0.459 ' CD1' ' CD1' ' J' ' 31' ' ' LEU . 8.8 m-85 -77.62 -69.6 0.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.089 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 55' ' ' ILE . . . . . 0.511 HG12 ' HA ' ' J' ' 52' ' ' GLN . 28.9 pt -44.57 -33.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.828 0.346 . . . . 0.0 110.971 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 56' ' ' VAL . . . . . . . . . . . . . 92.1 t -76.81 -46.07 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 57' ' ' MET . . . . . . . . . . . . . 49.1 ttm -50.6 -29.52 11.1 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 58' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' J' ' 24' ' ' ALA . . . -84.57 -33.69 18.57 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 59' ' ' LEU . . . . . . . . . . . . . 45.4 tp -73.13 -7.44 51.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.941 0.401 . . . . 0.0 110.182 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 60' ' ' VAL . . . . . 0.5 ' O ' ' HD3' ' J' ' 64' ' ' PRO . 64.9 t -109.56 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.884 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 61' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' J' ' 24' ' ' ALA . 38.6 t70 -81.47 -23.55 37.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.935 0.398 . . . . 0.0 110.591 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 62' ' ' ALA . . . . . 0.574 ' CB ' ' HA ' ' J' ' 21' ' ' ALA . . . -88.67 -42.05 12.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.532 0.682 . . . . 0.0 110.041 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 63' ' ' ILE . . . . . 0.574 ' N ' ' CD ' ' J' ' 64' ' ' PRO . 2.4 mm -47.13 -34.5 4.41 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.507 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 64' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' J' ' 63' ' ' ILE . 3.5 Cg_exo -78.34 -54.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.973 1.782 . . . . 0.0 111.634 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 65' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' J' ' 16' ' ' MET . 2.0 tpt -52.86 -37.39 60.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 66' ' ' ILE . . . . . 0.513 ' HA ' ' HG2' ' J' ' 17' ' ' MET . 75.4 mt -66.22 -54.42 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.601 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.26 -31.5 61.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 68' ' ' VAL . . . . . . . . . . . . . 56.5 t -75.66 -43.96 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.941 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.75 -35.64 91.23 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 70' ' ' LEU . . . . . 0.436 ' O ' ' CG2' ' J' ' 74' ' ' VAL . 0.5 OUTLIER -67.28 -38.07 84.46 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.694 178.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 71' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' J' ' 75' ' ' MET . . . -64.96 -60.75 6.49 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 72' ' ' LEU . . . . . . . . . . . . . 58.7 mt -52.18 -34.48 45.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.522 0.677 . . . . 0.0 109.636 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 73' ' ' TYR . . . . . 0.59 ' CE2' ' CE2' ' J' ' 10' ' ' TYR . 10.7 t80 -71.22 -47.0 59.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.488 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 74' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' J' ' 70' ' ' LEU . 92.9 t -62.39 -26.24 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.838 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 75' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' J' ' 71' ' ' GLY . 89.3 mtp -63.74 -49.99 70.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 76' ' ' PHE . . . . . 0.458 ' CG ' ' HE1' ' J' ' 10' ' ' TYR . 2.4 t80 -53.0 -35.91 59.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.35 -32.51 68.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.137 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.21 -32.67 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.993 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.126 179.95 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.593 0.235 . . . . 1.0 111.222 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.63 -29.47 0.75 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.414 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.06 -62.76 1.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.106 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.6 -17.93 64.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.109 0.481 . . . . 0.0 109.939 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.72 -71.69 0.17 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.5 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 6' ' ' MET . . . . . . . . . . . . . 23.4 ptp -59.22 -21.93 60.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.673 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.27 -44.88 28.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.238 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 8' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' L' ' 7' ' ' ASP . 0.7 OUTLIER -75.06 -40.01 60.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.969 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 9' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' K' ' 73' ' ' TYR . 6.8 tt -56.16 -59.11 5.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.514 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 10' ' ' TYR . . . . . 0.578 ' CE2' ' CE2' ' K' ' 73' ' ' TYR . 14.9 m-85 -56.13 -54.2 47.91 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.256 0.55 . . . . 0.0 110.167 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 11' ' ' MET . . . . . . . . . . . . . 57.2 ttp -54.37 -20.2 6.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.118 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 12' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' K' ' 16' ' ' MET . . . -70.55 -54.23 12.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.032 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 13' ' ' ALA . . . . . 0.582 ' O ' ' HG3' ' K' ' 17' ' ' MET . . . -62.94 -19.15 63.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.752 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.7 -39.23 11.95 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.493 0.663 . . . . 0.0 109.43 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 15' ' ' VAL . . . . . 0.443 ' O ' ' CB ' ' K' ' 19' ' ' LEU . 46.1 t -74.92 -37.07 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.148 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 16' ' ' MET . . . . . 0.615 ' O ' ' HG2' ' K' ' 65' ' ' MET . 57.8 mtm -70.14 -62.58 1.33 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.444 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 17' ' ' MET . . . . . 0.582 ' HG3' ' O ' ' K' ' 13' ' ' ALA . 40.6 mtm -63.09 -51.47 66.45 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.405 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 18' ' ' GLY . . . . . 0.455 ' O ' ' CG2' ' K' ' 22' ' ' ILE . . . -54.63 -37.06 60.18 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.587 -1.292 . . . . 0.0 111.595 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 19' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' K' ' 15' ' ' VAL . 24.5 tp -79.56 -38.43 34.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 20' ' ' ALA . . . . . 0.576 ' HB2' ' CB ' ' K' ' 65' ' ' MET . . . -85.68 -35.95 20.57 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.609 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 21' ' ' ALA . . . . . 0.576 ' HA ' ' CB ' ' K' ' 62' ' ' ALA . . . -62.54 -43.7 98.16 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 22' ' ' ILE . . . . . 0.517 ' CD1' ' N ' ' K' ' 23' ' ' GLY . 2.6 pp -65.27 -40.56 88.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 23' ' ' GLY . . . . . 0.517 ' N ' ' CD1' ' K' ' 22' ' ' ILE . . . -61.05 -29.27 70.5 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 177.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 24' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' K' ' 58' ' ' GLY . . . -73.26 -56.63 4.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.052 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.5 -54.4 18.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.216 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.11 -56.42 8.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.717 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 27' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' K' ' 31' ' ' LEU . . . -48.0 -54.03 13.01 Favored Glycine 0 CA--C 1.509 -0.322 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.922 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 28' ' ' ILE . . . . . 0.441 HG13 ' O ' ' K' ' 24' ' ' ALA . 68.5 mt -49.92 -34.31 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.301 0.572 . . . . 0.0 109.461 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.72 -34.4 28.02 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.32 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mm -77.16 -62.02 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.981 0.419 . . . . 0.0 110.439 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 31' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' K' ' 54' ' ' PHE . 0.5 OUTLIER -61.0 -43.12 99.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.808 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.97 -50.44 67.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.837 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.28 -52.0 24.53 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.838 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.81 -42.16 88.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.636 0.255 . . . . 0.0 111.392 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 35' ' ' PHE . . . . . 0.492 ' CZ ' ' HD2' ' K' ' 50' ' ' ARG . 60.0 t80 -58.7 -47.39 84.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.802 0.334 . . . . 0.0 110.908 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 36' ' ' LEU . . . . . 0.428 HD22 ' CD1' ' J' ' 35' ' ' PHE . 64.2 tp -55.23 -44.26 75.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.049 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.33 -31.42 67.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.022 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.0 24.17 27.86 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.717 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.28 31.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.764 0.316 . . . . 0.0 111.328 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.34 -34.35 21.85 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.024 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 41' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' K' ' 41' ' ' ARG . 0.4 OUTLIER -67.83 -47.3 69.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 42' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -58.09 163.56 4.3 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 43' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' K' ' 47' ' ' PRO . 52.3 Cg_exo -53.23 161.39 3.74 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.498 2.132 . . . . 0.0 111.972 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.65 30.92 1.9 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.853 0.359 . . . . 0.0 110.813 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.71 -60.59 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.354 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 46' ' ' ILE . . . . . 0.484 ' N ' ' HD2' ' K' ' 47' ' ' PRO . 1.7 mp -76.38 -54.57 1.86 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.891 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 47' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' K' ' 46' ' ' ILE . 29.0 Cg_endo -63.22 -32.57 73.62 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 121.866 1.711 . . . . 0.0 112.391 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -61.15 -34.39 74.94 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 49' ' ' LEU . . . . . 0.406 ' O ' ' CG ' ' K' ' 52' ' ' GLN . 0.3 OUTLIER -75.33 -42.11 55.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.401 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 50' ' ' ARG . . . . . 0.492 ' HD2' ' CZ ' ' K' ' 35' ' ' PHE . 0.0 OUTLIER -73.42 -35.92 65.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.937 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 51' ' ' THR . . . . . 0.448 ' HA ' ' CD2' ' K' ' 35' ' ' PHE . 53.6 m -59.35 -46.61 88.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.562 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 52' ' ' GLN . . . . . 0.512 ' HA ' HG12 ' K' ' 55' ' ' ILE . 15.4 pt20 -61.76 -45.15 95.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.184 0.516 . . . . 0.0 109.809 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.29 -36.95 22.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.454 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 54' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' K' ' 31' ' ' LEU . 8.8 m-85 -77.7 -69.55 0.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.018 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 55' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' K' ' 52' ' ' GLN . 29.0 pt -44.62 -33.9 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.768 0.318 . . . . 0.0 110.914 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 56' ' ' VAL . . . . . . . . . . . . . 93.0 t -76.78 -46.09 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 57' ' ' MET . . . . . 0.439 ' HE1' ' CE2' ' L' ' 53' ' ' PHE . 49.3 ttm -50.63 -29.51 11.18 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 58' ' ' GLY . . . . . 0.52 ' O ' ' HB1' ' K' ' 24' ' ' ALA . . . -84.61 -33.63 18.61 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 59' ' ' LEU . . . . . . . . . . . . . 45.4 tp -73.05 -7.55 51.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.979 0.418 . . . . 0.0 110.237 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 60' ' ' VAL . . . . . 0.5 ' O ' ' HD3' ' K' ' 64' ' ' PRO . 65.3 t -109.51 -1.38 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.854 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 61' ' ' ASP . . . . . 0.457 ' HB3' ' HB1' ' K' ' 24' ' ' ALA . 38.6 t70 -81.45 -23.5 37.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.929 0.395 . . . . 0.0 110.615 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 62' ' ' ALA . . . . . 0.576 ' CB ' ' HA ' ' K' ' 21' ' ' ALA . . . -88.66 -42.1 12.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.549 0.69 . . . . 0.0 110.032 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 63' ' ' ILE . . . . . 0.576 ' N ' ' CD ' ' K' ' 64' ' ' PRO . 2.4 mm -47.13 -34.5 4.41 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.788 -1.096 . . . . 0.0 113.526 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 64' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' K' ' 63' ' ' ILE . 3.6 Cg_exo -78.35 -54.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.948 1.765 . . . . 0.0 111.619 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 65' ' ' MET . . . . . 0.615 ' HG2' ' O ' ' K' ' 16' ' ' MET . 2.0 tpt -52.81 -37.39 59.85 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 66' ' ' ILE . . . . . 0.515 ' HA ' ' HG2' ' K' ' 17' ' ' MET . 75.4 mt -66.18 -54.46 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.58 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.24 -31.48 61.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 68' ' ' VAL . . . . . . . . . . . . . 55.5 t -75.61 -44.02 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.866 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.72 -35.76 91.42 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 70' ' ' LEU . . . . . 0.441 ' O ' ' CG2' ' K' ' 74' ' ' VAL . 0.5 OUTLIER -67.29 -38.04 84.38 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.695 178.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 71' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' K' ' 75' ' ' MET . . . -64.96 -60.7 6.55 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 72' ' ' LEU . . . . . . . . . . . . . 58.9 mt -52.23 -34.5 46.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.481 0.658 . . . . 0.0 109.605 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 73' ' ' TYR . . . . . 0.578 ' CE2' ' CE2' ' K' ' 10' ' ' TYR . 10.7 t80 -71.23 -46.95 60.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.526 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 74' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' K' ' 70' ' ' LEU . 92.7 t -62.42 -26.19 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.846 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 75' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' K' ' 71' ' ' GLY . 89.3 mtp -63.73 -50.02 70.75 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 76' ' ' PHE . . . . . 0.448 ' CG ' ' HE1' ' K' ' 10' ' ' TYR . 2.4 t80 -52.97 -35.96 59.55 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.29 -32.53 68.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.09 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.24 -32.68 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.102 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.664 0.269 . . . . 1.0 111.539 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 2' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -43.17 -37.69 2.18 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -64.07 -66.28 0.56 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.412 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 4' ' ' LEU . . . . . 0.535 ' HA ' ' OD1' ' L' ' 7' ' ' ASP . 85.7 mt -62.52 -19.82 64.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.985 0.422 . . . . 0.0 110.403 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 5' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -66.92 -65.15 0.72 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.158 0.504 . . . . 0.0 110.299 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 6' ' ' MET . . . . . . . . . . . . . 21.4 ptp -58.51 -33.92 70.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.465 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 7' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' L' ' 4' ' ' LEU . 0.0 OUTLIER -72.24 -47.73 48.05 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.738 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 8' ' ' LEU . . . . . 0.44 ' N ' ' OD1' ' L' ' 7' ' ' ASP . 57.2 mt -64.07 -42.28 97.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.89 0.376 . . . . 0.0 110.6 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 9' ' ' LEU . . . . . 0.407 ' CD1' ' HG3' ' L' ' 75' ' ' MET . 53.5 tp -56.93 -59.3 5.26 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.955 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 10' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -52.98 -56.9 12.6 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.563 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 11' ' ' MET . . . . . . . . . . . . . 21.1 ttt -52.72 -27.17 16.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.423 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 12' ' ' ALA . . . . . 0.748 ' O ' ' HB2' ' L' ' 16' ' ' MET . . . -65.2 -50.77 64.59 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 13' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' L' ' 17' ' ' MET . . . -56.32 -38.56 71.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.447 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.99 -44.56 39.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.413 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 15' ' ' VAL . . . . . 0.444 ' O ' HD22 ' L' ' 19' ' ' LEU . 60.3 t -70.41 -44.38 77.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.072 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 16' ' ' MET . . . . . 0.748 ' HB2' ' O ' ' L' ' 12' ' ' ALA . 1.3 tmm? -66.49 -53.29 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.531 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 17' ' ' MET . . . . . 0.547 ' O ' ' CB ' ' L' ' 21' ' ' ALA . 11.3 mmt -68.31 -44.61 75.03 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.589 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 18' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' L' ' 22' ' ' ILE . . . -68.94 -33.41 74.79 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 118.395 -1.86 . . . . 0.0 111.555 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 19' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' L' ' 16' ' ' MET . 2.1 pp -74.34 -45.29 48.14 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.456 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 20' ' ' ALA . . . . . 0.458 ' N ' ' CD1' ' L' ' 19' ' ' LEU . . . -76.1 -36.07 59.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 120.885 0.374 . . . . 0.0 110.745 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 21' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' L' ' 17' ' ' MET . . . -64.43 -41.93 96.31 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.878 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 22' ' ' ILE . . . . . 0.528 ' N ' HD11 ' L' ' 22' ' ' ILE . 1.5 mp -65.96 -46.83 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.76 68.47 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.85 -65.59 0.65 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.462 -0.869 . . . . 0.0 110.44 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 25' ' ' ALA . . . . . 0.486 ' O ' HG21 ' L' ' 28' ' ' ILE . . . -46.64 -53.5 11.45 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.035 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 26' ' ' ILE . . . . . 0.451 HD12 HG23 ' L' ' 26' ' ' ILE . 73.9 mt -51.02 -55.75 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 121.079 -0.249 . . . . 0.0 110.857 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 27' ' ' GLY . . . . . 0.427 ' HA2' ' HB ' ' L' ' 30' ' ' ILE . . . -53.05 -49.45 55.52 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.599 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 28' ' ' ILE . . . . . 0.694 HG23 ' N ' ' L' ' 29' ' ' GLY . 4.6 tp -50.13 -42.28 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 29' ' ' GLY . . . . . 0.694 ' N ' HG23 ' L' ' 28' ' ' ILE . . . -68.34 -42.87 81.29 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.588 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 30' ' ' ILE . . . . . 0.427 ' HB ' ' HA2' ' L' ' 27' ' ' GLY . 35.8 mm -66.1 -70.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 122.966 0.506 . . . . 0.0 111.161 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 31' ' ' LEU . . . . . 0.459 ' HA ' ' HG2' ' L' ' 34' ' ' LYS . 52.0 tp -61.3 -38.06 85.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.988 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.73 -46.27 93.66 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.396 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.65 -58.98 11.46 Favored Glycine 0 C--O 1.241 0.569 0 C-N-CA 119.733 -1.222 . . . . 0.0 111.862 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 34' ' ' LYS . . . . . 0.459 ' HG2' ' HA ' ' L' ' 31' ' ' LEU . 17.8 ptpt -55.96 -50.9 69.52 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.44 0.638 . . . . 0.0 110.936 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 35' ' ' PHE . . . . . 0.418 ' N ' ' HG3' ' L' ' 34' ' ' LYS . 28.9 t80 -52.4 -54.82 27.02 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.858 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 36' ' ' LEU . . . . . 0.42 ' CD1' HD11 ' L' ' 49' ' ' LEU . 18.6 tp -45.61 -53.07 9.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.135 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 37' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -52.03 -45.23 64.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.39 -64.87 2.38 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.186 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 39' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' L' ' 45' ' ' LEU . . . -50.28 -29.11 8.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.795 -0.202 . . . . 0.0 111.537 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 40' ' ' ALA . . . . . 0.457 ' HB3' HD21 ' L' ' 49' ' ' LEU . . . -87.39 -38.53 16.08 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.721 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 41' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -56.17 -32.88 64.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.37 0.605 . . . . 0.0 109.606 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 42' ' ' GLN . . . . . 0.604 ' HB3' ' HD2' ' L' ' 43' ' ' PRO . 81.0 mt-30 -52.25 164.96 0.55 Allowed Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.738 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 43' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' L' ' 42' ' ' GLN . 80.8 Cg_exo -44.13 -67.4 0.12 Allowed 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 124.296 3.331 . . . . 0.0 114.219 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 44' ' ' ASP . . . . . 0.415 ' HA ' HD12 ' L' ' 46' ' ' ILE . 9.9 t70 -146.74 55.54 1.13 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.729 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 45' ' ' LEU . . . . . 0.701 ' O ' ' HB3' ' L' ' 48' ' ' LEU . 6.5 mp -110.78 12.16 22.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.299 0.571 . . . . 0.0 110.664 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 46' ' ' ILE . . . . . 0.628 ' N ' ' HD2' ' L' ' 47' ' ' PRO . 1.8 mp -47.71 -50.22 52.83 Favored Pre-proline 0 C--O 1.226 -0.145 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 47' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' L' ' 46' ' ' ILE . 19.1 Cg_endo -60.77 -32.09 92.56 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.607 1.538 . . . . 0.0 110.374 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 48' ' ' LEU . . . . . 0.701 ' HB3' ' O ' ' L' ' 45' ' ' LEU . 11.0 tp -55.31 -39.82 70.38 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 49' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' L' ' 46' ' ' ILE . 90.5 mt -44.81 -66.76 0.35 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.345 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 50' ' ' ARG . . . . . 0.444 ' O ' ' CD2' ' L' ' 54' ' ' PHE . 99.4 mtt180 -64.08 -54.52 32.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.791 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 51' ' ' THR . . . . . . . . . . . . . 85.3 m -46.65 -42.27 16.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.566 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 52' ' ' GLN . . . . . 0.565 ' O ' HG21 ' L' ' 55' ' ' ILE . 26.7 mt-30 -90.01 -17.21 28.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.836 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 53' ' ' PHE . . . . . 0.439 ' CE2' ' HE1' ' K' ' 57' ' ' MET . 40.5 t80 -63.64 -46.39 85.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.332 0.587 . . . . 0.0 109.793 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 54' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' M' ' 206' ' ' SER . 37.7 m-85 -63.86 -41.67 97.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.094 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 55' ' ' ILE . . . . . 0.565 HG21 ' O ' ' L' ' 52' ' ' GLN . 11.0 tt -70.73 -45.53 73.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.859 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 56' ' ' VAL . . . . . 0.469 ' O ' ' CG2' ' L' ' 60' ' ' VAL . 64.1 t -65.25 -31.03 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.044 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 57' ' ' MET . . . . . 0.408 ' HA ' ' CD1' ' L' ' 28' ' ' ILE . 25.5 ttt -72.76 -56.18 5.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.522 0.677 . . . . 0.0 110.137 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 58' ' ' GLY . . . . . 0.413 ' HA3' ' CD2' ' M' ' 209' ' ' LEU . . . -55.28 -40.16 74.67 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.588 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 59' ' ' LEU . . . . . . . . . . . . . 76.9 mt -65.65 -27.95 68.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.76 0.314 . . . . 0.0 110.862 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 60' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' L' ' 56' ' ' VAL . 81.7 t -77.75 -37.17 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.93 0.395 . . . . 0.0 110.142 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -78.2 -31.39 49.46 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.831 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 62' ' ' ALA . . . . . 0.491 ' O ' HG12 ' L' ' 66' ' ' ILE . . . -50.33 -24.66 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.568 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 63' ' ' ILE . . . . . 0.585 ' HB ' ' HD3' ' L' ' 64' ' ' PRO . 44.0 mt -62.14 -82.88 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.324 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 64' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' L' ' 63' ' ' ILE . 75.6 Cg_exo -50.55 -30.13 27.03 Favored 'Trans proline' 0 C--N 1.359 1.118 0 CA-C-N 121.17 1.454 . . . . 0.0 111.643 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 65' ' ' MET . . . . . . . . . . . . . 46.9 tpp -60.66 -37.23 80.85 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.626 0.727 . . . . 0.0 109.493 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 66' ' ' ILE . . . . . 0.491 HG12 ' O ' ' L' ' 62' ' ' ALA . 9.4 mm -74.98 -37.69 41.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.819 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 67' ' ' ALA . . . . . 0.472 ' CB ' ' HE1' ' L' ' 17' ' ' MET . . . -69.52 -29.9 67.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.373 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 68' ' ' VAL . . . . . 0.438 ' O ' ' HG ' ' L' ' 72' ' ' LEU . 47.2 t -72.48 -55.53 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.35 -51.28 60.06 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 119.855 -1.164 . . . . 0.0 111.586 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 tt -67.31 -38.61 85.23 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.109 0.481 . . . . 0.0 110.096 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 71' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' L' ' 75' ' ' MET . . . -62.58 -60.88 7.14 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.444 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 72' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' L' ' 68' ' ' VAL . 3.9 pp -61.69 -31.38 71.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.912 0.387 . . . . 0.0 110.716 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 73' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -50.15 -42.17 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.908 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 74' ' ' VAL . . . . . . . . . . . . . 14.9 p -111.6 -14.66 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.807 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 75' ' ' MET . . . . . 0.526 ' HB2' ' O ' ' L' ' 71' ' ' GLY . 0.1 OUTLIER -84.36 -87.09 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 110.383 179.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 76' ' ' PHE . . . . . 0.468 ' HB3' HD13 ' M' ' 224' ' ' LEU . 46.1 m-85 -54.05 -29.01 42.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.611 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.15 -80.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 111.447 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 78' ' ' VAL . . . . . . . . . . . . . 45.7 t -61.98 -22.29 28.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.336 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 79' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' L' ' 75' ' ' MET . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.053 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 95' ' ' HIS . . . . . . . . . . . . . 17.8 m80 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.762 0.315 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' M' M ' 96' ' ' GLY . . . . . . . . . . . . . . . -113.76 128.83 8.48 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.444 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 97' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' M' ' 97' ' ' LYS . 0.7 OUTLIER -67.82 -79.67 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.72 0.295 . . . . 0.0 110.798 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' M' M ' 98' ' ' SER . . . . . . . . . . . . . 47.7 t -56.87 -22.66 38.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.091 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 99' ' ' LYS . . . . . 0.551 ' O ' ' HD3' ' M' ' 103' ' ' PRO . 1.0 OUTLIER -61.52 -63.81 1.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.596 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' M' M ' 100' ' ' LEU . . . . . 0.741 ' O ' ' HD2' ' M' ' 103' ' ' PRO . 3.6 pp -61.29 -36.94 81.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.886 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 101' ' ' ILE . . . . . 0.461 ' N ' HD11 ' M' ' 100' ' ' LEU . 39.0 mm -61.14 -40.92 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 102' ' ' ALA . . . . . 0.425 ' N ' ' CD ' ' M' ' 103' ' ' PRO . . . -60.93 -45.36 96.63 Favored Pre-proline 0 N--CA 1.471 0.598 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 103' ' ' PRO . . . . . 0.741 ' HD2' ' O ' ' M' ' 100' ' ' LEU . 10.1 Cg_exo -72.91 -42.0 1.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.445 2.097 . . . . 0.0 112.375 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 104' ' ' LEU . . . . . 0.407 HD12 ' O ' ' M' ' 100' ' ' LEU . 9.7 mp -62.06 -42.26 99.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.008 0.432 . . . . 0.0 110.595 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 105' ' ' ALA . . . . . 0.454 ' O ' HG12 ' M' ' 108' ' ' ILE . . . -62.2 -41.67 98.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.577 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 106' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.98 -41.31 97.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.394 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 107' ' ' THR . . . . . 0.42 ' O ' ' CG1' ' M' ' 110' ' ' VAL . 74.1 p -61.71 -43.4 98.92 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 108' ' ' ILE . . . . . 0.454 HG12 ' O ' ' M' ' 105' ' ' ALA . 28.8 pt -63.85 -42.98 97.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.747 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 109' ' ' PHE . . . . . 0.424 ' HD1' HG13 ' M' ' 108' ' ' ILE . 13.9 m-85 -62.7 -42.84 99.85 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.798 0.332 . . . . 0.0 111.851 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 110' ' ' VAL . . . . . 0.427 HG12 ' N ' ' M' ' 111' ' ' TRP . 7.1 p -62.97 -41.05 91.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 111' ' ' TRP . . . . . 0.427 ' N ' HG12 ' M' ' 110' ' ' VAL . 2.6 t-105 -61.61 -44.41 97.04 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.39 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 112' ' ' VAL . . . . . 0.446 HG13 ' N ' ' M' ' 113' ' ' PHE . 7.4 p -63.2 -41.35 92.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.362 0.601 . . . . 0.0 109.812 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 113' ' ' PHE . . . . . 0.446 ' N ' HG13 ' M' ' 112' ' ' VAL . 5.8 t80 -61.69 -38.86 89.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.112 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 114' ' ' LEU . . . . . . . . . . . . . 48.8 tp -59.21 -42.07 90.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.13 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 115' ' ' MET . . . . . 0.416 ' HE2' ' CD1' ' M' ' 111' ' ' TRP . 65.4 mtt -61.88 -43.68 98.34 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.334 0.588 . . . . 0.0 109.835 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 116' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -62.43 -39.24 92.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.881 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 117' ' ' LEU . . . . . . . . . . . . . 63.6 tp -60.47 -40.82 92.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.061 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 118' ' ' MET . . . . . 0.434 ' O ' ' CD ' ' M' ' 122' ' ' PRO . 26.4 ttt -60.89 -44.58 96.92 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.263 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 119' ' ' ASP . . . . . 0.561 ' O ' ' HD2' ' M' ' 122' ' ' PRO . 1.7 m-20 -64.38 -37.87 89.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.559 0.695 . . . . 0.0 110.465 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 120' ' ' LEU . . . . . 0.446 ' HA ' ' CG2' ' M' ' 123' ' ' ILE . 56.8 tp -61.49 -39.32 90.54 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 121' ' ' LEU . . . . . 0.528 ' N ' ' HD2' ' M' ' 122' ' ' PRO . 54.0 tp -59.35 -44.94 98.95 Favored Pre-proline 0 N--CA 1.468 0.457 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 122' ' ' PRO . . . . . 0.561 ' HD2' ' O ' ' M' ' 119' ' ' ASP . 58.1 Cg_endo -72.07 -41.7 1.86 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 121.933 1.756 . . . . 0.0 112.25 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 123' ' ' ILE . . . . . 0.446 ' CG2' ' HA ' ' M' ' 120' ' ' LEU . 6.2 tp -61.07 -42.08 91.77 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.183 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 124' ' ' ASP . . . . . 0.569 ' O ' ' HD2' ' M' ' 127' ' ' PRO . 39.3 m-20 -62.79 -38.63 91.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.026 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 125' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.19 -40.13 95.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 126' ' ' LEU . . . . . 0.513 ' N ' ' HD2' ' M' ' 127' ' ' PRO . 60.5 tp -58.59 -44.53 99.16 Favored Pre-proline 0 N--CA 1.47 0.543 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 127' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' M' ' 124' ' ' ASP . 91.0 Cg_exo -40.1 -39.51 2.46 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.79 2.326 . . . . 0.0 112.721 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 128' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -111.16 110.66 21.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.828 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 129' ' ' ILE . . . . . . . . . . . . . 28.6 pt -107.43 166.19 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.231 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 130' ' ' ALA . . . . . . . . . . . . . . . -147.43 -65.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.028 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -123.94 155.15 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.803 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 132' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -162.03 91.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.083 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 133' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' M' ' 133' ' ' VAL . 12.6 p -104.31 25.12 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 134' ' ' LEU . . . . . . . . . . . . . 84.2 mt 66.57 -64.83 0.22 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.602 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.38 -78.22 0.17 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.378 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 136' ' ' LEU . . . . . 0.609 ' HB3' ' HD3' ' M' ' 137' ' ' PRO . 58.8 tp -41.74 -49.6 10.18 Favored Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 137' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' M' ' 136' ' ' LEU . 57.1 Cg_exo -51.66 -64.09 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.303 2.002 . . . . 0.0 112.668 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.49 95.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.677 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 139' ' ' LEU . . . . . 0.553 ' O ' ' HD3' ' M' ' 143' ' ' PRO . 4.3 mm? -60.81 -41.83 96.46 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.747 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 140' ' ' ARG . . . . . 0.727 ' O ' ' HD2' ' M' ' 143' ' ' PRO . 16.9 tpp85 -63.29 -39.24 94.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.25 0.548 . . . . 0.0 111.281 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 141' ' ' VAL . . . . . 0.452 ' CG1' ' CD1' ' M' ' 223' ' ' ILE . 21.2 t -62.83 -41.22 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 142' ' ' VAL . . . . . 0.515 ' HB ' ' HD3' ' M' ' 143' ' ' PRO . 48.7 t -59.09 -45.35 99.44 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.328 -177.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 143' ' ' PRO . . . . . 0.727 ' HD2' ' O ' ' M' ' 140' ' ' ARG . 16.7 Cg_exo -66.69 -39.09 16.29 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.468 2.112 . . . . 0.0 110.722 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 144' ' ' SER . . . . . . . . . . . . . 52.8 m -59.23 -41.85 89.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.695 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.47 -42.16 98.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.083 0.468 . . . . 0.0 109.978 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 146' ' ' ASP . . . . . 0.419 ' O ' HG13 ' M' ' 149' ' ' VAL . 23.5 m-20 -61.68 -41.18 97.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.448 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 147' ' ' VAL . . . . . . . . . . . . . 49.1 t -61.93 -41.4 90.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.407 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 148' ' ' ASN . . . . . 0.421 ' HB3' ' HG3' ' M' ' 118' ' ' MET . 5.2 m120 -61.88 -43.08 99.58 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 149' ' ' VAL . . . . . 0.465 HG12 ' N ' ' M' ' 150' ' ' THR . 7.5 p -62.34 -41.63 92.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.906 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 150' ' ' THR . . . . . 0.465 ' N ' HG12 ' M' ' 149' ' ' VAL . 80.7 p -62.14 -40.9 97.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.093 0.473 . . . . 0.0 110.317 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 151' ' ' LEU . . . . . 0.42 ' CD2' ' C ' ' M' ' 151' ' ' LEU . 5.5 tt -61.0 -41.16 95.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.05 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 152' ' ' SER . . . . . . . . . . . . . 90.9 p -60.89 -41.71 96.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.835 0.35 . . . . 0.0 110.602 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 153' ' ' MET . . . . . . . . . . . . . 57.5 ttp -61.35 -41.24 96.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.087 0.47 . . . . 0.0 110.319 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.56 94.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.138 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 155' ' ' LEU . . . . . 0.409 ' C ' ' CD1' ' M' ' 155' ' ' LEU . 3.0 tm? -60.51 -41.55 94.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.506 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 156' ' ' GLY . . . . . 0.457 ' O ' ' CG2' ' M' ' 159' ' ' ILE . . . -61.39 -41.6 99.57 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.927 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 157' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.47 -40.71 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.869 0.366 . . . . 0.0 110.879 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 158' ' ' PHE . . . . . 0.475 ' O ' HG12 ' M' ' 161' ' ' ILE . 3.5 t80 -61.37 -42.45 98.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.78 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 159' ' ' ILE . . . . . 0.457 ' CG2' ' O ' ' M' ' 156' ' ' GLY . 6.5 tp -63.26 -41.77 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.386 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 160' ' ' LEU . . . . . 0.437 HD21 HG22 ' M' ' 159' ' ' ILE . 4.5 mm? -62.41 -42.68 99.62 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 161' ' ' ILE . . . . . 0.475 HG12 ' O ' ' M' ' 158' ' ' PHE . 28.1 pt -61.81 -40.4 86.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.22 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 162' ' ' LEU . . . . . . . . . . . . . 88.1 mt -60.82 -41.17 95.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.889 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 163' ' ' PHE . . . . . 0.443 ' O ' ' CG2' ' M' ' 166' ' ' ILE . 48.1 t80 -61.17 -42.02 97.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.18 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 164' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -62.67 -41.45 99.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.713 0.292 . . . . 0.0 111.629 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 165' ' ' SER . . . . . . . . . . . . . 83.6 p -61.74 -42.35 98.84 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 166' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' M' ' 163' ' ' PHE . 7.1 tp -61.68 -38.85 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.711 0.291 . . . . 0.0 111.146 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 167' ' ' LYS . . . . . 0.432 ' N ' HG22 ' M' ' 166' ' ' ILE . 54.8 mtpt -63.99 109.86 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 0.0 110.937 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 168' ' ' MET . . . . . . . . . . . . . 26.5 mmt 60.92 169.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 169' ' ' LYS . . . . . 0.405 ' HD3' ' C ' ' M' ' 169' ' ' LYS . 5.1 tmtm? . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.311 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 199' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.849 0.357 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' M' M ' 200' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.2 -24.28 64.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.036 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 201' ' ' LEU . . . . . 0.687 ' C ' ' HD2' ' M' ' 204' ' ' PRO . 2.2 pt? -113.6 -29.14 7.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.582 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 202' ' ' SER . . . . . 0.434 ' HB3' ' CE2' ' L' ' 54' ' ' PHE . 56.4 m -63.14 -42.94 99.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 203' ' ' LYS . . . . . 0.538 ' HB2' ' HD3' ' M' ' 204' ' ' PRO . 63.8 mttp -62.49 -46.09 89.4 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.7 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 204' ' ' PRO . . . . . 0.687 ' HD2' ' C ' ' M' ' 201' ' ' LEU . 41.6 Cg_exo -56.48 -41.76 72.75 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.188 1.926 . . . . 0.0 111.715 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 205' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.48 -41.15 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.384 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 206' ' ' SER . . . . . 0.564 ' HB2' ' CD1' ' L' ' 54' ' ' PHE . 37.2 t -61.5 -42.97 99.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.898 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 207' ' ' LEU . . . . . 0.406 HD23 ' O ' ' M' ' 203' ' ' LYS . 3.8 mm? -61.91 -41.46 97.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.118 0.485 . . . . 0.0 110.347 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 208' ' ' GLY . . . . . 0.479 ' O ' ' HG ' ' M' ' 211' ' ' LEU . . . -61.37 -40.69 98.99 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.425 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 209' ' ' LEU . . . . . 0.413 ' CD2' ' HA3' ' L' ' 58' ' ' GLY . 41.1 tp -62.16 -43.51 98.67 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 210' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -63.6 -46.52 85.42 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.545 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 211' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' M' ' 212' ' ' PHE . 4.0 pp -65.32 -40.88 94.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.44 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 212' ' ' PHE . . . . . 0.485 ' N ' ' CD1' ' M' ' 211' ' ' LEU . 7.1 t80 -61.05 -43.55 98.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.639 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.89 -44.6 95.86 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.768 -1.206 . . . . 0.0 112.435 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 214' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -64.48 -42.95 95.58 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 215' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' M' ' 212' ' ' PHE . 16.6 ptp -62.33 -42.85 99.72 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 216' ' ' TYR . . . . . 0.439 ' O ' HD22 ' M' ' 220' ' ' LEU . 49.4 t80 -62.35 -44.74 95.78 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.688 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 217' ' ' ALA . . . . . 0.422 ' O ' ' CG2' ' M' ' 221' ' ' ILE . . . -63.61 -43.28 97.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.133 0.492 . . . . 0.0 110.571 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 218' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' M' ' 222' ' ' PHE . . . -62.92 -42.26 99.71 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.407 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 219' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.23 -46.81 87.2 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.276 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 220' ' ' LEU . . . . . 0.473 ' O ' HG21 ' M' ' 223' ' ' ILE . 3.4 mm? -68.29 -48.14 65.75 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 221' ' ' ILE . . . . . 0.435 ' O ' ' HG ' ' M' ' 224' ' ' LEU . 9.7 tt -66.68 -44.17 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 222' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' M' ' 218' ' ' GLY . 5.6 m-85 -64.29 -42.63 96.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 223' ' ' ILE . . . . . 0.473 HG21 ' O ' ' M' ' 220' ' ' LEU . 9.2 tt -63.25 -45.05 99.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 224' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' M' ' 225' ' ' ILE . 4.4 pp -64.55 -43.66 93.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.798 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 225' ' ' ILE . . . . . 0.483 ' N ' ' CD1' ' M' ' 224' ' ' LEU . 7.7 tp -63.39 -41.78 93.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.855 0.36 . . . . 0.0 111.694 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 226' ' ' ALA . . . . . 0.546 ' O ' ' CD ' ' M' ' 230' ' ' PRO . . . -60.7 -42.08 96.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.396 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 227' ' ' GLY . . . . . 0.554 ' O ' ' HD2' ' M' ' 230' ' ' PRO . . . -63.95 -41.54 98.63 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.422 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 228' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.82 -42.18 97.7 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 229' ' ' LEU . . . . . 0.451 HD23 ' O ' ' M' ' 225' ' ' ILE . 4.4 mm? -61.48 -44.79 93.43 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 230' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' M' ' 227' ' ' GLY . 68.0 Cg_endo -96.93 -178.76 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.122 2.548 . . . . 0.0 113.149 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 231' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -101.24 -41.21 6.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.042 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 232' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -89.23 66.64 7.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.018 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 233' ' ' SER . . . . . 0.547 ' O ' ' CB ' ' M' ' 237' ' ' LEU . 54.7 m -47.83 -25.36 1.26 Allowed 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.903 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 234' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -51.4 -93.52 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.16 -0.337 . . . . 0.0 111.536 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 235' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -69.01 -38.21 79.11 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 236' ' ' ILE . . . . . 0.512 ' O ' ' CD ' ' M' ' 240' ' ' PRO . 48.5 mm -61.0 -44.42 98.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.993 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 237' ' ' LEU . . . . . 0.554 ' O ' ' HD2' ' M' ' 240' ' ' PRO . 5.4 tt -65.83 -41.67 91.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 0.0 111.931 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 238' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -62.37 -43.0 99.85 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 239' ' ' VAL . . . . . 0.473 ' HB ' ' HD3' ' M' ' 240' ' ' PRO . 41.8 t -62.57 -45.62 88.9 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 240' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' M' ' 237' ' ' LEU . 4.8 Cg_exo -78.82 -41.25 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.7 2.267 . . . . 0.0 112.306 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 241' ' ' TRP . . . . . 0.404 ' NE1' ' HB ' ' M' ' 223' ' ' ILE . 10.8 t90 -62.07 -44.58 96.37 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.082 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 242' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.32 80.32 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 243' ' ' ILE . . . . . 0.483 HG23 ' O ' ' M' ' 240' ' ' PRO . 5.6 tp -64.82 -42.85 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 244' ' ' PHE . . . . . 0.463 ' HB3' ' CD2' ' M' ' 222' ' ' PHE . 4.7 m-85 -64.16 -43.62 94.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 245' ' ' HIS . . . . . 0.419 ' O ' HG12 ' M' ' 248' ' ' ILE . 77.2 t60 -62.78 -42.88 99.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.805 0.336 . . . . 0.0 111.42 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 246' ' ' ILE . . . . . 0.494 ' O ' HG13 ' M' ' 249' ' ' ILE . 6.8 tp -62.98 -40.79 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.779 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 247' ' ' LEU . . . . . 0.427 ' C ' ' CD1' ' M' ' 247' ' ' LEU . 3.1 tm? -62.53 -44.21 96.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 248' ' ' ILE . . . . . 0.419 HG12 ' O ' ' M' ' 245' ' ' HIS . 25.5 pt -64.05 -44.82 97.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 249' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' M' ' 250' ' ' THR . 2.4 pp -63.32 -39.32 84.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.04 0.448 . . . . 0.0 110.581 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 250' ' ' THR . . . . . 0.511 ' N ' ' CD1' ' M' ' 249' ' ' ILE . 92.2 m -61.6 -41.15 97.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.385 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 251' ' ' LEU . . . . . 0.428 ' C ' ' CD2' ' M' ' 251' ' ' LEU . 5.2 tt -61.22 -44.75 96.77 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.101 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 252' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' M' ' 211' ' ' LEU . 7.9 mm100 -63.63 -41.57 98.25 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.977 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.37 94.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.946 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 254' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -59.25 -41.18 88.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.333 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' M' M ' 255' ' ' ILE . . . . . 0.411 ' O ' ' CG2' ' M' ' 258' ' ' VAL . 49.4 mm -61.1 -41.05 87.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.119 0.485 . . . . 0.0 110.145 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 256' ' ' PHE . . . . . 0.404 ' O ' ' CD1' ' M' ' 256' ' ' PHE . 1.5 t80 -61.8 -41.83 98.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.117 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 257' ' ' MET . . . . . 0.409 ' O ' ' CG2' ' M' ' 260' ' ' THR . 95.2 mmm -61.67 -43.04 99.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 258' ' ' VAL . . . . . 0.446 HG21 ' N ' ' M' ' 259' ' ' LEU . 28.8 m -63.13 -40.89 90.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.569 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 259' ' ' LEU . . . . . 0.446 ' N ' HG21 ' M' ' 258' ' ' VAL . 5.6 tt -62.85 -43.08 99.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.749 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 260' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' M' ' 257' ' ' MET . 6.3 t -63.59 -42.99 98.21 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 261' ' ' ILE . . . . . 0.423 HG12 ' O ' ' M' ' 258' ' ' VAL . 29.0 pt -63.02 -42.47 96.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 262' ' ' VAL . . . . . 0.447 HG13 ' N ' ' M' ' 263' ' ' TYR . 7.3 p -62.24 -39.41 83.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 111.294 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 263' ' ' TYR . . . . . 0.447 ' N ' HG13 ' M' ' 262' ' ' VAL . 5.5 t80 -60.83 -40.65 93.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.846 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 264' ' ' LEU . . . . . 0.421 ' C ' ' CD2' ' M' ' 264' ' ' LEU . 5.2 tt -87.04 110.7 20.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.561 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' M' M ' 265' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.889 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.58 0.229 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.7 -29.48 0.77 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.367 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -71.01 -62.85 1.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.081 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 4' ' ' LEU . 3.0 mm? -65.59 -17.94 64.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 109.953 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.61 -71.78 0.17 Allowed 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.525 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.17 -21.96 60.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.661 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' HD11 ' L' ' 8' ' ' LEU . 37.7 t70 -77.27 -44.85 28.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.26 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.754 HD22 ' CE ' ' A' ' 11' ' ' MET . 0.7 OUTLIER -75.04 -40.04 60.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.976 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.815 HD13 ' HB2' ' A' ' 76' ' ' PHE . 6.8 tt -56.11 -59.11 5.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.551 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.578 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 14.8 m-85 -56.2 -54.15 48.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.201 0.524 . . . . 0.0 110.119 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.754 ' CE ' HD22 ' A' ' 8' ' ' LEU . 57.2 ttp -54.46 -20.14 7.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.166 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -70.57 -54.2 13.03 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.032 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.634 ' O ' ' HE2' ' A' ' 17' ' ' MET . . . -62.91 -19.19 63.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.786 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.69 -39.18 11.98 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.529 0.68 . . . . 0.0 109.49 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 11' ' ' MET . 46.0 t -74.89 -37.06 41.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.146 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.896 ' CE ' HD12 ' A' ' 72' ' ' LEU . 57.8 mtm -70.24 -62.52 1.36 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.419 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.634 ' HE2' ' O ' ' A' ' 13' ' ' ALA . 40.6 mtm -63.1 -51.49 66.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.397 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.686 ' O ' HG23 ' A' ' 22' ' ' ILE . . . -54.6 -37.08 60.07 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.583 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.694 HD23 ' HA3' ' B' ' 18' ' ' GLY . 24.7 tp -79.6 -38.47 33.86 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.843 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -85.64 -35.94 20.63 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.514 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -62.57 -43.71 98.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.939 HD12 ' N ' ' A' ' 23' ' ' GLY . 2.6 pp -65.26 -40.53 88.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.939 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -60.98 -29.35 70.58 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 119.859 -1.162 . . . . 0.0 110.22 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -73.21 -56.62 4.84 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.005 -0.598 . . . . 0.0 110.07 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.53 -54.4 18.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.227 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.12 -56.4 8.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.747 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -47.97 -54.08 12.79 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.898 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.752 HD11 ' HA ' ' A' ' 59' ' ' LEU . 68.2 mt -49.86 -34.38 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.66 -34.36 28.33 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.356 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mm -77.17 -62.06 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.0 0.429 . . . . 0.0 110.42 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.672 HD22 ' CG ' ' A' ' 54' ' ' PHE . 0.5 OUTLIER -60.95 -43.13 99.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.781 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.98 -50.42 67.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.882 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.33 -51.97 24.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.786 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -58.78 -42.18 88.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.594 0.235 . . . . 0.0 111.402 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.67 ' CD1' HD22 ' B' ' 36' ' ' LEU . 59.9 t80 -58.68 -47.36 84.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.786 0.327 . . . . 0.0 110.889 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.1 tp -55.25 -44.3 75.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.0 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.28 -31.46 67.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.99 24.17 27.83 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.656 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.27 31.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.297 . . . . 0.0 111.333 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.32 -34.29 21.89 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.908 0.385 . . . . 0.0 111.078 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -67.85 -47.3 69.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.117 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.411 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 84.8 mt-30 -58.17 163.55 4.4 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.079 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.475 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 52.0 Cg_exo -53.16 161.3 3.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.553 2.169 . . . . 0.0 111.98 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.56 30.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.84 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.0 tp -97.73 -60.66 1.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.615 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -76.27 -54.63 1.91 Allowed Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.91 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 28.9 Cg_endo -63.26 -32.51 73.25 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.862 1.708 . . . . 0.0 112.358 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 48' ' ' LEU . 5.5 tt -61.14 -34.38 74.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -75.33 -42.13 55.14 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.359 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.495 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -73.45 -35.89 65.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.911 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.455 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 53.6 m -59.37 -46.57 88.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.592 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.655 ' O ' HG23 ' A' ' 56' ' ' VAL . 9.9 pt20 -61.78 -45.14 95.14 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.269 0.557 . . . . 0.0 109.836 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 1.2 t80 -49.25 -36.96 21.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.502 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.672 ' CG ' HD22 ' A' ' 31' ' ' LEU . 8.8 m-85 -77.66 -69.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.056 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.491 HG12 ' HA ' ' A' ' 52' ' ' GLN . 28.9 pt -44.55 -33.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 52' ' ' GLN . 92.8 t -76.83 -46.05 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 49.3 ttm -50.61 -29.54 11.15 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.571 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -84.59 -33.63 18.67 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.752 ' HA ' HD11 ' A' ' 28' ' ' ILE . 45.2 tp -73.07 -7.51 51.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.199 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 60' ' ' VAL . 65.0 t -109.56 -1.33 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.877 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.446 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 38.6 t70 -81.47 -23.5 37.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.912 0.387 . . . . 0.0 110.609 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -88.7 -42.08 12.19 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.559 0.695 . . . . 0.0 110.026 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.567 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.4 mm -47.11 -34.42 4.28 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.799 -1.091 . . . . 0.0 113.613 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.83 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.6 Cg_exo -78.37 -54.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.936 1.757 . . . . 0.0 111.616 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.843 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 2.0 tpt -52.85 -37.36 60.14 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.512 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 75.5 mt -66.22 -54.46 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.638 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.32 -31.4 61.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 64' ' ' PRO . 56.2 t -75.7 -43.98 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.891 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.437 ' HA2' ' HE1' ' A' ' 16' ' ' MET . . . -65.69 -35.73 91.43 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.907 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -67.25 -38.12 84.66 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.762 -0.719 . . . . 0.0 109.703 178.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 75' ' ' MET . . . -64.91 -60.77 6.48 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.271 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.916 HD22 ' CZ ' ' B' ' 73' ' ' TYR . 58.4 mt -52.2 -34.51 45.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.494 0.664 . . . . 0.0 109.624 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.578 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 10.7 t80 -71.18 -47.05 59.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.48 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 70' ' ' LEU . 93.2 t -62.31 -26.28 39.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.852 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 71' ' ' GLY . 89.3 mtp -63.73 -49.97 70.96 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.815 ' HB2' HD13 ' A' ' 9' ' ' LEU . 2.4 t80 -53.03 -35.88 59.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -58.24 -32.64 68.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.058 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.13 -32.74 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.973 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.087 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.571 0.224 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.68 -29.45 0.76 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.371 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.11 -62.84 1.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.522 HD22 ' N ' ' B' ' 4' ' ' LEU . 3.0 mm? -65.53 -17.88 64.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 109.98 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.74 -71.66 0.17 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.508 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 23.4 ptp -59.23 -21.98 60.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.624 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.17 -44.92 28.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.281 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.751 HD22 ' CE ' ' B' ' 11' ' ' MET . 0.7 OUTLIER -75.05 -39.98 60.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.964 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.803 HD13 ' HB2' ' B' ' 76' ' ' PHE . 6.8 tt -56.15 -59.13 5.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' TYR . . . . . 0.747 ' HB3' HD12 ' A' ' 8' ' ' LEU . 15.0 m-85 -56.13 -54.21 47.77 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.207 0.527 . . . . 0.0 110.146 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' MET . . . . . 0.751 ' CE ' HD22 ' B' ' 8' ' ' LEU . 57.2 ttp -54.44 -20.1 6.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.124 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' B' ' 9' ' ' LEU . . . -70.57 -54.22 12.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.055 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.57 ' O ' ' HG3' ' B' ' 17' ' ' MET . . . -62.94 -19.17 64.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.794 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.67 -39.26 11.95 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.396 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 11' ' ' MET . 46.3 t -74.85 -37.1 41.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.167 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.893 ' CE ' HD12 ' B' ' 72' ' ' LEU . 57.6 mtm -70.16 -62.57 1.34 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.44 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' MET . . . . . 0.57 ' HG3' ' O ' ' B' ' 13' ' ' ALA . 40.6 mtm -63.1 -51.42 66.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.412 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.698 ' O ' HG23 ' B' ' 22' ' ' ILE . . . -54.69 -37.02 60.3 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.582 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.714 HD23 ' HA3' ' C' ' 18' ' ' GLY . 24.5 tp -79.61 -38.45 33.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.817 ' HB3' ' HG2' ' B' ' 65' ' ' MET . . . -85.65 -35.97 20.6 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.484 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.59 ' HA ' ' CB ' ' B' ' 62' ' ' ALA . . . -62.53 -43.68 98.23 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.919 HD12 ' N ' ' B' ' 23' ' ' GLY . 2.6 pp -65.28 -40.54 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.919 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -60.97 -29.28 70.37 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.237 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' B' ' 58' ' ' GLY . . . -73.31 -56.59 4.86 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.023 -0.589 . . . . 0.0 110.01 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.56 -54.37 18.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.187 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.14 -56.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.727 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 31' ' ' LEU . . . -47.99 -54.01 13.04 Favored Glycine 0 CA--C 1.508 -0.388 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.895 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.744 HD11 ' HA ' ' B' ' 59' ' ' LEU . 68.5 mt -49.93 -34.27 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.285 0.564 . . . . 0.0 109.489 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.46 ' HA2' ' HG ' ' A' ' 31' ' ' LEU . . . -80.67 -34.42 28.13 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.356 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.15 -62.07 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.027 0.441 . . . . 0.0 110.454 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' LEU . . . . . 0.658 HD22 ' CG ' ' B' ' 54' ' ' PHE . 0.5 OUTLIER -60.91 -43.2 98.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.811 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.94 -50.46 67.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.844 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.28 -52.03 24.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.789 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.8 -42.12 88.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.558 0.218 . . . . 0.0 111.409 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' PHE . . . . . 0.722 ' CD1' HD22 ' C' ' 36' ' ' LEU . 59.9 t80 -58.68 -47.42 84.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.93 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.67 HD22 ' CD1' ' A' ' 35' ' ' PHE . 64.2 tp -55.2 -44.26 75.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.035 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.38 -31.39 67.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.99 24.17 27.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.704 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.25 31.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.75 0.31 . . . . 0.0 111.305 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.38 -34.27 21.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.911 0.386 . . . . 0.0 111.093 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' B' ' 41' ' ' ARG . 0.3 OUTLIER -67.79 -47.29 69.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.186 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.42 ' HB3' ' HD2' ' B' ' 43' ' ' PRO . 85.0 mt-30 -58.14 163.56 4.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.124 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' PRO . . . . . 0.475 ' O ' ' CG ' ' B' ' 47' ' ' PRO . 51.8 Cg_exo -53.18 161.29 3.73 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.518 2.145 . . . . 0.0 112.041 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.55 30.9 1.88 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.807 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.74 -60.57 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.391 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.615 HD12 ' N ' ' B' ' 46' ' ' ILE . 1.7 mp -76.37 -54.6 1.86 Allowed Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.857 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' B' ' 46' ' ' ILE . 28.8 Cg_endo -63.26 -32.57 73.16 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.888 1.725 . . . . 0.0 112.34 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.811 HD23 ' O ' ' B' ' 48' ' ' LEU . 5.6 tt -61.08 -34.48 74.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.723 HD12 ' O ' ' B' ' 49' ' ' LEU . 0.3 OUTLIER -75.28 -42.09 55.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.425 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.488 ' HD2' ' CZ ' ' B' ' 35' ' ' PHE . 0.0 OUTLIER -73.48 -35.92 65.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.908 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.455 ' HA ' ' CD2' ' B' ' 35' ' ' PHE . 54.2 m -59.31 -46.61 88.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.607 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.653 ' O ' HG23 ' B' ' 56' ' ' VAL . 9.9 pt20 -61.73 -45.19 95.01 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.203 0.525 . . . . 0.0 109.793 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.3 -36.91 22.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.452 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' PHE . . . . . 0.658 ' CG ' HD22 ' B' ' 31' ' ' LEU . 8.7 m-85 -77.64 -69.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.071 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.574 HG21 ' CE1' ' A' ' 54' ' ' PHE . 29.0 pt -44.65 -33.92 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.743 0.306 . . . . 0.0 110.901 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.653 HG23 ' O ' ' B' ' 52' ' ' GLN . 91.2 t -76.72 -46.18 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 49.3 ttm -50.6 -29.47 10.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' B' ' 24' ' ' ALA . . . -84.61 -33.64 18.61 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.744 ' HA ' HD11 ' B' ' 28' ' ' ILE . 45.4 tp -73.1 -7.51 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 110.183 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.586 HG12 ' O ' ' B' ' 60' ' ' VAL . 65.0 t -109.54 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.884 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.446 ' O ' ' HD2' ' B' ' 64' ' ' PRO . 38.6 t70 -81.38 -23.59 37.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.912 0.387 . . . . 0.0 110.58 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' B' ' 21' ' ' ALA . . . -88.66 -42.11 12.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.54 0.686 . . . . 0.0 110.001 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.562 ' N ' ' CD ' ' B' ' 64' ' ' PRO . 2.4 mm -47.16 -34.42 4.37 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.527 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.826 ' O ' HG23 ' B' ' 68' ' ' VAL . 3.6 Cg_exo -78.36 -54.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.923 1.748 . . . . 0.0 111.623 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' MET . . . . . 0.817 ' HG2' ' HB3' ' B' ' 20' ' ' ALA . 2.0 tpt -52.83 -37.39 59.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.507 ' HA ' ' HG2' ' B' ' 17' ' ' MET . 75.6 mt -66.22 -54.47 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.596 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.23 -31.49 61.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.826 HG23 ' O ' ' B' ' 64' ' ' PRO . 56.4 t -75.69 -43.92 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.963 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' B' ' 16' ' ' MET . . . -65.79 -35.62 91.16 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.896 ' O ' HG23 ' B' ' 74' ' ' VAL . 0.5 OUTLIER -67.33 -38.04 84.25 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.781 -0.71 . . . . 0.0 109.672 178.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' B' ' 75' ' ' MET . . . -65.0 -60.68 6.56 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.26 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.893 HD12 ' CE ' ' B' ' 16' ' ' MET . 58.8 mt -52.22 -34.48 45.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.484 0.659 . . . . 0.0 109.63 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.916 ' CZ ' HD22 ' A' ' 72' ' ' LEU . 10.7 t80 -71.25 -47.0 59.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.484 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.896 HG23 ' O ' ' B' ' 70' ' ' LEU . 92.9 t -62.31 -26.33 40.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.813 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' B' ' 71' ' ' GLY . 89.2 mtp -63.65 -50.03 70.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' PHE . . . . . 0.803 ' HB2' HD13 ' B' ' 9' ' ' LEU . 2.4 t80 -53.0 -35.94 59.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 74' ' ' VAL . . . -58.3 -32.5 68.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.17 -32.75 55.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.974 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.12 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.596 0.236 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.6 -29.53 0.75 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.407 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.07 -62.82 1.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.04 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' LEU . . . . . 0.524 HD22 ' N ' ' C' ' 4' ' ' LEU . 3.0 mm? -65.52 -17.93 64.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 0.0 109.925 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.65 -71.79 0.17 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.476 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' MET . . . . . . . . . . . . . 23.3 ptp -59.13 -22.0 60.21 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.638 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.25 -44.86 28.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.809 HD21 ' HB2' ' D' ' 11' ' ' MET . 0.7 OUTLIER -75.0 -40.12 60.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.958 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 9' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' C' ' 76' ' ' PHE . 6.8 tt -56.08 -59.13 5.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.557 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' TYR . . . . . 0.737 ' HB3' HD12 ' B' ' 8' ' ' LEU . 14.9 m-85 -56.15 -54.16 48.48 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 110.147 178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' MET . . . . . 0.756 ' CE ' HD22 ' C' ' 8' ' ' LEU . 57.2 ttp -54.4 -20.2 6.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.152 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' C' ' 9' ' ' LEU . . . -70.56 -54.2 13.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.042 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.567 ' O ' ' HG3' ' C' ' 17' ' ' MET . . . -62.9 -19.22 63.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.761 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.67 -39.24 11.96 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.506 0.67 . . . . 0.0 109.454 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' VAL . . . . . 0.531 HG23 ' O ' ' C' ' 11' ' ' MET . 46.2 t -74.88 -37.03 41.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.168 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' MET . . . . . 0.908 ' CE ' HD12 ' C' ' 72' ' ' LEU . 57.5 mtm -70.28 -62.46 1.38 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.411 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 17' ' ' MET . . . . . 0.567 ' HG3' ' O ' ' C' ' 13' ' ' ALA . 40.7 mtm -63.13 -51.52 66.17 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.376 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.714 ' HA3' HD23 ' B' ' 19' ' ' LEU . . . -54.58 -37.06 59.94 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.585 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.714 HD23 ' HA3' ' D' ' 18' ' ' GLY . 24.0 tp -79.64 -38.42 33.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ALA . . . . . 0.818 ' HB3' ' HG2' ' C' ' 65' ' ' MET . . . -85.7 -35.94 20.54 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.533 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.593 ' HA ' ' CB ' ' C' ' 62' ' ' ALA . . . -62.53 -43.7 98.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.932 HD12 ' N ' ' C' ' 23' ' ' GLY . 2.6 pp -65.33 -40.56 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' GLY . . . . . 0.932 ' N ' HD12 ' C' ' 22' ' ' ILE . . . -60.94 -29.32 70.38 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 24' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' C' ' 58' ' ' GLY . . . -73.29 -56.57 4.9 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.045 -0.578 . . . . 0.0 110.069 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.55 -54.38 18.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.259 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 49.1 mm -53.12 -56.42 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.719 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' C' ' 31' ' ' LEU . . . -48.0 -54.06 12.95 Favored Glycine 0 CA--C 1.509 -0.324 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.864 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ILE . . . . . 0.741 HD11 ' HA ' ' C' ' 59' ' ' LEU . 68.3 mt -49.81 -34.38 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.299 0.571 . . . . 0.0 109.496 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.69 -34.41 28.08 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.32 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.16 -62.04 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.102 0 CA-C-O 121.009 0.433 . . . . 0.0 110.433 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' LEU . . . . . 0.657 HD22 ' CG ' ' C' ' 54' ' ' PHE . 0.5 OUTLIER -60.9 -43.18 98.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.817 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.95 -50.42 67.7 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.855 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.34 -51.99 24.31 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.761 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.81 -42.14 88.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.568 0.223 . . . . 0.0 111.416 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' PHE . . . . . 0.772 ' CD1' HD22 ' D' ' 36' ' ' LEU . 60.0 t80 -58.73 -47.32 85.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.722 HD22 ' CD1' ' B' ' 35' ' ' PHE . 64.1 tp -55.27 -44.3 75.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.023 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.33 -31.37 67.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.97 24.12 28.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.711 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.2 31.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 111.331 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.32 -34.3 21.89 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 120.955 0.407 . . . . 0.0 111.064 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.478 ' N ' ' HD2' ' C' ' 41' ' ' ARG . 0.4 OUTLIER -67.82 -47.3 69.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.116 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 42' ' ' GLN . . . . . 0.419 ' HB3' ' HD2' ' C' ' 43' ' ' PRO . 84.8 mt-30 -58.14 163.61 4.32 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.115 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 43' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' C' ' 47' ' ' PRO . 52.1 Cg_exo -53.22 161.29 3.79 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.566 2.178 . . . . 0.0 111.957 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.51 30.84 1.89 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.86 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 59.0 tp -97.71 -60.61 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.359 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' ILE . . . . . 0.616 HD12 ' N ' ' C' ' 46' ' ' ILE . 1.7 mp -76.33 -54.57 1.89 Allowed Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.905 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' C' ' 46' ' ' ILE . 28.9 Cg_endo -63.29 -32.47 72.92 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.848 1.699 . . . . 0.0 112.378 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.803 HD23 ' O ' ' C' ' 48' ' ' LEU . 5.5 tt -61.17 -34.45 75.05 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.704 HD12 ' O ' ' C' ' 49' ' ' LEU . 0.3 OUTLIER -75.22 -42.2 55.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.403 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 50' ' ' ARG . . . . . 0.505 ' HD2' ' CZ ' ' C' ' 35' ' ' PHE . 0.0 OUTLIER -73.36 -36.02 66.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.922 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.455 ' HA ' ' CD2' ' C' ' 35' ' ' PHE . 53.8 m -59.28 -46.6 88.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.558 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' GLN . . . . . 0.649 ' O ' HG23 ' C' ' 56' ' ' VAL . 9.9 pt20 -61.8 -45.14 95.12 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.234 0.54 . . . . 0.0 109.824 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.28 -36.95 22.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.488 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.657 ' CG ' HD22 ' C' ' 31' ' ' LEU . 8.7 m-85 -77.66 -69.58 0.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.051 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' ILE . . . . . 0.639 HG21 ' CE1' ' B' ' 54' ' ' PHE . 29.1 pt -44.5 -34.0 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.779 0.323 . . . . 0.0 110.941 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.649 HG23 ' O ' ' C' ' 52' ' ' GLN . 89.8 t -76.69 -46.14 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.63 -29.48 11.09 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' C' ' 24' ' ' ALA . . . -84.64 -33.61 18.6 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.741 ' HA ' HD11 ' C' ' 28' ' ' ILE . 45.0 tp -73.11 -7.49 51.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 110.202 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.573 HG12 ' O ' ' C' ' 60' ' ' VAL . 64.8 t -109.55 -1.33 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.85 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' ASP . . . . . 0.444 ' O ' ' HD2' ' C' ' 64' ' ' PRO . 38.6 t70 -81.48 -23.57 37.32 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.922 0.392 . . . . 0.0 110.601 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 62' ' ' ALA . . . . . 0.593 ' CB ' ' HA ' ' C' ' 21' ' ' ALA . . . -88.6 -42.06 12.27 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.551 0.691 . . . . 0.0 110.089 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 63' ' ' ILE . . . . . 0.576 ' N ' ' CD ' ' C' ' 64' ' ' PRO . 2.4 mm -47.17 -34.45 4.42 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.569 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' PRO . . . . . 0.802 ' O ' HG23 ' C' ' 68' ' ' VAL . 3.6 Cg_exo -78.38 -54.47 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.948 1.766 . . . . 0.0 111.599 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 65' ' ' MET . . . . . 0.818 ' HG2' ' HB3' ' C' ' 20' ' ' ALA . 2.0 tpt -52.87 -37.37 60.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 66' ' ' ILE . . . . . 0.511 ' HA ' ' HG2' ' C' ' 17' ' ' MET . 75.4 mt -66.13 -54.47 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.653 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.29 -31.43 61.61 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' C' ' 64' ' ' PRO . 56.7 t -75.72 -43.98 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.901 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' GLY . . . . . 0.513 ' HA2' ' HE1' ' C' ' 16' ' ' MET . . . -65.67 -35.74 91.46 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' LEU . . . . . 0.913 ' O ' HG23 ' C' ' 74' ' ' VAL . 0.5 OUTLIER -67.28 -38.03 84.4 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.801 -0.7 . . . . 0.0 109.726 178.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 71' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' C' ' 75' ' ' MET . . . -64.96 -60.74 6.51 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.269 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.909 HD22 ' CZ ' ' D' ' 73' ' ' TYR . 58.3 mt -52.19 -34.53 45.78 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.5 0.667 . . . . 0.0 109.648 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.892 ' CZ ' HD22 ' B' ' 72' ' ' LEU . 10.6 t80 -71.18 -46.96 60.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.537 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.913 HG23 ' O ' ' C' ' 70' ' ' LEU . 92.9 t -62.42 -26.22 39.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.819 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' C' ' 71' ' ' GLY . 89.2 mtp -63.71 -50.0 70.89 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' PHE . . . . . 0.8 ' HB2' HD13 ' C' ' 9' ' ' LEU . 2.4 t80 -53.03 -35.91 59.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' C' ' 74' ' ' VAL . . . -58.3 -32.54 68.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.105 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.19 -32.73 55.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.09 179.937 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.579 0.228 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.69 -29.41 0.75 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.438 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.08 -62.83 1.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.067 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' LEU . . . . . 0.534 HD22 ' N ' ' D' ' 4' ' ' LEU . 3.0 mm? -65.59 -17.87 64.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.087 0.47 . . . . 0.0 109.979 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.68 -71.75 0.17 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.473 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.17 -21.98 60.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.622 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.22 -44.91 28.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.272 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.936 HD21 ' HB2' ' E' ' 11' ' ' MET . 0.7 OUTLIER -75.02 -40.08 60.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.959 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 9' ' ' LEU . . . . . 0.811 HD13 ' HB2' ' D' ' 76' ' ' PHE . 6.8 tt -56.08 -59.09 5.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.568 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.739 ' HB3' HD12 ' C' ' 8' ' ' LEU . 14.8 m-85 -56.17 -54.1 49.2 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.166 0.508 . . . . 0.0 110.148 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 11' ' ' MET . . . . . 0.809 ' HB2' HD21 ' C' ' 8' ' ' LEU . 57.2 ttp -54.49 -20.19 7.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.128 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' D' ' 9' ' ' LEU . . . -70.56 -54.16 13.19 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.075 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' D' ' 17' ' ' MET . . . -62.96 -19.19 64.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.804 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.64 -39.21 11.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.523 0.677 . . . . 0.0 109.49 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' VAL . . . . . 0.531 HG23 ' O ' ' D' ' 11' ' ' MET . 46.2 t -74.86 -37.11 41.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.805 -1.088 . . . . 0.0 109.182 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 16' ' ' MET . . . . . 0.906 ' CE ' HD12 ' D' ' 72' ' ' LEU . 57.7 mtm -70.23 -62.51 1.36 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.425 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 17' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' D' ' 13' ' ' ALA . 40.6 mtm -63.09 -51.49 66.38 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.434 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' GLY . . . . . 0.714 ' HA3' HD23 ' C' ' 19' ' ' LEU . . . -54.62 -37.07 60.15 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.557 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.721 HD23 ' HA3' ' E' ' 18' ' ' GLY . 24.0 tp -79.64 -38.41 33.81 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.841 ' HB3' ' HG2' ' D' ' 65' ' ' MET . . . -85.65 -35.93 20.62 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.536 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ALA . . . . . 0.592 ' HA ' ' CB ' ' D' ' 62' ' ' ALA . . . -62.63 -43.69 98.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.931 HD12 ' N ' ' D' ' 23' ' ' GLY . 2.6 pp -65.29 -40.59 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 23' ' ' GLY . . . . . 0.931 ' N ' HD12 ' D' ' 22' ' ' ILE . . . -60.94 -29.34 70.44 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.216 177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' D' ' 58' ' ' GLY . . . -73.17 -56.6 4.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.039 -0.581 . . . . 0.0 110.104 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.57 -54.29 19.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.26 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.23 -56.39 8.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.737 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' D' ' 31' ' ' LEU . . . -47.96 -54.1 12.71 Favored Glycine 0 CA--C 1.508 -0.352 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.902 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 28' ' ' ILE . . . . . 0.727 HD11 ' HA ' ' D' ' 59' ' ' LEU . 68.1 mt -49.86 -34.32 9.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' GLY . . . . . 0.438 ' HA2' ' HG ' ' C' ' 31' ' ' LEU . . . -80.62 -34.5 28.05 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.327 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.14 -62.04 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.987 0.422 . . . . 0.0 110.443 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' D' ' 54' ' ' PHE . 0.5 OUTLIER -60.93 -43.18 98.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.787 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.99 -50.43 67.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.811 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.29 -51.97 24.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.862 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.8 -42.17 88.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.608 0.242 . . . . 0.0 111.402 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' PHE . . . . . 0.772 ' CD1' HD22 ' E' ' 36' ' ' LEU . 60.0 t80 -58.65 -47.39 84.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.799 0.333 . . . . 0.0 110.931 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.772 HD22 ' CD1' ' C' ' 35' ' ' PHE . 64.4 tp -55.24 -44.23 75.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.31 -31.47 67.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.047 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.92 24.07 28.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.695 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.23 31.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.746 0.308 . . . . 0.0 111.324 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.4 -34.35 21.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.043 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' ARG . . . . . 0.477 ' N ' ' HD2' ' D' ' 41' ' ' ARG . 0.4 OUTLIER -67.72 -47.29 69.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.172 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 42' ' ' GLN . . . . . 0.427 ' HB3' ' HD2' ' D' ' 43' ' ' PRO . 84.9 mt-30 -58.15 163.6 4.34 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.122 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 43' ' ' PRO . . . . . 0.475 ' O ' ' CG ' ' D' ' 47' ' ' PRO . 52.1 Cg_exo -53.2 161.33 3.73 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.504 2.136 . . . . 0.0 111.998 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.6 30.91 1.89 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.7 -60.67 1.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.366 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' ILE . . . . . 0.622 HD12 ' N ' ' D' ' 46' ' ' ILE . 1.7 mp -76.32 -54.58 1.89 Allowed Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.909 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' D' ' 46' ' ' ILE . 28.8 Cg_endo -63.16 -32.61 74.22 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 121.873 1.715 . . . . 0.0 112.404 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 48' ' ' LEU . . . . . 0.817 HD23 ' O ' ' D' ' 48' ' ' LEU . 5.5 tt -61.11 -34.43 74.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.209 0.528 . . . . 0.0 109.611 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 49' ' ' LEU . . . . . 0.723 HD12 ' O ' ' D' ' 49' ' ' LEU . 0.3 OUTLIER -75.28 -42.14 55.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.384 179.224 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 50' ' ' ARG . . . . . 0.503 ' HD2' ' CZ ' ' D' ' 35' ' ' PHE . 0.0 OUTLIER -73.41 -35.94 65.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.917 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.446 ' HA ' ' CD2' ' D' ' 35' ' ' PHE . 53.9 m -59.34 -46.55 88.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.595 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 52' ' ' GLN . . . . . 0.646 ' O ' HG23 ' D' ' 56' ' ' VAL . 9.9 pt20 -61.86 -45.05 95.45 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.187 0.518 . . . . 0.0 109.8 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.28 -36.98 22.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.429 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.677 ' CG ' HD22 ' D' ' 31' ' ' LEU . 8.8 m-85 -77.65 -69.55 0.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.069 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 55' ' ' ILE . . . . . 0.646 HG21 ' CE1' ' C' ' 54' ' ' PHE . 29.0 pt -44.57 -33.96 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.785 0.326 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 56' ' ' VAL . . . . . 0.646 HG23 ' O ' ' D' ' 52' ' ' GLN . 90.4 t -76.73 -46.17 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.56 -29.55 11.0 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.56 ' O ' ' HB1' ' D' ' 24' ' ' ALA . . . -84.64 -33.58 18.68 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 59' ' ' LEU . . . . . 0.727 ' HA ' HD11 ' D' ' 28' ' ' ILE . 45.1 tp -73.1 -7.53 51.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.188 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' VAL . . . . . 0.589 HG12 ' O ' ' D' ' 60' ' ' VAL . 65.7 t -109.53 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ASP . . . . . 0.452 ' O ' ' HD2' ' D' ' 64' ' ' PRO . 38.6 t70 -81.43 -23.54 37.46 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 110.627 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 62' ' ' ALA . . . . . 0.592 ' CB ' ' HA ' ' D' ' 21' ' ' ALA . . . -88.66 -42.06 12.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.533 0.682 . . . . 0.0 110.045 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 63' ' ' ILE . . . . . 0.575 ' N ' ' CD ' ' D' ' 64' ' ' PRO . 2.4 mm -47.17 -34.47 4.44 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.532 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 64' ' ' PRO . . . . . 0.819 ' O ' HG23 ' D' ' 68' ' ' VAL . 3.6 Cg_exo -78.33 -54.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.021 1.814 . . . . 0.0 111.631 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 65' ' ' MET . . . . . 0.841 ' HG2' ' HB3' ' D' ' 20' ' ' ALA . 2.0 tpt -52.89 -37.36 60.48 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 66' ' ' ILE . . . . . 0.508 ' HA ' ' HG2' ' D' ' 17' ' ' MET . 75.6 mt -66.14 -54.46 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.658 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.26 -31.43 61.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 68' ' ' VAL . . . . . 0.819 HG23 ' O ' ' D' ' 64' ' ' PRO . 56.2 t -75.7 -44.0 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.931 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.72 -35.65 91.28 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' LEU . . . . . 0.91 ' O ' HG23 ' D' ' 74' ' ' VAL . 0.5 OUTLIER -67.34 -38.02 84.19 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.779 -0.71 . . . . 0.0 109.708 178.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 71' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' D' ' 75' ' ' MET . . . -64.97 -60.7 6.55 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.277 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 72' ' ' LEU . . . . . 0.908 HD22 ' CZ ' ' E' ' 73' ' ' TYR . 58.1 mt -52.24 -34.46 46.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.529 0.68 . . . . 0.0 109.675 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 73' ' ' TYR . . . . . 0.909 ' CZ ' HD22 ' C' ' 72' ' ' LEU . 10.7 t80 -71.22 -46.95 60.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.523 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.91 HG23 ' O ' ' D' ' 70' ' ' LEU . 92.9 t -62.4 -26.26 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.791 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' D' ' 71' ' ' GLY . 89.2 mtp -63.64 -50.06 70.79 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 76' ' ' PHE . . . . . 0.811 ' HB2' HD13 ' D' ' 9' ' ' LEU . 2.4 t80 -52.99 -35.92 59.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.439 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' D' ' 74' ' ' VAL . . . -58.32 -32.51 68.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.125 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.16 -32.71 55.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.134 -179.976 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.609 0.242 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.6 -29.52 0.75 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.421 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -71.11 -62.79 1.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.043 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 4' ' ' LEU . . . . . 0.527 HD22 ' N ' ' E' ' 4' ' ' LEU . 3.0 mm? -65.57 -17.91 64.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.116 0.484 . . . . 0.0 109.97 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.66 -71.75 0.17 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.512 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.13 -21.99 60.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.3 -44.85 28.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.244 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.899 HD21 ' HB2' ' F' ' 11' ' ' MET . 0.7 OUTLIER -75.08 -40.0 60.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.972 179.621 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 9' ' ' LEU . . . . . 0.805 HD13 ' HB2' ' E' ' 76' ' ' PHE . 6.8 tt -56.13 -59.12 5.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.568 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.788 ' HB3' HD12 ' D' ' 8' ' ' LEU . 14.8 m-85 -56.17 -54.03 50.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.139 0.495 . . . . 0.0 110.107 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 11' ' ' MET . . . . . 0.936 ' HB2' HD21 ' D' ' 8' ' ' LEU . 56.5 ttp -54.49 -20.23 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.124 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 12' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' E' ' 9' ' ' LEU . . . -70.54 -54.26 12.87 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.048 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 13' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' E' ' 17' ' ' MET . . . -62.87 -19.19 63.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.811 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.72 -39.23 11.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.483 0.658 . . . . 0.0 109.392 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' VAL . . . . . 0.527 HG23 ' O ' ' E' ' 11' ' ' MET . 45.9 t -74.9 -37.06 40.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.163 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 16' ' ' MET . . . . . 0.902 ' CE ' HD12 ' E' ' 72' ' ' LEU . 57.7 mtm -70.23 -62.5 1.36 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.424 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 17' ' ' MET . . . . . 0.571 ' HG3' ' O ' ' E' ' 13' ' ' ALA . 40.5 mtm -63.06 -51.51 66.38 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.471 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.721 ' HA3' HD23 ' D' ' 19' ' ' LEU . . . -54.63 -37.08 60.21 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.562 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 19' ' ' LEU . . . . . 0.767 HD23 ' HA3' ' F' ' 18' ' ' GLY . 23.8 tp -79.61 -38.37 34.02 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.832 ' HB3' ' HG2' ' E' ' 65' ' ' MET . . . -85.73 -35.89 20.52 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.542 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 21' ' ' ALA . . . . . 0.588 ' HA ' ' CB ' ' E' ' 62' ' ' ALA . . . -62.63 -43.63 98.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.916 HD12 ' N ' ' E' ' 23' ' ' GLY . 2.6 pp -65.29 -40.57 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 23' ' ' GLY . . . . . 0.916 ' N ' HD12 ' E' ' 22' ' ' ILE . . . -60.88 -29.41 70.46 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.237 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 24' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' E' ' 58' ' ' GLY . . . -73.2 -56.65 4.81 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.05 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.49 -54.39 18.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.277 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.12 -56.46 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.715 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 27' ' ' GLY . . . . . 0.452 ' O ' ' N ' ' E' ' 31' ' ' LEU . . . -47.92 -54.13 12.53 Favored Glycine 0 CA--C 1.509 -0.329 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.894 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 28' ' ' ILE . . . . . 0.742 HD11 ' HA ' ' E' ' 59' ' ' LEU . 68.3 mt -49.85 -34.3 9.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 29' ' ' GLY . . . . . 0.545 ' HA2' ' HG ' ' D' ' 31' ' ' LEU . . . -80.58 -34.54 28.09 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.358 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.13 -62.04 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 121.011 0.434 . . . . 0.0 110.439 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 31' ' ' LEU . . . . . 0.669 HD22 ' CG ' ' E' ' 54' ' ' PHE . 0.5 OUTLIER -60.98 -43.15 99.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.765 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.96 -50.45 67.44 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.871 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.31 -51.97 24.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.794 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.83 -42.13 88.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.56 0.219 . . . . 0.0 111.357 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 35' ' ' PHE . . . . . 0.774 ' CD1' HD22 ' F' ' 36' ' ' LEU . 60.0 t80 -58.73 -47.34 84.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.803 0.335 . . . . 0.0 110.891 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.772 HD22 ' CD1' ' D' ' 35' ' ' PHE . 64.5 tp -55.24 -44.26 75.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.046 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -58.32 -31.45 67.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.043 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.98 24.17 27.8 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.673 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.28 31.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.734 0.302 . . . . 0.0 111.322 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.32 -34.33 21.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.984 0.421 . . . . 0.0 111.089 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 41' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' E' ' 41' ' ' ARG . 0.4 OUTLIER -67.86 -47.25 69.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.169 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 42' ' ' GLN . . . . . 0.427 ' HB3' ' HD2' ' E' ' 43' ' ' PRO . 84.8 mt-30 -58.13 163.59 4.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 43' ' ' PRO . . . . . 0.473 ' O ' ' CG ' ' E' ' 47' ' ' PRO . 52.2 Cg_exo -53.2 161.32 3.74 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.541 2.16 . . . . 0.0 111.963 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.54 30.87 1.89 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.838 0.351 . . . . 0.0 110.864 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.76 -60.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.334 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 46' ' ' ILE . . . . . 0.619 HD12 ' N ' ' E' ' 46' ' ' ILE . 1.7 mp -76.26 -54.61 1.91 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.889 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 47' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' E' ' 46' ' ' ILE . 28.9 Cg_endo -63.26 -32.53 73.23 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.815 1.676 . . . . 0.0 112.391 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 48' ' ' LEU . . . . . 0.805 HD23 ' O ' ' E' ' 48' ' ' LEU . 5.5 tt -61.15 -34.44 75.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 49' ' ' LEU . . . . . 0.716 HD12 ' O ' ' E' ' 49' ' ' LEU . 0.3 OUTLIER -75.29 -42.03 55.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.445 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 50' ' ' ARG . . . . . 0.504 ' HD2' ' CZ ' ' E' ' 35' ' ' PHE . 0.0 OUTLIER -73.54 -35.92 65.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.858 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 51' ' ' THR . . . . . 0.45 ' HA ' ' CD2' ' E' ' 35' ' ' PHE . 53.6 m -59.35 -46.56 88.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.601 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 52' ' ' GLN . . . . . 0.654 ' O ' HG23 ' E' ' 56' ' ' VAL . 9.9 pt20 -61.76 -45.17 95.07 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.238 0.542 . . . . 0.0 109.796 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.26 -36.96 21.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.486 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 54' ' ' PHE . . . . . 0.669 ' CG ' HD22 ' E' ' 31' ' ' LEU . 8.8 m-85 -77.6 -69.58 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 55' ' ' ILE . . . . . 0.589 HG21 ' CE1' ' D' ' 54' ' ' PHE . 29.0 pt -44.58 -33.97 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.789 0.328 . . . . 0.0 110.883 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 56' ' ' VAL . . . . . 0.654 HG23 ' O ' ' E' ' 52' ' ' GLN . 91.3 t -76.74 -46.11 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.63 -29.46 11.04 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 58' ' ' GLY . . . . . 0.562 ' O ' ' HB1' ' E' ' 24' ' ' ALA . . . -84.64 -33.63 18.53 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 59' ' ' LEU . . . . . 0.742 ' HA ' HD11 ' E' ' 28' ' ' ILE . 45.4 tp -73.08 -7.51 51.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.96 0.409 . . . . 0.0 110.218 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 60' ' ' VAL . . . . . 0.586 HG12 ' O ' ' E' ' 60' ' ' VAL . 64.9 t -109.52 -1.29 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.892 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 61' ' ' ASP . . . . . 0.447 ' O ' ' HD2' ' E' ' 64' ' ' PRO . 38.6 t70 -81.45 -23.6 37.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.579 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 62' ' ' ALA . . . . . 0.588 ' CB ' ' HA ' ' E' ' 21' ' ' ALA . . . -88.61 -42.13 12.22 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.565 0.697 . . . . 0.0 110.046 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 63' ' ' ILE . . . . . 0.563 ' N ' ' CD ' ' E' ' 64' ' ' PRO . 2.4 mm -47.09 -34.44 4.27 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.611 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 64' ' ' PRO . . . . . 0.807 ' O ' HG23 ' E' ' 68' ' ' VAL . 3.6 Cg_exo -78.32 -54.54 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.981 1.787 . . . . 0.0 111.624 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 65' ' ' MET . . . . . 0.832 ' HG2' ' HB3' ' E' ' 20' ' ' ALA . 2.0 tpt -52.8 -37.41 59.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 66' ' ' ILE . . . . . 0.518 ' HA ' ' HG2' ' E' ' 17' ' ' MET . 75.6 mt -66.22 -54.47 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.608 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.26 -31.46 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' E' ' 64' ' ' PRO . 56.5 t -75.66 -43.99 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.93 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 69' ' ' GLY . . . . . 0.425 ' HA2' ' HE3' ' E' ' 16' ' ' MET . . . -65.76 -35.6 91.16 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 70' ' ' LEU . . . . . 0.894 ' O ' HG23 ' E' ' 74' ' ' VAL . 0.5 OUTLIER -67.33 -38.06 84.3 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.755 -0.723 . . . . 0.0 109.717 178.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 71' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' E' ' 75' ' ' MET . . . -65.0 -60.66 6.59 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.256 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 72' ' ' LEU . . . . . 0.905 HD22 ' CZ ' ' F' ' 73' ' ' TYR . 58.2 mt -52.27 -34.47 46.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.524 0.678 . . . . 0.0 109.645 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 73' ' ' TYR . . . . . 0.908 ' CZ ' HD22 ' D' ' 72' ' ' LEU . 10.6 t80 -71.2 -47.03 59.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.498 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 74' ' ' VAL . . . . . 0.894 HG23 ' O ' ' E' ' 70' ' ' LEU . 92.9 t -62.34 -26.2 39.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.804 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 75' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' E' ' 71' ' ' GLY . 89.3 mtp -63.71 -50.04 70.73 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 76' ' ' PHE . . . . . 0.805 ' HB2' HD13 ' E' ' 9' ' ' LEU . 2.4 t80 -53.01 -35.94 59.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 77' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' E' ' 74' ' ' VAL . . . -58.28 -32.57 68.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.123 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 78' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.16 -32.74 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.996 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.104 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 1' ' ' MET . . . . . 0.455 ' HG3' ' OD1' ' G' ' 3' ' ' ASN . 68.2 mtm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.651 0.262 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.56 -29.57 0.75 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.05 -62.8 1.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 4' ' ' LEU . . . . . 0.532 HD22 ' N ' ' F' ' 4' ' ' LEU . 3.0 mm? -65.58 -17.88 64.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.091 0.472 . . . . 0.0 109.967 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.7 -71.71 0.17 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.487 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 6' ' ' MET . . . . . . . . . . . . . 23.1 ptp -59.19 -22.0 60.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.635 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.23 -44.89 28.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.267 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.85 HD21 ' HB2' ' G' ' 11' ' ' MET . 0.7 OUTLIER -75.02 -40.06 60.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.954 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 9' ' ' LEU . . . . . 0.812 HD13 ' HB2' ' F' ' 76' ' ' PHE . 6.8 tt -56.14 -59.11 5.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.548 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 10' ' ' TYR . . . . . 0.759 ' HB3' HD12 ' E' ' 8' ' ' LEU . 14.8 m-85 -56.16 -53.98 50.59 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.175 0.512 . . . . 0.0 110.146 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 11' ' ' MET . . . . . 0.899 ' HB2' HD21 ' E' ' 8' ' ' LEU . 56.4 ttp -54.55 -20.22 7.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.085 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 12' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' F' ' 9' ' ' LEU . . . -70.53 -54.24 12.95 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.042 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 13' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' F' ' 17' ' ' MET . . . -62.95 -19.11 63.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.823 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.67 -39.25 11.95 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.523 0.678 . . . . 0.0 109.455 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 15' ' ' VAL . . . . . 0.53 HG23 ' O ' ' F' ' 11' ' ' MET . 46.1 t -74.85 -37.09 41.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.152 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 16' ' ' MET . . . . . 0.905 ' CE ' HD12 ' F' ' 72' ' ' LEU . 57.5 mtm -70.26 -62.54 1.35 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.387 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 17' ' ' MET . . . . . 0.572 ' HG3' ' O ' ' F' ' 13' ' ' ALA . 40.6 mtm -63.08 -51.48 66.49 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.433 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 18' ' ' GLY . . . . . 0.767 ' HA3' HD23 ' E' ' 19' ' ' LEU . . . -54.66 -37.07 60.3 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.592 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 19' ' ' LEU . . . . . 0.835 HD23 ' HA3' ' G' ' 18' ' ' GLY . 23.6 tp -79.54 -38.4 34.27 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 20' ' ' ALA . . . . . 0.825 ' HB3' ' HG2' ' F' ' 65' ' ' MET . . . -85.73 -35.91 20.51 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.497 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 21' ' ' ALA . . . . . 0.584 ' HA ' ' CB ' ' F' ' 62' ' ' ALA . . . -62.57 -43.64 98.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.92 HD12 ' N ' ' F' ' 23' ' ' GLY . 2.6 pp -65.29 -40.55 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 23' ' ' GLY . . . . . 0.92 ' N ' HD12 ' F' ' 22' ' ' ILE . . . -60.92 -29.33 70.35 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.257 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 24' ' ' ALA . . . . . 0.565 ' HB1' ' O ' ' F' ' 58' ' ' GLY . . . -73.25 -56.63 4.83 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 114.965 -0.618 . . . . 0.0 110.08 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.46 -54.45 17.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.235 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.06 -56.48 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.747 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 27' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' F' ' 31' ' ' LEU . . . -48.03 -54.0 13.19 Favored Glycine 0 CA--C 1.509 -0.324 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.91 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 28' ' ' ILE . . . . . 0.75 HD11 ' HA ' ' F' ' 59' ' ' LEU . 68.6 mt -49.87 -34.32 9.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 29' ' ' GLY . . . . . 0.455 ' HA2' ' HG ' ' E' ' 31' ' ' LEU . . . -80.65 -34.43 28.14 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.364 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.15 -62.1 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.993 0.425 . . . . 0.0 110.446 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 31' ' ' LEU . . . . . 0.671 HD22 ' CG ' ' F' ' 54' ' ' PHE . 0.5 OUTLIER -60.89 -43.21 98.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.778 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.97 -50.39 68.11 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.882 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.3 -52.03 24.33 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.806 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.68 -42.24 88.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.619 0.247 . . . . 0.0 111.43 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 35' ' ' PHE . . . . . 0.495 ' CZ ' ' HD2' ' F' ' 50' ' ' ARG . 59.8 t80 -58.66 -47.46 84.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.802 0.334 . . . . 0.0 110.859 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.774 HD22 ' CD1' ' E' ' 35' ' ' PHE . 64.2 tp -55.25 -44.19 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -58.41 -31.36 67.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.015 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.95 24.12 27.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.719 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.28 31.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.763 0.316 . . . . 0.0 111.357 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.33 -34.3 21.87 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.114 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 41' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' F' ' 41' ' ' ARG . 0.4 OUTLIER -67.85 -47.29 69.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 42' ' ' GLN . . . . . 0.415 ' HB3' ' HD2' ' F' ' 43' ' ' PRO . 84.9 mt-30 -58.1 163.6 4.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 43' ' ' PRO . . . . . 0.465 ' O ' ' CG ' ' F' ' 47' ' ' PRO . 52.3 Cg_exo -53.22 161.36 3.74 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.505 2.137 . . . . 0.0 111.973 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.63 30.93 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.836 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.71 -60.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.089 0.471 . . . . 0.0 111.333 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 46' ' ' ILE . . . . . 0.608 HD12 ' N ' ' F' ' 46' ' ' ILE . 1.7 mp -76.34 -54.58 1.88 Allowed Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.857 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 47' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' F' ' 46' ' ' ILE . 28.8 Cg_endo -63.28 -32.49 72.98 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.85 1.7 . . . . 0.0 112.374 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 48' ' ' LEU . . . . . 0.812 HD23 ' O ' ' F' ' 48' ' ' LEU . 5.5 tt -61.16 -34.43 75.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.205 0.526 . . . . 0.0 109.594 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 49' ' ' LEU . . . . . 0.722 HD12 ' O ' ' F' ' 49' ' ' LEU . 0.3 OUTLIER -75.27 -42.1 55.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.438 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 50' ' ' ARG . . . . . 0.495 ' HD2' ' CZ ' ' F' ' 35' ' ' PHE . 0.0 OUTLIER -73.49 -35.96 65.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.857 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 51' ' ' THR . . . . . 0.449 ' HA ' ' CD2' ' F' ' 35' ' ' PHE . 53.4 m -59.36 -46.53 88.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.601 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 52' ' ' GLN . . . . . 0.646 ' O ' HG23 ' F' ' 56' ' ' VAL . 9.9 pt20 -61.8 -45.12 95.23 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.247 0.546 . . . . 0.0 109.83 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.31 -36.9 22.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.464 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 54' ' ' PHE . . . . . 0.671 ' CG ' HD22 ' F' ' 31' ' ' LEU . 8.9 m-85 -77.63 -69.57 0.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.095 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 55' ' ' ILE . . . . . 0.62 HG21 ' CE1' ' E' ' 54' ' ' PHE . 29.0 pt -44.62 -33.97 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.76 0.314 . . . . 0.0 110.883 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 56' ' ' VAL . . . . . 0.646 HG23 ' O ' ' F' ' 52' ' ' GLN . 92.1 t -76.72 -46.15 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 57' ' ' MET . . . . . . . . . . . . . 49.3 ttm -50.58 -29.45 10.84 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 58' ' ' GLY . . . . . 0.565 ' O ' ' HB1' ' F' ' 24' ' ' ALA . . . -84.66 -33.61 18.53 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 59' ' ' LEU . . . . . 0.75 ' HA ' HD11 ' F' ' 28' ' ' ILE . 45.5 tp -73.06 -7.55 51.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.964 0.412 . . . . 0.0 110.227 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 60' ' ' VAL . . . . . 0.57 HG12 ' O ' ' F' ' 60' ' ' VAL . 64.5 t -109.48 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.893 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 61' ' ' ASP . . . . . 0.454 ' O ' ' HD2' ' F' ' 64' ' ' PRO . 38.6 t70 -81.45 -23.6 37.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.926 0.393 . . . . 0.0 110.552 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 62' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' F' ' 21' ' ' ALA . . . -88.63 -42.04 12.27 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.572 0.701 . . . . 0.0 110.099 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 63' ' ' ILE . . . . . 0.574 ' N ' ' CD ' ' F' ' 64' ' ' PRO . 2.4 mm -47.1 -34.52 4.37 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.774 -1.103 . . . . 0.0 113.509 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 64' ' ' PRO . . . . . 0.812 ' O ' HG23 ' F' ' 68' ' ' VAL . 3.5 Cg_exo -78.34 -54.54 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.994 1.796 . . . . 0.0 111.593 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 65' ' ' MET . . . . . 0.825 ' HG2' ' HB3' ' F' ' 20' ' ' ALA . 2.0 tpt -52.79 -37.4 59.69 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 66' ' ' ILE . . . . . 0.521 ' HA ' ' HG2' ' F' ' 17' ' ' MET . 75.7 mt -66.18 -54.46 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.684 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.24 -31.44 61.51 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 68' ' ' VAL . . . . . 0.812 HG23 ' O ' ' F' ' 64' ' ' PRO . 56.6 t -75.68 -44.04 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.86 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.73 -35.65 91.27 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 70' ' ' LEU . . . . . 0.909 ' O ' HG23 ' F' ' 74' ' ' VAL . 0.5 OUTLIER -67.33 -38.05 84.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.696 178.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 71' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' F' ' 75' ' ' MET . . . -64.96 -60.7 6.55 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.278 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 72' ' ' LEU . . . . . 0.905 HD12 ' CE ' ' F' ' 16' ' ' MET . 58.2 mt -52.18 -34.52 45.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.514 0.674 . . . . 0.0 109.623 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 73' ' ' TYR . . . . . 0.905 ' CZ ' HD22 ' E' ' 72' ' ' LEU . 10.7 t80 -71.24 -47.02 59.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.469 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 74' ' ' VAL . . . . . 0.909 HG23 ' O ' ' F' ' 70' ' ' LEU . 92.8 t -62.33 -26.19 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.807 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 75' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' F' ' 71' ' ' GLY . 89.3 mtp -63.75 -50.0 70.8 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 76' ' ' PHE . . . . . 0.812 ' HB2' HD13 ' F' ' 9' ' ' LEU . 2.4 t80 -52.96 -35.98 59.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 77' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' F' ' 74' ' ' VAL . . . -58.23 -32.58 68.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.151 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.16 -32.77 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.122 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 1' ' ' MET . . . . . 0.417 ' HG3' ' OD1' ' H' ' 3' ' ' ASN . 68.1 mtm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.6 0.238 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.67 -29.5 0.77 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.395 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 3' ' ' ASN . . . . . 0.455 ' OD1' ' HG3' ' F' ' 1' ' ' MET . 75.3 m-20 -70.96 -62.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.088 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 4' ' ' LEU . . . . . 0.529 HD22 ' N ' ' G' ' 4' ' ' LEU . 3.0 mm? -65.54 -17.98 64.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.47 . . . . 0.0 109.97 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 5' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' G' ' 1' ' ' MET . 11.9 t-20 -64.62 -71.78 0.17 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.518 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.11 -22.02 60.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.657 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.2 -44.94 28.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.261 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.757 HD12 ' HB3' ' H' ' 10' ' ' TYR . 0.7 OUTLIER -75.0 -40.0 60.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.009 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 9' ' ' LEU . . . . . 0.784 HD13 ' HB2' ' G' ' 76' ' ' PHE . 6.8 tt -56.11 -59.2 5.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.528 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 10' ' ' TYR . . . . . 0.774 ' HB3' HD12 ' F' ' 8' ' ' LEU . 14.9 m-85 -56.12 -54.06 49.6 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.19 0.519 . . . . 0.0 110.182 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 11' ' ' MET . . . . . 0.85 ' HB2' HD21 ' F' ' 8' ' ' LEU . 57.1 ttp -54.48 -20.19 7.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.129 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 12' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' G' ' 9' ' ' LEU . . . -70.56 -54.22 12.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.052 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 13' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' G' ' 17' ' ' MET . . . -62.87 -19.22 63.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.784 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.7 -39.24 11.94 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.491 0.662 . . . . 0.0 109.456 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 15' ' ' VAL . . . . . 0.528 HG23 ' O ' ' G' ' 11' ' ' MET . 46.1 t -74.88 -37.03 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.195 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 16' ' ' MET . . . . . 0.903 ' CE ' HD12 ' G' ' 72' ' ' LEU . 57.7 mtm -70.29 -62.54 1.35 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.407 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 17' ' ' MET . . . . . 0.561 ' HG3' ' O ' ' G' ' 13' ' ' ALA . 40.6 mtm -63.05 -51.5 66.44 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.434 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 18' ' ' GLY . . . . . 0.835 ' HA3' HD23 ' F' ' 19' ' ' LEU . . . -54.61 -37.13 60.25 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.591 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 19' ' ' LEU . . . . . 0.776 HD23 ' HA3' ' H' ' 18' ' ' GLY . 23.9 tp -79.55 -38.38 34.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 20' ' ' ALA . . . . . 0.812 ' HB3' ' HG2' ' G' ' 65' ' ' MET . . . -85.72 -35.94 20.51 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.558 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.588 ' HA ' ' CB ' ' G' ' 62' ' ' ALA . . . -62.54 -43.64 98.31 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 22' ' ' ILE . . . . . 0.928 HD12 ' N ' ' G' ' 23' ' ' GLY . 2.6 pp -65.36 -40.57 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 23' ' ' GLY . . . . . 0.928 ' N ' HD12 ' G' ' 22' ' ' ILE . . . -60.9 -29.35 70.36 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.21 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 24' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' G' ' 58' ' ' GLY . . . -73.26 -56.58 4.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.101 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.49 -54.42 17.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.236 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.12 -56.43 8.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.71 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 27' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' G' ' 31' ' ' LEU . . . -47.95 -54.07 12.75 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.908 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 28' ' ' ILE . . . . . 0.753 HD11 ' HA ' ' G' ' 59' ' ' LEU . 68.7 mt -49.87 -34.34 9.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.74 -34.34 28.08 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.297 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.19 -62.04 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 CA-C-O 121.026 0.441 . . . . 0.0 110.454 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 31' ' ' LEU . . . . . 0.673 HD22 ' CG ' ' G' ' 54' ' ' PHE . 0.5 OUTLIER -60.91 -43.15 98.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.831 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.95 -50.44 67.46 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.878 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.3 -51.99 24.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.827 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.77 -42.22 88.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.58 0.229 . . . . 0.0 111.406 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 35' ' ' PHE . . . . . 0.502 ' CZ ' ' HD2' ' G' ' 50' ' ' ARG . 59.9 t80 -58.67 -47.41 84.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.736 0.303 . . . . 0.0 110.916 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 36' ' ' LEU . . . . . 0.404 HD22 ' CD1' ' F' ' 35' ' ' PHE . 64.0 tp -55.21 -44.23 75.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.037 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.39 -31.38 67.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.02 24.17 27.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.662 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.27 31.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.75 0.31 . . . . 0.0 111.306 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.34 -34.34 21.85 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.937 0.399 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 41' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' G' ' 41' ' ' ARG . 0.4 OUTLIER -67.8 -47.28 69.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.163 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 42' ' ' GLN . . . . . 0.427 ' HB3' ' HD2' ' G' ' 43' ' ' PRO . 84.9 mt-30 -58.15 163.57 4.36 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 43' ' ' PRO . . . . . 0.47 ' O ' ' CG ' ' G' ' 47' ' ' PRO . 52.0 Cg_exo -53.16 161.29 3.69 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.536 2.157 . . . . 0.0 111.982 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.52 30.82 1.89 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 45' ' ' LEU . . . . . . . . . . . . . 58.8 tp -97.67 -60.6 1.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.378 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 46' ' ' ILE . . . . . 0.618 HD12 ' N ' ' G' ' 46' ' ' ILE . 1.7 mp -76.36 -54.59 1.87 Allowed Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.891 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 47' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' G' ' 46' ' ' ILE . 29.0 Cg_endo -63.29 -32.47 72.94 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.8 1.667 . . . . 0.0 112.41 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 48' ' ' LEU . . . . . 0.819 HD23 ' O ' ' G' ' 48' ' ' LEU . 5.5 tt -61.12 -34.46 75.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 49' ' ' LEU . . . . . 0.716 HD12 ' O ' ' G' ' 49' ' ' LEU . 0.3 OUTLIER -75.31 -42.06 55.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.419 179.237 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 50' ' ' ARG . . . . . 0.502 ' HD2' ' CZ ' ' G' ' 35' ' ' PHE . 0.0 OUTLIER -73.49 -35.95 65.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.869 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 51' ' ' THR . . . . . 0.455 ' HA ' ' CD2' ' G' ' 35' ' ' PHE . 55.4 m -59.41 -46.52 88.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.557 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 52' ' ' GLN . . . . . 0.65 ' O ' HG23 ' G' ' 56' ' ' VAL . 9.9 pt20 -61.8 -45.18 94.96 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.268 0.556 . . . . 0.0 109.802 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.23 -36.98 21.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.512 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 54' ' ' PHE . . . . . 0.673 ' CG ' HD22 ' G' ' 31' ' ' LEU . 8.9 m-85 -77.58 -69.58 0.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.112 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 55' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' G' ' 52' ' ' GLN . 28.9 pt -44.6 -33.9 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.802 0.335 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 56' ' ' VAL . . . . . 0.65 HG23 ' O ' ' G' ' 52' ' ' GLN . 91.6 t -76.76 -46.13 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 57' ' ' MET . . . . . . . . . . . . . 49.3 ttm -50.6 -29.52 11.09 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 58' ' ' GLY . . . . . 0.571 ' O ' ' HB1' ' G' ' 24' ' ' ALA . . . -84.6 -33.62 18.68 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 59' ' ' LEU . . . . . 0.753 ' HA ' HD11 ' G' ' 28' ' ' ILE . 45.4 tp -73.09 -7.54 51.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.915 0.388 . . . . 0.0 110.191 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 60' ' ' VAL . . . . . 0.576 HG12 ' O ' ' G' ' 60' ' ' VAL . 64.8 t -109.52 -1.32 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.894 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 61' ' ' ASP . . . . . 0.454 ' O ' ' HD2' ' G' ' 64' ' ' PRO . 38.6 t70 -81.43 -23.55 37.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.972 0.415 . . . . 0.0 110.625 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 62' ' ' ALA . . . . . 0.588 ' CB ' ' HA ' ' G' ' 21' ' ' ALA . . . -88.66 -42.1 12.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.578 0.704 . . . . 0.0 110.043 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 63' ' ' ILE . . . . . 0.57 ' N ' ' CD ' ' G' ' 64' ' ' PRO . 2.4 mm -47.12 -34.42 4.29 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.572 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 64' ' ' PRO . . . . . 0.815 ' O ' HG23 ' G' ' 68' ' ' VAL . 3.6 Cg_exo -78.35 -54.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.975 1.783 . . . . 0.0 111.629 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 65' ' ' MET . . . . . 0.812 ' HG2' ' HB3' ' G' ' 20' ' ' ALA . 2.0 tpt -52.86 -37.35 60.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 66' ' ' ILE . . . . . 0.523 ' HA ' ' HG2' ' G' ' 17' ' ' MET . 75.4 mt -66.23 -54.41 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.643 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.44 61.58 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 68' ' ' VAL . . . . . 0.815 HG23 ' O ' ' G' ' 64' ' ' PRO . 56.2 t -75.68 -43.97 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.9 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.75 -35.66 91.26 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 70' ' ' LEU . . . . . 0.917 ' O ' HG23 ' G' ' 74' ' ' VAL . 0.5 OUTLIER -67.3 -38.0 84.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.716 178.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 71' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' G' ' 75' ' ' MET . . . -65.03 -60.7 6.52 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.252 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 72' ' ' LEU . . . . . 0.903 HD12 ' CE ' ' G' ' 16' ' ' MET . 58.2 mt -52.19 -34.5 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.521 0.677 . . . . 0.0 109.628 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 73' ' ' TYR . . . . . 0.895 ' CZ ' HD22 ' F' ' 72' ' ' LEU . 10.7 t80 -71.19 -47.0 60.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.513 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 74' ' ' VAL . . . . . 0.917 HG23 ' O ' ' G' ' 70' ' ' LEU . 92.7 t -62.4 -26.2 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.784 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 75' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' G' ' 71' ' ' GLY . 89.3 mtp -63.76 -49.97 70.9 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 76' ' ' PHE . . . . . 0.784 ' HB2' HD13 ' G' ' 9' ' ' LEU . 2.4 t80 -52.97 -35.95 59.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 77' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' G' ' 74' ' ' VAL . . . -58.33 -32.52 68.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.108 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.13 -32.77 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.966 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.141 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 1' ' ' MET . . . . . 0.496 ' HG3' ' OD1' ' I' ' 3' ' ' ASN . 68.0 mtm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.643 0.259 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.72 -29.49 0.77 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.362 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 3' ' ' ASN . . . . . 0.417 ' OD1' ' HG3' ' G' ' 1' ' ' MET . 75.3 m-20 -71.02 -62.85 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.047 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 4' ' ' LEU . . . . . 0.517 HD22 ' N ' ' H' ' 4' ' ' LEU . 3.0 mm? -65.61 -17.82 64.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.111 0.481 . . . . 0.0 109.978 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.74 -71.77 0.17 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.454 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.12 -22.0 60.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.67 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.22 -44.89 28.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.255 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 8' ' ' LEU . . . . . 0.761 HD22 ' CE ' ' H' ' 11' ' ' MET . 0.7 OUTLIER -75.02 -40.01 60.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.946 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 9' ' ' LEU . . . . . 0.778 HD13 ' HB2' ' H' ' 76' ' ' PHE . 6.8 tt -56.19 -59.11 5.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.521 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 10' ' ' TYR . . . . . 0.757 ' HB3' HD12 ' G' ' 8' ' ' LEU . 14.9 m-85 -56.12 -54.17 48.33 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.225 0.535 . . . . 0.0 110.163 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 11' ' ' MET . . . . . 0.761 ' CE ' HD22 ' H' ' 8' ' ' LEU . 57.2 ttp -54.46 -20.13 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.145 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 12' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' H' ' 9' ' ' LEU . . . -70.55 -54.26 12.83 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.013 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 13' ' ' ALA . . . . . 0.559 ' O ' ' HG3' ' H' ' 17' ' ' MET . . . -62.92 -19.16 63.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.768 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.68 -39.27 11.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.478 0.656 . . . . 0.0 109.454 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 15' ' ' VAL . . . . . 0.531 HG23 ' O ' ' H' ' 11' ' ' MET . 46.0 t -74.89 -37.03 40.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.163 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 16' ' ' MET . . . . . 0.896 ' CE ' HD12 ' H' ' 72' ' ' LEU . 57.7 mtm -70.24 -62.56 1.34 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.404 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 17' ' ' MET . . . . . 0.559 ' HG3' ' O ' ' H' ' 13' ' ' ALA . 40.6 mtm -63.08 -51.44 66.62 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.436 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 18' ' ' GLY . . . . . 0.776 ' HA3' HD23 ' G' ' 19' ' ' LEU . . . -54.62 -37.1 60.21 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 119.573 -1.299 . . . . 0.0 111.597 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 19' ' ' LEU . . . . . 0.709 HD23 ' HA3' ' I' ' 18' ' ' GLY . 24.5 tp -79.59 -38.4 34.1 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 20' ' ' ALA . . . . . 0.821 ' HB3' ' HG2' ' H' ' 65' ' ' MET . . . -85.68 -35.93 20.58 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.567 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.597 ' HA ' ' CB ' ' H' ' 62' ' ' ALA . . . -62.59 -43.66 98.26 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 22' ' ' ILE . . . . . 0.928 HD12 ' N ' ' H' ' 23' ' ' GLY . 2.6 pp -65.34 -40.54 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.928 ' N ' HD12 ' H' ' 22' ' ' ILE . . . -60.9 -29.34 70.33 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 24' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' H' ' 58' ' ' GLY . . . -73.29 -56.6 4.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.038 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.53 -54.36 18.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.195 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 26' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' H' ' 30' ' ' ILE . 49.1 mm -53.23 -56.36 8.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.732 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 27' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' H' ' 31' ' ' LEU . . . -47.95 -54.07 12.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.935 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 28' ' ' ILE . . . . . 0.748 HD11 ' HA ' ' H' ' 59' ' ' LEU . 68.8 mt -49.91 -34.34 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.73 -34.32 28.17 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.333 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 30' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' H' ' 26' ' ' ILE . 49.4 mm -77.19 -62.07 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.974 0.416 . . . . 0.0 110.407 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 31' ' ' LEU . . . . . 0.666 HD22 ' CG ' ' H' ' 54' ' ' PHE . 0.5 OUTLIER -60.91 -43.16 98.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.83 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.99 -50.39 68.02 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.888 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.27 -52.01 24.54 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.822 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.82 -42.15 88.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.563 0.221 . . . . 0.0 111.368 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 35' ' ' PHE . . . . . 0.499 ' CZ ' ' HD2' ' H' ' 50' ' ' ARG . 59.9 t80 -58.7 -47.39 84.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.896 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 36' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' G' ' 35' ' ' PHE . 64.2 tp -55.25 -44.25 75.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 37' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -58.39 -31.35 67.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.013 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.02 24.14 28.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.688 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.24 31.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 111.313 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.28 -34.32 21.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.942 0.401 . . . . 0.0 111.112 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 41' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' H' ' 41' ' ' ARG . 0.4 OUTLIER -67.83 -47.29 69.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.15 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 42' ' ' GLN . . . . . 0.429 ' HB3' ' HD2' ' H' ' 43' ' ' PRO . 84.8 mt-30 -58.09 163.58 4.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.092 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 43' ' ' PRO . . . . . 0.471 ' O ' ' CG ' ' H' ' 47' ' ' PRO . 52.2 Cg_exo -53.26 161.29 3.85 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.496 2.13 . . . . 0.0 111.968 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.49 30.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.834 0.349 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.68 -60.62 1.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.053 0.454 . . . . 0.0 111.343 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 46' ' ' ILE . . . . . 0.607 HD12 ' N ' ' H' ' 46' ' ' ILE . 1.7 mp -76.29 -54.65 1.89 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.908 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 47' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' H' ' 46' ' ' ILE . 29.0 Cg_endo -63.21 -32.55 73.73 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.835 1.69 . . . . 0.0 112.401 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 48' ' ' LEU . . . . . 0.805 HD23 ' O ' ' H' ' 48' ' ' LEU . 5.5 tt -61.08 -34.49 74.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 109.594 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 49' ' ' LEU . . . . . 0.721 HD12 ' O ' ' H' ' 49' ' ' LEU . 0.3 OUTLIER -75.29 -42.09 55.55 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.423 179.204 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 50' ' ' ARG . . . . . 0.499 ' HD2' ' CZ ' ' H' ' 35' ' ' PHE . 0.0 OUTLIER -73.5 -35.87 65.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.899 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 51' ' ' THR . . . . . 0.45 ' HA ' ' CD2' ' H' ' 35' ' ' PHE . 53.3 m -59.38 -46.58 88.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.548 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 52' ' ' GLN . . . . . 0.643 ' O ' HG23 ' H' ' 56' ' ' VAL . 9.9 pt20 -61.78 -45.12 95.27 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.233 0.539 . . . . 0.0 109.851 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 53' ' ' PHE . . . . . 0.4 ' N ' ' HG3' ' H' ' 52' ' ' GLN . 1.2 t80 -49.3 -36.88 22.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.484 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 54' ' ' PHE . . . . . 0.666 ' CG ' HD22 ' H' ' 31' ' ' LEU . 8.9 m-85 -77.74 -69.54 0.54 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.034 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 55' ' ' ILE . . . . . 0.506 HG12 ' HA ' ' H' ' 52' ' ' GLN . 28.8 pt -44.6 -33.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.81 0.338 . . . . 0.0 110.878 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 56' ' ' VAL . . . . . 0.643 HG23 ' O ' ' H' ' 52' ' ' GLN . 91.7 t -76.74 -46.1 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.67 -29.43 11.12 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 58' ' ' GLY . . . . . 0.564 ' O ' ' HB1' ' H' ' 24' ' ' ALA . . . -84.64 -33.65 18.47 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 59' ' ' LEU . . . . . 0.748 ' HA ' HD11 ' H' ' 28' ' ' ILE . 45.4 tp -73.09 -7.54 51.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.958 0.408 . . . . 0.0 110.194 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 60' ' ' VAL . . . . . 0.591 HG12 ' O ' ' H' ' 60' ' ' VAL . 64.8 t -109.53 -1.33 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.873 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 61' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' H' ' 64' ' ' PRO . 38.6 t70 -81.46 -23.53 37.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.916 0.389 . . . . 0.0 110.593 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 62' ' ' ALA . . . . . 0.597 ' CB ' ' HA ' ' H' ' 21' ' ' ALA . . . -88.67 -42.07 12.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.589 0.709 . . . . 0.0 110.048 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 63' ' ' ILE . . . . . 0.574 ' N ' ' CD ' ' H' ' 64' ' ' PRO . 2.4 mm -47.18 -34.42 4.41 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.525 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 64' ' ' PRO . . . . . 0.825 ' O ' HG23 ' H' ' 68' ' ' VAL . 3.6 Cg_exo -78.34 -54.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.968 1.778 . . . . 0.0 111.616 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 65' ' ' MET . . . . . 0.821 ' HG2' ' HB3' ' H' ' 20' ' ' ALA . 2.0 tpt -52.84 -37.37 60.04 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 66' ' ' ILE . . . . . 0.513 ' HA ' ' HG2' ' H' ' 17' ' ' MET . 75.6 mt -66.18 -54.44 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.646 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.3 -31.39 61.59 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 68' ' ' VAL . . . . . 0.825 HG23 ' O ' ' H' ' 64' ' ' PRO . 55.8 t -75.64 -44.02 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.894 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 69' ' ' GLY . . . . . 0.442 ' HA2' ' HE1' ' H' ' 16' ' ' MET . . . -65.76 -35.66 91.24 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 70' ' ' LEU . . . . . 0.907 ' O ' HG23 ' H' ' 74' ' ' VAL . 0.5 OUTLIER -67.31 -38.1 84.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.664 178.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 71' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' H' ' 75' ' ' MET . . . -64.98 -60.73 6.5 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.235 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 72' ' ' LEU . . . . . 0.971 HD22 ' CZ ' ' I' ' 73' ' ' TYR . 58.5 mt -52.16 -34.5 45.2 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.508 0.67 . . . . 0.0 109.646 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 73' ' ' TYR . . . . . 0.877 ' CZ ' HD22 ' G' ' 72' ' ' LEU . 10.7 t80 -71.21 -46.99 60.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.497 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 74' ' ' VAL . . . . . 0.907 HG23 ' O ' ' H' ' 70' ' ' LEU . 92.6 t -62.41 -26.22 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.822 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 75' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' H' ' 71' ' ' GLY . 89.3 mtp -63.72 -49.93 71.12 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 76' ' ' PHE . . . . . 0.778 ' HB2' HD13 ' H' ' 9' ' ' LEU . 2.4 t80 -52.97 -35.99 59.66 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 77' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' H' ' 74' ' ' VAL . . . -58.28 -32.53 68.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.1 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.18 -32.69 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.114 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.635 0.255 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.74 -29.42 0.77 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.398 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 3' ' ' ASN . . . . . 0.496 ' OD1' ' HG3' ' H' ' 1' ' ' MET . 75.3 m-20 -71.08 -62.83 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.046 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 4' ' ' LEU . . . . . 0.532 HD22 ' N ' ' I' ' 4' ' ' LEU . 3.0 mm? -65.57 -17.92 64.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 0.0 109.944 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.73 -71.67 0.17 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.516 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 6' ' ' MET . . . . . . . . . . . . . 23.3 ptp -59.15 -22.0 60.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.688 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.24 -44.84 28.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.274 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 8' ' ' LEU . . . . . 0.761 HD22 ' CE ' ' I' ' 11' ' ' MET . 0.7 OUTLIER -75.02 -40.09 60.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.962 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 9' ' ' LEU . . . . . 0.807 HD13 ' HB2' ' I' ' 76' ' ' PHE . 6.8 tt -56.06 -59.2 5.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.545 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 10' ' ' TYR . . . . . 0.719 ' HB3' HD12 ' H' ' 8' ' ' LEU . 14.9 m-85 -56.1 -54.15 48.56 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.202 0.525 . . . . 0.0 110.192 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 11' ' ' MET . . . . . 0.761 ' CE ' HD22 ' I' ' 8' ' ' LEU . 57.3 ttp -54.44 -20.16 7.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.131 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 12' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' I' ' 9' ' ' LEU . . . -70.5 -54.21 13.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 13' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' I' ' 17' ' ' MET . . . -62.89 -19.24 63.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.723 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.67 -39.26 11.94 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.503 0.668 . . . . 0.0 109.493 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 15' ' ' VAL . . . . . 0.535 HG23 ' O ' ' I' ' 11' ' ' MET . 46.1 t -74.89 -37.04 40.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.171 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 16' ' ' MET . . . . . 0.894 ' CE ' HD12 ' I' ' 72' ' ' LEU . 57.8 mtm -70.22 -62.55 1.34 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.451 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 17' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' I' ' 13' ' ' ALA . 40.6 mtm -63.07 -51.47 66.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.409 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 18' ' ' GLY . . . . . 0.709 ' HA3' HD23 ' H' ' 19' ' ' LEU . . . -54.61 -37.08 60.13 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.614 -1.279 . . . . 0.0 111.622 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 19' ' ' LEU . . . . . 0.625 HD23 ' HA3' ' J' ' 18' ' ' GLY . 24.5 tp -79.57 -38.48 34.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 20' ' ' ALA . . . . . 0.842 ' HB3' ' HG2' ' I' ' 65' ' ' MET . . . -85.65 -35.97 20.6 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.504 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 21' ' ' ALA . . . . . 0.594 ' HA ' ' CB ' ' I' ' 62' ' ' ALA . . . -62.55 -43.69 98.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 22' ' ' ILE . . . . . 0.92 HD12 ' N ' ' I' ' 23' ' ' GLY . 2.6 pp -65.27 -40.58 89.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 23' ' ' GLY . . . . . 0.92 ' N ' HD12 ' I' ' 22' ' ' ILE . . . -60.91 -29.38 70.45 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.203 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 24' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' I' ' 58' ' ' GLY . . . -73.22 -56.63 4.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.054 -0.573 . . . . 0.0 110.065 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.49 -54.35 18.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.226 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.23 -56.4 8.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.684 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 27' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' I' ' 31' ' ' LEU . . . -47.95 -54.11 12.66 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.875 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 28' ' ' ILE . . . . . 0.734 HD11 ' HA ' ' I' ' 59' ' ' LEU . 68.6 mt -49.83 -34.38 9.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.68 -34.35 28.29 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.345 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.24 -62.05 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.938 0.399 . . . . 0.0 110.389 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 31' ' ' LEU . . . . . 0.667 HD22 ' CG ' ' I' ' 54' ' ' PHE . 0.5 OUTLIER -60.92 -43.18 98.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.781 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.99 -50.45 67.41 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.841 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.23 -52.06 24.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.818 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.78 -42.12 88.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.595 0.236 . . . . 0.0 111.429 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 35' ' ' PHE . . . . . 0.597 ' CD1' HD22 ' J' ' 36' ' ' LEU . 60.0 t80 -58.72 -47.41 84.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 36' ' ' LEU . . . . . . . . . . . . . 64.1 tp -55.2 -44.27 75.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 37' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -58.37 -31.4 67.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.061 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.99 24.16 27.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.675 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.25 31.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.762 0.315 . . . . 0.0 111.313 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.3 -34.34 21.91 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.064 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 41' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' I' ' 41' ' ' ARG . 0.4 OUTLIER -67.81 -47.29 69.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.147 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 42' ' ' GLN . . . . . 0.425 ' HB3' ' HD2' ' I' ' 43' ' ' PRO . 84.8 mt-30 -58.16 163.51 4.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.143 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 43' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' I' ' 47' ' ' PRO . 52.2 Cg_exo -53.2 161.34 3.72 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.507 2.138 . . . . 0.0 111.987 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.55 30.92 1.87 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.78 -60.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.323 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 46' ' ' ILE . . . . . 0.615 HD12 ' N ' ' I' ' 46' ' ' ILE . 1.7 mp -76.26 -54.64 1.91 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.891 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 47' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' I' ' 46' ' ' ILE . 29.0 Cg_endo -63.19 -32.58 73.94 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.83 1.686 . . . . 0.0 112.407 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 48' ' ' LEU . . . . . 0.815 HD23 ' O ' ' I' ' 48' ' ' LEU . 5.5 tt -61.1 -34.45 74.96 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 49' ' ' LEU . . . . . 0.716 ' O ' HD12 ' I' ' 49' ' ' LEU . 0.3 OUTLIER -75.29 -42.09 55.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.416 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 50' ' ' ARG . . . . . 0.498 ' HD2' ' CZ ' ' I' ' 35' ' ' PHE . 0.0 OUTLIER -73.49 -35.89 65.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.93 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 51' ' ' THR . . . . . 0.454 ' HA ' ' CD2' ' I' ' 35' ' ' PHE . 53.6 m -59.39 -46.54 88.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.556 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 52' ' ' GLN . . . . . 0.653 ' O ' HG23 ' I' ' 56' ' ' VAL . 9.9 pt20 -61.84 -45.14 95.1 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.215 0.531 . . . . 0.0 109.802 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 53' ' ' PHE . . . . . 0.401 ' N ' ' HG3' ' I' ' 52' ' ' GLN . 1.2 t80 -49.29 -36.89 22.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.478 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 54' ' ' PHE . . . . . 0.667 ' CG ' HD22 ' I' ' 31' ' ' LEU . 8.7 m-85 -77.67 -69.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.053 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 55' ' ' ILE . . . . . 0.505 HG12 ' HA ' ' I' ' 52' ' ' GLN . 29.0 pt -44.54 -33.94 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.754 0.312 . . . . 0.0 110.932 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 56' ' ' VAL . . . . . 0.653 HG23 ' O ' ' I' ' 52' ' ' GLN . 91.3 t -76.75 -46.17 30.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.59 -29.47 10.94 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 58' ' ' GLY . . . . . 0.559 ' C ' HD11 ' I' ' 28' ' ' ILE . . . -84.62 -33.59 18.71 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 59' ' ' LEU . . . . . 0.734 ' HA ' HD11 ' I' ' 28' ' ' ILE . 44.9 tp -73.1 -7.53 51.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.939 0.4 . . . . 0.0 110.178 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 60' ' ' VAL . . . . . 0.59 HG12 ' O ' ' I' ' 60' ' ' VAL . 64.7 t -109.54 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.84 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 61' ' ' ASP . . . . . 0.455 ' O ' ' HD2' ' I' ' 64' ' ' PRO . 38.6 t70 -81.44 -23.56 37.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.949 0.404 . . . . 0.0 110.61 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 62' ' ' ALA . . . . . 0.594 ' CB ' ' HA ' ' I' ' 21' ' ' ALA . . . -88.69 -42.08 12.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.524 0.678 . . . . 0.0 109.994 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 63' ' ' ILE . . . . . 0.579 ' N ' ' CD ' ' I' ' 64' ' ' PRO . 2.4 mm -47.04 -34.55 4.28 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.548 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 64' ' ' PRO . . . . . 0.827 ' O ' HG23 ' I' ' 68' ' ' VAL . 3.6 Cg_exo -78.33 -54.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.934 1.756 . . . . 0.0 111.618 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 65' ' ' MET . . . . . 0.842 ' HG2' ' HB3' ' I' ' 20' ' ' ALA . 2.0 tpt -52.83 -37.36 59.95 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 66' ' ' ILE . . . . . 0.511 ' HA ' ' HG2' ' I' ' 17' ' ' MET . 75.6 mt -66.25 -54.46 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.638 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.26 -31.4 61.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 68' ' ' VAL . . . . . 0.827 HG23 ' O ' ' I' ' 64' ' ' PRO . 56.6 t -75.73 -44.02 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.888 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' HE1' ' I' ' 16' ' ' MET . . . -65.71 -35.67 91.32 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 70' ' ' LEU . . . . . 0.911 ' O ' HG23 ' I' ' 74' ' ' VAL . 0.5 OUTLIER -67.24 -38.06 84.59 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.795 -0.702 . . . . 0.0 109.699 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 71' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' I' ' 75' ' ' MET . . . -65.0 -60.69 6.55 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 72' ' ' LEU . . . . . 0.944 HD22 ' CZ ' ' J' ' 73' ' ' TYR . 58.6 mt -52.22 -34.5 46.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.503 0.668 . . . . 0.0 109.63 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 73' ' ' TYR . . . . . 0.971 ' CZ ' HD22 ' H' ' 72' ' ' LEU . 10.6 t80 -71.18 -47.05 59.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.491 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 74' ' ' VAL . . . . . 0.911 HG23 ' O ' ' I' ' 70' ' ' LEU . 93.0 t -62.35 -26.22 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.83 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 75' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' I' ' 71' ' ' GLY . 89.2 mtp -63.78 -49.91 71.06 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 76' ' ' PHE . . . . . 0.807 ' HB2' HD13 ' I' ' 9' ' ' LEU . 2.4 t80 -53.03 -35.92 59.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 77' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' I' ' 74' ' ' VAL . . . -58.33 -32.5 68.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.08 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 78' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.19 -32.78 55.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.101 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' J' J ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.622 0.249 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' J' J ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.62 -29.45 0.74 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.436 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.12 -62.81 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.07 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 4' ' ' LEU . . . . . 0.518 HD22 ' N ' ' J' ' 4' ' ' LEU . 3.0 mm? -65.52 -17.97 64.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.164 0.507 . . . . 0.0 109.973 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.65 -71.71 0.17 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.517 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.22 -21.95 60.31 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.624 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.23 -44.94 28.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.225 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 8' ' ' LEU . . . . . 0.748 HD22 ' CE ' ' J' ' 11' ' ' MET . 0.7 OUTLIER -74.98 -40.08 60.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.958 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 9' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' J' ' 76' ' ' PHE . 6.8 tt -56.13 -59.13 5.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.548 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 10' ' ' TYR . . . . . 0.707 ' HB3' HD12 ' I' ' 8' ' ' LEU . 14.8 m-85 -56.15 -54.17 48.28 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 110.114 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 11' ' ' MET . . . . . 0.748 ' CE ' HD22 ' J' ' 8' ' ' LEU . 57.2 ttp -54.42 -20.19 7.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.145 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 12' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' J' ' 9' ' ' LEU . . . -70.51 -54.2 13.17 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.066 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 13' ' ' ALA . . . . . 0.558 ' O ' ' HG3' ' J' ' 17' ' ' MET . . . -62.95 -19.13 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.815 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.74 -39.18 11.95 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.505 0.669 . . . . 0.0 109.45 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 15' ' ' VAL . . . . . 0.531 HG23 ' O ' ' J' ' 11' ' ' MET . 46.1 t -74.89 -37.08 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.161 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 16' ' ' MET . . . . . 0.908 ' CE ' HD12 ' J' ' 72' ' ' LEU . 57.6 mtm -70.24 -62.52 1.36 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.379 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 17' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' J' ' 13' ' ' ALA . 40.5 mtm -63.11 -51.43 66.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.429 -178.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 18' ' ' GLY . . . . . 0.693 ' O ' HG23 ' J' ' 22' ' ' ILE . . . -54.63 -37.08 60.19 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.569 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 19' ' ' LEU . . . . . 0.733 HD23 ' HA3' ' K' ' 18' ' ' GLY . 24.2 tp -79.63 -38.42 33.81 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 20' ' ' ALA . . . . . 0.829 ' HB3' ' HG2' ' J' ' 65' ' ' MET . . . -85.63 -35.98 20.63 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.478 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 21' ' ' ALA . . . . . 0.588 ' HA ' ' CB ' ' J' ' 62' ' ' ALA . . . -62.55 -43.69 98.19 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 22' ' ' ILE . . . . . 0.92 HD12 ' N ' ' J' ' 23' ' ' GLY . 2.6 pp -65.32 -40.51 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 23' ' ' GLY . . . . . 0.92 ' N ' HD12 ' J' ' 22' ' ' ILE . . . -61.0 -29.3 70.52 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 24' ' ' ALA . . . . . 0.556 ' HB1' ' O ' ' J' ' 58' ' ' GLY . . . -73.23 -56.66 4.79 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.044 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.52 -54.38 18.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.15 -56.41 8.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.741 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 27' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' J' ' 31' ' ' LEU . . . -47.95 -54.09 12.71 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.89 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 28' ' ' ILE . . . . . 0.736 HD11 ' HA ' ' J' ' 59' ' ' LEU . 68.4 mt -49.86 -34.32 9.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.73 -34.32 28.16 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.353 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.19 -62.05 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 120.981 0.419 . . . . 0.0 110.446 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 31' ' ' LEU . . . . . 0.672 HD22 ' CG ' ' J' ' 54' ' ' PHE . 0.5 OUTLIER -60.9 -43.17 98.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.837 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.96 -50.47 67.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.861 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.27 -51.99 24.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.845 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 34' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -58.81 -42.11 88.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.586 0.232 . . . . 0.0 111.403 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 35' ' ' PHE . . . . . 0.7 ' CD1' HD22 ' K' ' 36' ' ' LEU . 59.7 t80 -58.69 -47.47 84.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.894 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 36' ' ' LEU . . . . . 0.597 HD22 ' CD1' ' I' ' 35' ' ' PHE . 64.1 tp -55.13 -44.32 74.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.39 -31.35 67.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.045 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.01 24.17 27.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.693 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.25 31.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.768 0.318 . . . . 0.0 111.362 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.3 -34.36 21.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 41' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' J' ' 41' ' ' ARG . 0.4 OUTLIER -67.8 -47.32 69.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.149 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 42' ' ' GLN . . . . . 0.417 ' HB3' ' HD2' ' J' ' 43' ' ' PRO . 84.8 mt-30 -58.1 163.55 4.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 43' ' ' PRO . . . . . 0.477 ' O ' ' CG ' ' J' ' 47' ' ' PRO . 52.1 Cg_exo -53.17 161.36 3.66 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.52 2.147 . . . . 0.0 111.934 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.59 30.86 1.9 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.7 -60.62 1.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.343 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 46' ' ' ILE . . . . . 0.619 HD12 ' N ' ' J' ' 46' ' ' ILE . 1.7 mp -76.37 -54.57 1.87 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.891 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 47' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' J' ' 46' ' ' ILE . 29.0 Cg_endo -63.28 -32.48 72.97 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.837 1.692 . . . . 0.0 112.385 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 48' ' ' LEU . . . . . 0.815 HD23 ' O ' ' J' ' 48' ' ' LEU . 5.5 tt -61.13 -34.46 75.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 49' ' ' LEU . . . . . 0.722 ' O ' HD12 ' J' ' 49' ' ' LEU . 0.3 OUTLIER -75.25 -42.16 55.79 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.378 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 50' ' ' ARG . . . . . 0.498 ' HD2' ' CZ ' ' J' ' 35' ' ' PHE . 0.0 OUTLIER -73.44 -35.88 65.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.969 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 51' ' ' THR . . . . . 0.45 ' HA ' ' CD2' ' J' ' 35' ' ' PHE . 54.1 m -59.35 -46.58 88.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.573 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 52' ' ' GLN . . . . . 0.653 ' O ' HG23 ' J' ' 56' ' ' VAL . 9.9 pt20 -61.82 -45.13 95.17 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.197 0.523 . . . . 0.0 109.807 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.24 -36.95 21.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.509 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 54' ' ' PHE . . . . . 0.672 ' CG ' HD22 ' J' ' 31' ' ' LEU . 8.8 m-85 -77.62 -69.6 0.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.089 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 55' ' ' ILE . . . . . 0.595 HG21 ' CE1' ' I' ' 54' ' ' PHE . 28.9 pt -44.57 -33.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.828 0.346 . . . . 0.0 110.971 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 56' ' ' VAL . . . . . 0.653 HG23 ' O ' ' J' ' 52' ' ' GLN . 92.1 t -76.81 -46.07 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 57' ' ' MET . . . . . . . . . . . . . 49.1 ttm -50.6 -29.52 11.1 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 58' ' ' GLY . . . . . 0.556 ' O ' ' HB1' ' J' ' 24' ' ' ALA . . . -84.57 -33.69 18.57 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 59' ' ' LEU . . . . . 0.736 ' HA ' HD11 ' J' ' 28' ' ' ILE . 45.4 tp -73.13 -7.44 51.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.941 0.401 . . . . 0.0 110.182 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 60' ' ' VAL . . . . . 0.59 HG12 ' O ' ' J' ' 60' ' ' VAL . 64.9 t -109.56 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.884 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 61' ' ' ASP . . . . . 0.456 ' O ' ' HD2' ' J' ' 64' ' ' PRO . 38.6 t70 -81.47 -23.55 37.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.935 0.398 . . . . 0.0 110.591 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 62' ' ' ALA . . . . . 0.588 ' CB ' ' HA ' ' J' ' 21' ' ' ALA . . . -88.67 -42.05 12.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.532 0.682 . . . . 0.0 110.041 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 63' ' ' ILE . . . . . 0.574 ' N ' ' CD ' ' J' ' 64' ' ' PRO . 2.4 mm -47.13 -34.5 4.41 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.507 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 64' ' ' PRO . . . . . 0.832 ' O ' HG23 ' J' ' 68' ' ' VAL . 3.5 Cg_exo -78.34 -54.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.973 1.782 . . . . 0.0 111.634 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 65' ' ' MET . . . . . 0.829 ' HG2' ' HB3' ' J' ' 20' ' ' ALA . 2.0 tpt -52.86 -37.39 60.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 66' ' ' ILE . . . . . 0.517 ' HA ' ' HG2' ' J' ' 17' ' ' MET . 75.4 mt -66.22 -54.42 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.601 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.26 -31.5 61.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 68' ' ' VAL . . . . . 0.832 HG23 ' O ' ' J' ' 64' ' ' PRO . 56.5 t -75.66 -43.96 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.941 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' HE1' ' J' ' 16' ' ' MET . . . -65.75 -35.64 91.23 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 70' ' ' LEU . . . . . 0.908 ' O ' HG23 ' J' ' 74' ' ' VAL . 0.5 OUTLIER -67.28 -38.07 84.46 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.694 178.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 71' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' J' ' 75' ' ' MET . . . -64.96 -60.75 6.49 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 72' ' ' LEU . . . . . 0.908 HD12 ' CE ' ' J' ' 16' ' ' MET . 58.7 mt -52.18 -34.48 45.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.522 0.677 . . . . 0.0 109.636 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 73' ' ' TYR . . . . . 0.944 ' CZ ' HD22 ' I' ' 72' ' ' LEU . 10.7 t80 -71.22 -47.0 59.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.488 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 74' ' ' VAL . . . . . 0.908 HG23 ' O ' ' J' ' 70' ' ' LEU . 92.9 t -62.39 -26.24 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.838 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 75' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' J' ' 71' ' ' GLY . 89.3 mtp -63.74 -49.99 70.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 76' ' ' PHE . . . . . 0.81 ' HB2' HD13 ' J' ' 9' ' ' LEU . 2.4 t80 -53.0 -35.91 59.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 77' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' J' ' 74' ' ' VAL . . . -58.35 -32.51 68.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.137 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.21 -32.67 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.993 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.126 179.95 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.593 0.235 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.63 -29.47 0.75 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.414 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.06 -62.76 1.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.106 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 4' ' ' LEU . . . . . 0.522 HD22 ' N ' ' K' ' 4' ' ' LEU . 3.0 mm? -65.6 -17.93 64.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.109 0.481 . . . . 0.0 109.939 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.72 -71.69 0.17 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.5 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 6' ' ' MET . . . . . . . . . . . . . 23.4 ptp -59.22 -21.93 60.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.673 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.27 -44.88 28.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.238 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 8' ' ' LEU . . . . . 0.753 HD22 ' CE ' ' K' ' 11' ' ' MET . 0.7 OUTLIER -75.06 -40.01 60.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.969 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 9' ' ' LEU . . . . . 0.799 HD13 ' HB2' ' K' ' 76' ' ' PHE . 6.8 tt -56.16 -59.11 5.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.514 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 10' ' ' TYR . . . . . 0.746 ' HB3' HD12 ' J' ' 8' ' ' LEU . 14.9 m-85 -56.13 -54.2 47.91 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.256 0.55 . . . . 0.0 110.167 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 11' ' ' MET . . . . . 0.753 ' CE ' HD22 ' K' ' 8' ' ' LEU . 57.2 ttp -54.37 -20.2 6.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.118 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 12' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' K' ' 9' ' ' LEU . . . -70.55 -54.23 12.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.032 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 13' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' K' ' 17' ' ' MET . . . -62.94 -19.15 63.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.752 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.7 -39.23 11.95 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.493 0.663 . . . . 0.0 109.43 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 15' ' ' VAL . . . . . 0.532 HG23 ' O ' ' K' ' 11' ' ' MET . 46.1 t -74.92 -37.07 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.148 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 16' ' ' MET . . . . . 0.892 ' CE ' HD12 ' K' ' 72' ' ' LEU . 57.8 mtm -70.14 -62.58 1.33 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.444 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 17' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' K' ' 13' ' ' ALA . 40.6 mtm -63.09 -51.47 66.45 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.405 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 18' ' ' GLY . . . . . 0.733 ' HA3' HD23 ' J' ' 19' ' ' LEU . . . -54.63 -37.06 60.18 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.587 -1.292 . . . . 0.0 111.595 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 19' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' K' ' 15' ' ' VAL . 24.5 tp -79.56 -38.43 34.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 20' ' ' ALA . . . . . 0.84 ' HB3' ' HG2' ' K' ' 65' ' ' MET . . . -85.68 -35.95 20.57 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.609 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 21' ' ' ALA . . . . . 0.589 ' HA ' ' CB ' ' K' ' 62' ' ' ALA . . . -62.54 -43.7 98.16 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 22' ' ' ILE . . . . . 0.937 HD12 ' N ' ' K' ' 23' ' ' GLY . 2.6 pp -65.27 -40.56 88.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 23' ' ' GLY . . . . . 0.937 ' N ' HD12 ' K' ' 22' ' ' ILE . . . -61.05 -29.27 70.5 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 177.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 24' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' K' ' 58' ' ' GLY . . . -73.26 -56.63 4.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.052 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.5 -54.4 18.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.216 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.11 -56.42 8.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.717 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 27' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' K' ' 31' ' ' LEU . . . -48.0 -54.03 13.01 Favored Glycine 0 CA--C 1.509 -0.322 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.922 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 28' ' ' ILE . . . . . 0.756 HD11 ' HA ' ' K' ' 59' ' ' LEU . 68.5 mt -49.92 -34.31 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.301 0.572 . . . . 0.0 109.461 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.72 -34.4 28.02 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.32 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mm -77.16 -62.02 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.981 0.419 . . . . 0.0 110.439 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 31' ' ' LEU . . . . . 0.675 HD22 ' CG ' ' K' ' 54' ' ' PHE . 0.5 OUTLIER -61.0 -43.12 99.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.808 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.97 -50.44 67.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.837 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.28 -52.0 24.53 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.838 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.81 -42.16 88.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.636 0.255 . . . . 0.0 111.392 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 35' ' ' PHE . . . . . 0.495 ' CZ ' ' HD2' ' K' ' 50' ' ' ARG . 60.0 t80 -58.7 -47.39 84.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.802 0.334 . . . . 0.0 110.908 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 36' ' ' LEU . . . . . 0.7 HD22 ' CD1' ' J' ' 35' ' ' PHE . 64.2 tp -55.23 -44.26 75.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.049 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.33 -31.42 67.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.022 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.0 24.17 27.86 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.717 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.28 31.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.764 0.316 . . . . 0.0 111.328 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.34 -34.35 21.85 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.024 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 41' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' K' ' 41' ' ' ARG . 0.4 OUTLIER -67.83 -47.3 69.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 42' ' ' GLN . . . . . 0.409 ' HB3' ' HD2' ' K' ' 43' ' ' PRO . 84.8 mt-30 -58.09 163.56 4.3 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 43' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' K' ' 47' ' ' PRO . 52.3 Cg_exo -53.23 161.39 3.74 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.498 2.132 . . . . 0.0 111.972 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.65 30.92 1.9 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.853 0.359 . . . . 0.0 110.813 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.71 -60.59 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.354 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 46' ' ' ILE . . . . . 0.622 HD12 ' N ' ' K' ' 46' ' ' ILE . 1.7 mp -76.38 -54.57 1.86 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.891 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 47' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' K' ' 46' ' ' ILE . 29.0 Cg_endo -63.22 -32.57 73.62 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 121.866 1.711 . . . . 0.0 112.391 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 48' ' ' LEU . . . . . 0.805 HD23 ' O ' ' K' ' 48' ' ' LEU . 5.5 tt -61.15 -34.39 74.94 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 49' ' ' LEU . . . . . 0.712 ' O ' HD12 ' K' ' 49' ' ' LEU . 0.3 OUTLIER -75.33 -42.11 55.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.401 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 50' ' ' ARG . . . . . 0.495 ' HD2' ' CZ ' ' K' ' 35' ' ' PHE . 0.0 OUTLIER -73.42 -35.92 65.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.937 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 51' ' ' THR . . . . . 0.448 ' HA ' ' CD2' ' K' ' 35' ' ' PHE . 53.6 m -59.35 -46.61 88.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.562 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 52' ' ' GLN . . . . . 0.642 ' O ' HG23 ' K' ' 56' ' ' VAL . 9.9 pt20 -61.76 -45.15 95.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.184 0.516 . . . . 0.0 109.809 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.29 -36.95 22.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.454 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 54' ' ' PHE . . . . . 0.675 ' CG ' HD22 ' K' ' 31' ' ' LEU . 8.8 m-85 -77.7 -69.55 0.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.018 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 55' ' ' ILE . . . . . 0.598 HG21 ' CE1' ' J' ' 54' ' ' PHE . 29.0 pt -44.62 -33.9 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.768 0.318 . . . . 0.0 110.914 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 56' ' ' VAL . . . . . 0.642 HG23 ' O ' ' K' ' 52' ' ' GLN . 93.0 t -76.78 -46.09 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 57' ' ' MET . . . . . 0.562 ' HE1' ' CE2' ' L' ' 53' ' ' PHE . 49.3 ttm -50.63 -29.51 11.18 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 58' ' ' GLY . . . . . 0.57 ' O ' ' HB1' ' K' ' 24' ' ' ALA . . . -84.61 -33.63 18.61 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 59' ' ' LEU . . . . . 0.756 ' HA ' HD11 ' K' ' 28' ' ' ILE . 45.4 tp -73.05 -7.55 51.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.979 0.418 . . . . 0.0 110.237 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 60' ' ' VAL . . . . . 0.593 HG12 ' O ' ' K' ' 60' ' ' VAL . 65.3 t -109.51 -1.38 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.854 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 61' ' ' ASP . . . . . 0.452 ' O ' ' HD2' ' K' ' 64' ' ' PRO . 38.6 t70 -81.45 -23.5 37.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.929 0.395 . . . . 0.0 110.615 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 62' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' K' ' 21' ' ' ALA . . . -88.66 -42.1 12.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.549 0.69 . . . . 0.0 110.032 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 63' ' ' ILE . . . . . 0.576 ' N ' ' CD ' ' K' ' 64' ' ' PRO . 2.4 mm -47.13 -34.5 4.41 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.788 -1.096 . . . . 0.0 113.526 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 64' ' ' PRO . . . . . 0.829 ' O ' HG23 ' K' ' 68' ' ' VAL . 3.6 Cg_exo -78.35 -54.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.948 1.765 . . . . 0.0 111.619 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 65' ' ' MET . . . . . 0.84 ' HG2' ' HB3' ' K' ' 20' ' ' ALA . 2.0 tpt -52.81 -37.39 59.85 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 66' ' ' ILE . . . . . 0.506 ' HA ' ' HG2' ' K' ' 17' ' ' MET . 75.4 mt -66.18 -54.46 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.58 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.24 -31.48 61.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 68' ' ' VAL . . . . . 0.829 HG23 ' O ' ' K' ' 64' ' ' PRO . 55.5 t -75.61 -44.02 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.866 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 69' ' ' GLY . . . . . 0.414 ' HA2' ' HE3' ' K' ' 16' ' ' MET . . . -65.72 -35.76 91.42 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 70' ' ' LEU . . . . . 0.911 ' O ' HG23 ' K' ' 74' ' ' VAL . 0.5 OUTLIER -67.29 -38.04 84.38 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.695 178.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 71' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' K' ' 75' ' ' MET . . . -64.96 -60.7 6.55 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 72' ' ' LEU . . . . . 0.892 HD12 ' CE ' ' K' ' 16' ' ' MET . 58.9 mt -52.23 -34.5 46.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.481 0.658 . . . . 0.0 109.605 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 73' ' ' TYR . . . . . 0.892 ' CZ ' HD22 ' J' ' 72' ' ' LEU . 10.7 t80 -71.23 -46.95 60.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.526 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 74' ' ' VAL . . . . . 0.911 HG23 ' O ' ' K' ' 70' ' ' LEU . 92.7 t -62.42 -26.19 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.846 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 75' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' K' ' 71' ' ' GLY . 89.3 mtp -63.73 -50.02 70.75 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 76' ' ' PHE . . . . . 0.799 ' HB2' HD13 ' K' ' 9' ' ' LEU . 2.4 t80 -52.97 -35.96 59.55 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 77' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' K' ' 74' ' ' VAL . . . -58.29 -32.53 68.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.09 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 78' ' ' VAL . . . . . 0.447 HG11 ' HG ' ' M' ' 229' ' ' LEU . 48.3 t -69.24 -32.68 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.102 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' L' L ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.664 0.269 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' L' L ' 2' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -43.17 -37.69 2.18 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -64.07 -66.28 0.56 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.412 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 4' ' ' LEU . . . . . 0.536 ' HA ' ' OD1' ' L' ' 7' ' ' ASP . 85.7 mt -62.52 -19.82 64.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.985 0.422 . . . . 0.0 110.403 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 5' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -66.92 -65.15 0.72 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.158 0.504 . . . . 0.0 110.299 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 6' ' ' MET . . . . . . . . . . . . . 21.4 ptp -58.51 -33.92 70.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.465 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 7' ' ' ASP . . . . . 0.536 ' OD1' ' HA ' ' L' ' 4' ' ' LEU . 0.0 OUTLIER -72.24 -47.73 48.05 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.738 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 8' ' ' LEU . . . . . 0.459 HD11 ' OD1' ' A' ' 7' ' ' ASP . 57.2 mt -64.07 -42.28 97.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.89 0.376 . . . . 0.0 110.6 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 9' ' ' LEU . . . . . 0.876 HD11 ' HG3' ' L' ' 75' ' ' MET . 53.5 tp -56.93 -59.3 5.26 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.955 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 10' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -52.98 -56.9 12.6 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.563 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 11' ' ' MET . . . . . 0.742 ' O ' HG23 ' L' ' 15' ' ' VAL . 21.1 ttt -52.72 -27.17 16.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.423 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 12' ' ' ALA . . . . . 0.763 ' O ' ' HB2' ' L' ' 16' ' ' MET . . . -65.2 -50.77 64.59 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 13' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' L' ' 17' ' ' MET . . . -56.32 -38.56 71.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.447 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.42 ' HB1' ' CG ' ' K' ' 16' ' ' MET . . . -75.99 -44.56 39.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.413 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 15' ' ' VAL . . . . . 0.742 HG23 ' O ' ' L' ' 11' ' ' MET . 60.3 t -70.41 -44.38 77.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.072 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 16' ' ' MET . . . . . 0.763 ' HB2' ' O ' ' L' ' 12' ' ' ALA . 1.3 tmm? -66.49 -53.29 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.531 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 17' ' ' MET . . . . . 0.767 ' HE2' ' HA ' ' L' ' 17' ' ' MET . 11.3 mmt -68.31 -44.61 75.03 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.589 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 18' ' ' GLY . . . . . 0.897 ' O ' HD13 ' L' ' 22' ' ' ILE . . . -68.94 -33.41 74.79 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 118.395 -1.86 . . . . 0.0 111.555 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 19' ' ' LEU . . . . . 0.786 HD12 ' N ' ' L' ' 20' ' ' ALA . 2.1 pp -74.34 -45.29 48.14 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.456 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 20' ' ' ALA . . . . . 0.786 ' N ' HD12 ' L' ' 19' ' ' LEU . . . -76.1 -36.07 59.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 120.885 0.374 . . . . 0.0 110.745 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 21' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' L' ' 17' ' ' MET . . . -64.43 -41.93 96.31 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.878 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 22' ' ' ILE . . . . . 0.897 HD13 ' O ' ' L' ' 18' ' ' GLY . 1.5 mp -65.96 -46.83 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.76 68.47 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 24' ' ' ALA . . . . . 1.019 ' HB1' HG12 ' L' ' 60' ' ' VAL . . . -59.85 -65.59 0.65 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.462 -0.869 . . . . 0.0 110.44 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 25' ' ' ALA . . . . . 0.924 ' O ' HG22 ' L' ' 28' ' ' ILE . . . -46.64 -53.5 11.45 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.035 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 26' ' ' ILE . . . . . . . . . . . . . 73.9 mt -51.02 -55.75 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 121.079 -0.249 . . . . 0.0 110.857 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 27' ' ' GLY . . . . . 0.423 ' HA2' ' HB ' ' L' ' 30' ' ' ILE . . . -53.05 -49.45 55.52 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.599 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 28' ' ' ILE . . . . . 0.924 HG22 ' O ' ' L' ' 25' ' ' ALA . 4.6 tp -50.13 -42.28 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.34 -42.87 81.29 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.588 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 30' ' ' ILE . . . . . 0.423 ' HB ' ' HA2' ' L' ' 27' ' ' GLY . 35.8 mm -66.1 -70.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 122.966 0.506 . . . . 0.0 111.161 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 31' ' ' LEU . . . . . 0.554 HD12 ' HD2' ' L' ' 34' ' ' LYS . 52.0 tp -61.3 -38.06 85.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.988 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.73 -46.27 93.66 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.396 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.65 -58.98 11.46 Favored Glycine 0 C--O 1.241 0.569 0 C-N-CA 119.733 -1.222 . . . . 0.0 111.862 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 34' ' ' LYS . . . . . 0.554 ' HD2' HD12 ' L' ' 31' ' ' LEU . 17.8 ptpt -55.96 -50.9 69.52 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.44 0.638 . . . . 0.0 110.936 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 35' ' ' PHE . . . . . 0.435 ' N ' ' HG3' ' L' ' 34' ' ' LYS . 28.9 t80 -52.4 -54.82 27.02 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.858 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 36' ' ' LEU . . . . . 0.847 HD12 HD22 ' L' ' 49' ' ' LEU . 18.6 tp -45.61 -53.07 9.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.135 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 37' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' L' ' 41' ' ' ARG . 65.8 mm-40 -52.03 -45.23 64.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.39 -64.87 2.38 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.186 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 39' ' ' ALA . . . . . 0.543 ' HB1' HD23 ' L' ' 48' ' ' LEU . . . -50.28 -29.11 8.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.795 -0.202 . . . . 0.0 111.537 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 40' ' ' ALA . . . . . 0.968 ' HB2' HD11 ' L' ' 49' ' ' LEU . . . -87.39 -38.53 16.08 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.721 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 41' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' L' ' 37' ' ' GLU . 48.9 ttm-85 -56.17 -32.88 64.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.37 0.605 . . . . 0.0 109.606 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 42' ' ' GLN . . . . . 0.854 ' OE1' HD22 ' L' ' 45' ' ' LEU . 81.0 mt-30 -52.25 164.96 0.55 Allowed Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.738 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 43' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' L' ' 42' ' ' GLN . 80.8 Cg_exo -44.13 -67.4 0.12 Allowed 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 124.296 3.331 . . . . 0.0 114.219 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 44' ' ' ASP . . . . . 0.51 ' C ' HD12 ' L' ' 45' ' ' LEU . 9.9 t70 -146.74 55.54 1.13 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.729 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 45' ' ' LEU . . . . . 0.854 HD22 ' OE1' ' L' ' 42' ' ' GLN . 6.5 mp -110.78 12.16 22.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.299 0.571 . . . . 0.0 110.664 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 46' ' ' ILE . . . . . 0.702 ' H ' HD12 ' L' ' 46' ' ' ILE . 1.8 mp -47.71 -50.22 52.83 Favored Pre-proline 0 C--O 1.226 -0.145 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 47' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' L' ' 46' ' ' ILE . 19.1 Cg_endo -60.77 -32.09 92.56 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.607 1.538 . . . . 0.0 110.374 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 48' ' ' LEU . . . . . 0.83 HD11 ' OE1' ' L' ' 52' ' ' GLN . 11.0 tp -55.31 -39.82 70.38 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 49' ' ' LEU . . . . . 0.968 HD11 ' HB2' ' L' ' 40' ' ' ALA . 90.5 mt -44.81 -66.76 0.35 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.345 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 50' ' ' ARG . . . . . 0.444 ' O ' ' CD2' ' L' ' 54' ' ' PHE . 99.4 mtt180 -64.08 -54.52 32.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.791 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 51' ' ' THR . . . . . . . . . . . . . 85.3 m -46.65 -42.27 16.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.566 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 52' ' ' GLN . . . . . 0.83 ' OE1' HD11 ' L' ' 48' ' ' LEU . 26.7 mt-30 -90.01 -17.21 28.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.836 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 53' ' ' PHE . . . . . 0.562 ' CE2' ' HE1' ' K' ' 57' ' ' MET . 40.5 t80 -63.64 -46.39 85.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.332 0.587 . . . . 0.0 109.793 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 54' ' ' PHE . . . . . 0.579 ' CD1' ' HB2' ' M' ' 206' ' ' SER . 37.7 m-85 -63.86 -41.67 97.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.094 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 55' ' ' ILE . . . . . 0.594 HG22 ' HA ' ' L' ' 52' ' ' GLN . 11.0 tt -70.73 -45.53 73.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.859 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 56' ' ' VAL . . . . . 0.935 ' O ' HG23 ' L' ' 60' ' ' VAL . 64.1 t -65.25 -31.03 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.044 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 57' ' ' MET . . . . . 0.423 ' HA ' ' CD1' ' L' ' 28' ' ' ILE . 25.5 ttt -72.76 -56.18 5.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.522 0.677 . . . . 0.0 110.137 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 58' ' ' GLY . . . . . 0.438 ' HA3' ' CD2' ' M' ' 209' ' ' LEU . . . -55.28 -40.16 74.67 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.588 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 59' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' L' ' 55' ' ' ILE . 76.9 mt -65.65 -27.95 68.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.76 0.314 . . . . 0.0 110.862 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 60' ' ' VAL . . . . . 1.019 HG12 ' HB1' ' L' ' 24' ' ' ALA . 81.7 t -77.75 -37.17 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.93 0.395 . . . . 0.0 110.142 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -78.2 -31.39 49.46 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.831 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 62' ' ' ALA . . . . . 0.514 ' O ' HG12 ' L' ' 66' ' ' ILE . . . -50.33 -24.66 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.568 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 63' ' ' ILE . . . . . 0.662 ' HB ' ' HD3' ' L' ' 64' ' ' PRO . 44.0 mt -62.14 -82.88 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.324 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 64' ' ' PRO . . . . . 0.662 ' HD3' ' HB ' ' L' ' 63' ' ' ILE . 75.6 Cg_exo -50.55 -30.13 27.03 Favored 'Trans proline' 0 C--N 1.359 1.118 0 CA-C-N 121.17 1.454 . . . . 0.0 111.643 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 65' ' ' MET . . . . . . . . . . . . . 46.9 tpp -60.66 -37.23 80.85 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.626 0.727 . . . . 0.0 109.493 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 66' ' ' ILE . . . . . 0.514 HG12 ' O ' ' L' ' 62' ' ' ALA . 9.4 mm -74.98 -37.69 41.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.819 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 67' ' ' ALA . . . . . 0.586 ' HB3' ' HE1' ' L' ' 17' ' ' MET . . . -69.52 -29.9 67.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.373 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 68' ' ' VAL . . . . . 0.678 HG23 ' SD ' ' L' ' 17' ' ' MET . 47.2 t -72.48 -55.53 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.35 -51.28 60.06 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 119.855 -1.164 . . . . 0.0 111.586 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 70' ' ' LEU . . . . . 0.765 HD23 ' O ' ' L' ' 70' ' ' LEU . 4.4 tt -67.31 -38.61 85.23 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.109 0.481 . . . . 0.0 110.096 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 71' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' L' ' 75' ' ' MET . . . -62.58 -60.88 7.14 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.444 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 72' ' ' LEU . . . . . 0.773 HD22 ' HB ' ' M' ' 221' ' ' ILE . 3.9 pp -61.69 -31.38 71.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.912 0.387 . . . . 0.0 110.716 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 73' ' ' TYR . . . . . 0.705 ' N ' HD12 ' L' ' 72' ' ' LEU . 80.4 t80 -50.15 -42.17 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.908 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 74' ' ' VAL . . . . . 0.722 HG13 ' SD ' ' L' ' 75' ' ' MET . 14.9 p -111.6 -14.66 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.807 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 75' ' ' MET . . . . . 0.876 ' HG3' HD11 ' L' ' 9' ' ' LEU . 0.1 OUTLIER -84.36 -87.09 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 110.383 179.265 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 76' ' ' PHE . . . . . 0.409 ' HB3' HD11 ' M' ' 224' ' ' LEU . 46.1 m-85 -54.05 -29.01 42.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.611 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 77' ' ' ALA . . . . . 0.728 ' CA ' HD22 ' M' ' 224' ' ' LEU . . . -77.15 -80.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 111.447 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 78' ' ' VAL . . . . . . . . . . . . . 45.7 t -61.98 -22.29 28.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.336 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 79' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' L' ' 75' ' ' MET . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.053 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 95' ' ' HIS . . . . . . . . . . . . . 17.8 m80 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.762 0.315 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' M' M ' 96' ' ' GLY . . . . . . . . . . . . . . . -113.76 128.83 8.48 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.444 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 97' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' M' ' 97' ' ' LYS . 0.7 OUTLIER -67.82 -79.67 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.72 0.295 . . . . 0.0 110.798 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' M' M ' 98' ' ' SER . . . . . . . . . . . . . 47.7 t -56.87 -22.66 38.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.091 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 99' ' ' LYS . . . . . 0.574 ' O ' ' HD3' ' M' ' 103' ' ' PRO . 1.0 OUTLIER -61.52 -63.81 1.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.596 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' M' M ' 100' ' ' LEU . . . . . 0.755 ' O ' ' HD2' ' M' ' 103' ' ' PRO . 3.6 pp -61.29 -36.94 81.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.886 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 101' ' ' ILE . . . . . 0.73 ' N ' HD12 ' M' ' 100' ' ' LEU . 39.0 mm -61.14 -40.92 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 102' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' M' ' 103' ' ' PRO . . . -60.93 -45.36 96.63 Favored Pre-proline 0 N--CA 1.471 0.598 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 103' ' ' PRO . . . . . 0.755 ' HD2' ' O ' ' M' ' 100' ' ' LEU . 10.1 Cg_exo -72.91 -42.0 1.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.445 2.097 . . . . 0.0 112.375 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 104' ' ' LEU . . . . . 0.601 HD13 ' O ' ' M' ' 100' ' ' LEU . 9.7 mp -62.06 -42.26 99.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.008 0.432 . . . . 0.0 110.595 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 105' ' ' ALA . . . . . 0.478 ' O ' HG12 ' M' ' 108' ' ' ILE . . . -62.2 -41.67 98.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.577 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 106' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.98 -41.31 97.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.394 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 107' ' ' THR . . . . . 0.59 HG22 HG12 ' M' ' 159' ' ' ILE . 74.1 p -61.71 -43.4 98.92 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 108' ' ' ILE . . . . . 0.478 HG12 ' O ' ' M' ' 105' ' ' ALA . 28.8 pt -63.85 -42.98 97.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.747 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 109' ' ' PHE . . . . . 0.552 ' O ' HG12 ' M' ' 112' ' ' VAL . 13.9 m-85 -62.7 -42.84 99.85 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.798 0.332 . . . . 0.0 111.851 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 110' ' ' VAL . . . . . 0.547 HG12 ' O ' ' M' ' 107' ' ' THR . 7.1 p -62.97 -41.05 91.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 111' ' ' TRP . . . . . 0.439 ' HE1' ' HE2' ' M' ' 115' ' ' MET . 2.6 t-105 -61.61 -44.41 97.04 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.39 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 112' ' ' VAL . . . . . 0.552 HG12 ' O ' ' M' ' 109' ' ' PHE . 7.4 p -63.2 -41.35 92.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.362 0.601 . . . . 0.0 109.812 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 113' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -61.69 -38.86 89.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.112 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 114' ' ' LEU . . . . . 0.787 HD21 ' HA ' ' M' ' 152' ' ' SER . 48.8 tp -59.21 -42.07 90.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.13 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 115' ' ' MET . . . . . 0.506 ' SD ' HD13 ' M' ' 249' ' ' ILE . 65.4 mtt -61.88 -43.68 98.34 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.334 0.588 . . . . 0.0 109.835 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 116' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -62.43 -39.24 92.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.881 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 117' ' ' LEU . . . . . . . . . . . . . 63.6 tp -60.47 -40.82 92.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.061 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 118' ' ' MET . . . . . 0.445 ' O ' ' HD3' ' M' ' 122' ' ' PRO . 26.4 ttt -60.89 -44.58 96.92 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.263 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 119' ' ' ASP . . . . . 0.552 ' O ' ' HD2' ' M' ' 122' ' ' PRO . 1.7 m-20 -64.38 -37.87 89.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.559 0.695 . . . . 0.0 110.465 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 120' ' ' LEU . . . . . 0.488 ' HA ' ' CG2' ' M' ' 123' ' ' ILE . 56.8 tp -61.49 -39.32 90.54 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 121' ' ' LEU . . . . . 0.537 ' N ' ' HD2' ' M' ' 122' ' ' PRO . 54.0 tp -59.35 -44.94 98.95 Favored Pre-proline 0 N--CA 1.468 0.457 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 122' ' ' PRO . . . . . 0.552 ' HD2' ' O ' ' M' ' 119' ' ' ASP . 58.1 Cg_endo -72.07 -41.7 1.86 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 121.933 1.756 . . . . 0.0 112.25 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 123' ' ' ILE . . . . . 0.488 ' CG2' ' HA ' ' M' ' 120' ' ' LEU . 6.2 tp -61.07 -42.08 91.77 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.183 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 124' ' ' ASP . . . . . 0.562 ' O ' ' HD2' ' M' ' 127' ' ' PRO . 39.3 m-20 -62.79 -38.63 91.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.026 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 125' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.19 -40.13 95.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 126' ' ' LEU . . . . . 0.56 HD21 ' HA ' ' M' ' 235' ' ' TRP . 60.5 tp -58.59 -44.53 99.16 Favored Pre-proline 0 N--CA 1.47 0.543 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 127' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' M' ' 124' ' ' ASP . 91.0 Cg_exo -40.1 -39.51 2.46 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.79 2.326 . . . . 0.0 112.721 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 128' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -111.16 110.66 21.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.828 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 129' ' ' ILE . . . . . . . . . . . . . 28.6 pt -107.43 166.19 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.231 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 130' ' ' ALA . . . . . . . . . . . . . . . -147.43 -65.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.028 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -123.94 155.15 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.803 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 132' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -162.03 91.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.083 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 133' ' ' VAL . . . . . 0.659 HG22 ' O ' ' M' ' 133' ' ' VAL . 12.6 p -104.31 25.12 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 134' ' ' LEU . . . . . . . . . . . . . 84.2 mt 66.57 -64.83 0.22 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.602 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 135' ' ' GLY . . . . . 0.683 ' O ' HD23 ' M' ' 139' ' ' LEU . . . -61.38 -78.22 0.17 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.378 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 136' ' ' LEU . . . . . 0.626 ' HB3' ' HD3' ' M' ' 137' ' ' PRO . 58.8 tp -41.74 -49.6 10.18 Favored Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 137' ' ' PRO . . . . . 0.842 ' O ' HG23 ' M' ' 141' ' ' VAL . 57.1 Cg_exo -51.66 -64.09 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.303 2.002 . . . . 0.0 112.668 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.49 95.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.677 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 139' ' ' LEU . . . . . 0.683 HD23 ' O ' ' M' ' 135' ' ' GLY . 4.3 mm? -60.81 -41.83 96.46 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.747 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 140' ' ' ARG . . . . . 0.742 ' O ' ' HD2' ' M' ' 143' ' ' PRO . 16.9 tpp85 -63.29 -39.24 94.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.25 0.548 . . . . 0.0 111.281 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 141' ' ' VAL . . . . . 0.842 HG23 ' O ' ' M' ' 137' ' ' PRO . 21.2 t -62.83 -41.22 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 142' ' ' VAL . . . . . 0.935 HG13 HD12 ' M' ' 220' ' ' LEU . 48.7 t -59.09 -45.35 99.44 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.328 -177.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 143' ' ' PRO . . . . . 0.742 ' HD2' ' O ' ' M' ' 140' ' ' ARG . 16.7 Cg_exo -66.69 -39.09 16.29 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.468 2.112 . . . . 0.0 110.722 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 144' ' ' SER . . . . . 0.511 ' O ' ' ND2' ' M' ' 148' ' ' ASN . 52.8 m -59.23 -41.85 89.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.695 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 145' ' ' ALA . . . . . 0.769 ' HB1' ' CG ' ' M' ' 219' ' ' GLU . . . -61.47 -42.16 98.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.083 0.468 . . . . 0.0 109.978 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 146' ' ' ASP . . . . . 0.657 ' O ' HG12 ' M' ' 149' ' ' VAL . 23.5 m-20 -61.68 -41.18 97.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.448 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 147' ' ' VAL . . . . . 0.694 HG23 ' O ' ' M' ' 143' ' ' PRO . 49.1 t -61.93 -41.4 90.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.407 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 148' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' M' ' 144' ' ' SER . 2.0 m-80 -61.88 -43.08 99.58 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 149' ' ' VAL . . . . . 0.719 HG22 ' CZ ' ' M' ' 212' ' ' PHE . 7.5 p -62.34 -41.63 92.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.906 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 150' ' ' THR . . . . . . . . . . . . . 80.7 p -62.14 -40.9 97.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.093 0.473 . . . . 0.0 110.317 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 151' ' ' LEU . . . . . 0.749 HD23 ' O ' ' M' ' 151' ' ' LEU . 5.5 tt -61.0 -41.16 95.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.05 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 152' ' ' SER . . . . . 0.787 ' HA ' HD21 ' M' ' 114' ' ' LEU . 90.9 p -60.89 -41.71 96.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.835 0.35 . . . . 0.0 110.602 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 153' ' ' MET . . . . . . . . . . . . . 57.5 ttp -61.35 -41.24 96.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.087 0.47 . . . . 0.0 110.319 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.56 94.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.138 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 155' ' ' LEU . . . . . 0.703 ' O ' HD13 ' M' ' 155' ' ' LEU . 3.0 tm? -60.51 -41.55 94.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.506 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 156' ' ' GLY . . . . . 0.64 ' O ' HG22 ' M' ' 159' ' ' ILE . . . -61.39 -41.6 99.57 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.927 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 157' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.47 -40.71 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.869 0.366 . . . . 0.0 110.879 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 158' ' ' PHE . . . . . 0.659 ' HE1' HD11 ' M' ' 162' ' ' LEU . 3.5 t80 -61.37 -42.45 98.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.78 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 159' ' ' ILE . . . . . 0.64 HG22 ' O ' ' M' ' 156' ' ' GLY . 6.5 tp -63.26 -41.77 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.386 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 160' ' ' LEU . . . . . 0.538 HD22 HG23 ' M' ' 159' ' ' ILE . 4.5 mm? -62.41 -42.68 99.62 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 161' ' ' ILE . . . . . 0.503 HG12 ' O ' ' M' ' 158' ' ' PHE . 28.1 pt -61.81 -40.4 86.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.22 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 162' ' ' LEU . . . . . 0.659 HD11 ' HE1' ' M' ' 158' ' ' PHE . 88.1 mt -60.82 -41.17 95.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.889 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 163' ' ' PHE . . . . . 0.665 ' O ' HG22 ' M' ' 166' ' ' ILE . 48.1 t80 -61.17 -42.02 97.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.18 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 164' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -62.67 -41.45 99.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.713 0.292 . . . . 0.0 111.629 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 165' ' ' SER . . . . . . . . . . . . . 83.6 p -61.74 -42.35 98.84 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 166' ' ' ILE . . . . . 0.665 HG22 ' O ' ' M' ' 163' ' ' PHE . 7.1 tp -61.68 -38.85 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.711 0.291 . . . . 0.0 111.146 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 167' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -63.99 109.86 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 168' ' ' MET . . . . . . . . . . . . . 26.5 mmt 60.92 169.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 169' ' ' LYS . . . . . 0.425 ' HD3' ' C ' ' M' ' 169' ' ' LYS . 5.1 tmtm? . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.311 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 199' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.849 0.357 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' M' M ' 200' ' ' LEU . . . . . 0.553 HD22 ' N ' ' M' ' 200' ' ' LEU . 2.8 mm? -69.2 -24.28 64.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.036 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 201' ' ' LEU . . . . . 0.848 ' H ' HD23 ' M' ' 201' ' ' LEU . 2.2 pt? -113.6 -29.14 7.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.582 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 202' ' ' SER . . . . . 0.46 ' HB3' ' CE2' ' L' ' 54' ' ' PHE . 56.4 m -63.14 -42.94 99.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 203' ' ' LYS . . . . . 0.567 ' HB2' ' HD3' ' M' ' 204' ' ' PRO . 63.8 mttp -62.49 -46.09 89.4 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.7 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 204' ' ' PRO . . . . . 0.708 ' HD2' ' C ' ' M' ' 201' ' ' LEU . 41.6 Cg_exo -56.48 -41.76 72.75 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.188 1.926 . . . . 0.0 111.715 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 205' ' ' VAL . . . . . 0.69 HG23 ' O ' ' M' ' 201' ' ' LEU . 48.6 t -61.48 -41.15 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.384 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 206' ' ' SER . . . . . 0.579 ' HB2' ' CD1' ' L' ' 54' ' ' PHE . 37.2 t -61.5 -42.97 99.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.898 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 207' ' ' LEU . . . . . 0.455 HD23 ' O ' ' M' ' 203' ' ' LYS . 3.8 mm? -61.91 -41.46 97.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.118 0.485 . . . . 0.0 110.347 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 208' ' ' GLY . . . . . 0.49 ' O ' ' HG ' ' M' ' 211' ' ' LEU . . . -61.37 -40.69 98.99 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.425 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 209' ' ' LEU . . . . . 0.438 ' CD2' ' HA3' ' L' ' 58' ' ' GLY . 41.1 tp -62.16 -43.51 98.67 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 210' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -63.6 -46.52 85.42 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.545 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 211' ' ' LEU . . . . . 0.949 HD12 ' N ' ' M' ' 212' ' ' PHE . 4.0 pp -65.32 -40.88 94.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.44 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 212' ' ' PHE . . . . . 0.949 ' N ' HD12 ' M' ' 211' ' ' LEU . 7.1 t80 -61.05 -43.55 98.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.639 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.89 -44.6 95.86 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.768 -1.206 . . . . 0.0 112.435 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 214' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -64.48 -42.95 95.58 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 215' ' ' MET . . . . . 0.824 ' HB3' HG22 ' M' ' 249' ' ' ILE . 16.6 ptp -62.33 -42.85 99.72 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 216' ' ' TYR . . . . . 0.503 ' O ' HD23 ' M' ' 220' ' ' LEU . 49.4 t80 -62.35 -44.74 95.78 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.688 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 217' ' ' ALA . . . . . 0.927 ' O ' HG22 ' M' ' 221' ' ' ILE . . . -63.61 -43.28 97.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.133 0.492 . . . . 0.0 110.571 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 218' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' M' ' 222' ' ' PHE . . . -62.92 -42.26 99.71 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.407 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 219' ' ' GLU . . . . . 0.769 ' CG ' ' HB1' ' M' ' 145' ' ' ALA . 7.7 tp10 -62.23 -46.81 87.2 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.276 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 220' ' ' LEU . . . . . 0.935 HD12 HG13 ' M' ' 142' ' ' VAL . 3.4 mm? -68.29 -48.14 65.75 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 221' ' ' ILE . . . . . 0.927 HG22 ' O ' ' M' ' 217' ' ' ALA . 9.7 tt -66.68 -44.17 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 222' ' ' PHE . . . . . 0.809 ' HD1' HG23 ' M' ' 221' ' ' ILE . 5.6 m-85 -64.29 -42.63 96.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 223' ' ' ILE . . . . . 0.602 HD11 HG11 ' M' ' 141' ' ' VAL . 9.2 tt -63.25 -45.05 99.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 224' ' ' LEU . . . . . 0.928 HD12 ' N ' ' M' ' 225' ' ' ILE . 4.4 pp -64.55 -43.66 93.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.798 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 225' ' ' ILE . . . . . 0.928 ' N ' HD12 ' M' ' 224' ' ' LEU . 7.7 tp -63.39 -41.78 93.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.855 0.36 . . . . 0.0 111.694 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 226' ' ' ALA . . . . . 0.546 ' O ' ' CD ' ' M' ' 230' ' ' PRO . . . -60.7 -42.08 96.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.396 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 227' ' ' GLY . . . . . 0.714 ' CA ' HD12 ' M' ' 237' ' ' LEU . . . -63.95 -41.54 98.63 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.422 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 228' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.82 -42.18 97.7 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 229' ' ' LEU . . . . . 0.538 HD23 ' O ' ' M' ' 225' ' ' ILE . 4.4 mm? -61.48 -44.79 93.43 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 230' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' M' ' 227' ' ' GLY . 68.0 Cg_endo -96.93 -178.76 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.122 2.548 . . . . 0.0 113.149 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 231' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -101.24 -41.21 6.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.042 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 232' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -89.23 66.64 7.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.018 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 233' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' M' ' 237' ' ' LEU . 54.7 m -47.83 -25.36 1.26 Allowed 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.903 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 234' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -51.4 -93.52 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.16 -0.337 . . . . 0.0 111.536 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 235' ' ' TRP . . . . . 0.56 ' HA ' HD21 ' M' ' 126' ' ' LEU . 33.4 t90 -69.01 -38.21 79.11 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 236' ' ' ILE . . . . . 0.523 HG21 ' CB ' ' M' ' 230' ' ' PRO . 48.5 mm -61.0 -44.42 98.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.993 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 237' ' ' LEU . . . . . 0.822 HD23 ' O ' ' M' ' 237' ' ' LEU . 5.4 tt -65.83 -41.67 91.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 0.0 111.931 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 238' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -62.37 -43.0 99.85 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 239' ' ' VAL . . . . . 0.613 ' O ' HG22 ' M' ' 243' ' ' ILE . 41.8 t -62.57 -45.62 88.9 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 240' ' ' PRO . . . . . 0.575 ' HD2' ' O ' ' M' ' 237' ' ' LEU . 4.8 Cg_exo -78.82 -41.25 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.7 2.267 . . . . 0.0 112.306 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 241' ' ' TRP . . . . . 0.414 ' NE1' ' HB ' ' M' ' 223' ' ' ILE . 10.8 t90 -62.07 -44.58 96.37 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.082 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 242' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.32 80.32 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 243' ' ' ILE . . . . . 0.801 HG23 ' HD1' ' M' ' 244' ' ' PHE . 5.6 tp -64.82 -42.85 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 244' ' ' PHE . . . . . 0.801 ' HD1' HG23 ' M' ' 243' ' ' ILE . 4.7 m-85 -64.16 -43.62 94.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 245' ' ' HIS . . . . . 0.441 ' O ' HG12 ' M' ' 248' ' ' ILE . 24.7 t-80 -62.78 -42.88 99.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.805 0.336 . . . . 0.0 111.42 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 246' ' ' ILE . . . . . 0.867 HD12 HD11 ' M' ' 249' ' ' ILE . 6.8 tp -62.98 -40.79 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.779 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 247' ' ' LEU . . . . . 0.679 HD13 ' O ' ' M' ' 247' ' ' LEU . 3.1 tm? -62.53 -44.21 96.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 248' ' ' ILE . . . . . 0.441 HG12 ' O ' ' M' ' 245' ' ' HIS . 25.5 pt -64.05 -44.82 97.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 249' ' ' ILE . . . . . 0.95 HD12 ' N ' ' M' ' 250' ' ' THR . 2.4 pp -63.32 -39.32 84.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.04 0.448 . . . . 0.0 110.581 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 250' ' ' THR . . . . . 0.95 ' N ' HD12 ' M' ' 249' ' ' ILE . 92.2 m -61.6 -41.15 97.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.385 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 251' ' ' LEU . . . . . 0.678 HD23 ' O ' ' M' ' 251' ' ' LEU . 5.2 tt -61.22 -44.75 96.77 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.101 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 252' ' ' GLN . . . . . 0.484 ' HB3' ' HB3' ' M' ' 211' ' ' LEU . 7.9 mm100 -63.63 -41.57 98.25 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.977 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.37 94.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.946 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 254' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -59.25 -41.18 88.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.333 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 255' ' ' ILE . . . . . 0.633 ' O ' HG22 ' M' ' 258' ' ' VAL . 49.4 mm -61.1 -41.05 87.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.119 0.485 . . . . 0.0 110.145 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 256' ' ' PHE . . . . . 0.404 ' O ' ' CD1' ' M' ' 256' ' ' PHE . 1.5 t80 -61.8 -41.83 98.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.117 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 257' ' ' MET . . . . . 0.541 ' O ' HG22 ' M' ' 260' ' ' THR . 95.2 mmm -61.67 -43.04 99.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 258' ' ' VAL . . . . . 0.633 HG22 ' O ' ' M' ' 255' ' ' ILE . 28.8 m -63.13 -40.89 90.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.569 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 259' ' ' LEU . . . . . 0.735 HD23 ' O ' ' M' ' 259' ' ' LEU . 5.6 tt -62.85 -43.08 99.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.749 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 260' ' ' THR . . . . . 0.541 HG22 ' O ' ' M' ' 257' ' ' MET . 6.3 t -63.59 -42.99 98.21 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 261' ' ' ILE . . . . . 0.447 HG12 ' O ' ' M' ' 258' ' ' VAL . 29.0 pt -63.02 -42.47 96.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 262' ' ' VAL . . . . . 0.593 HG12 ' O ' ' M' ' 259' ' ' LEU . 7.3 p -62.24 -39.41 83.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 111.294 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 263' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -60.83 -40.65 93.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' M' M ' 264' ' ' LEU . . . . . 0.606 HD23 ' C ' ' M' ' 264' ' ' LEU . 5.2 tt -87.04 110.7 20.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.561 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' M' M ' 265' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.889 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.58 0.229 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.7 -29.48 0.77 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.367 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -71.01 -62.85 1.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.081 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 4' ' ' LEU . 3.0 mm? -65.59 -17.94 64.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 109.953 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.61 -71.78 0.17 Allowed 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.525 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.17 -21.96 60.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.661 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' HD11 ' L' ' 8' ' ' LEU . 37.7 t70 -77.27 -44.85 28.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.26 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.754 HD22 ' CE ' ' A' ' 11' ' ' MET . 0.7 OUTLIER -75.04 -40.04 60.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.976 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.815 HD13 ' HB2' ' A' ' 76' ' ' PHE . 6.8 tt -56.11 -59.11 5.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.551 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.578 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 14.8 m-85 -56.2 -54.15 48.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.201 0.524 . . . . 0.0 110.119 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.754 ' CE ' HD22 ' A' ' 8' ' ' LEU . 57.2 ttp -54.46 -20.14 7.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.166 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 9' ' ' LEU . . . -70.57 -54.2 13.03 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.032 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.634 ' O ' ' HE2' ' A' ' 17' ' ' MET . . . -62.91 -19.19 63.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.786 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.69 -39.18 11.98 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.529 0.68 . . . . 0.0 109.49 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 11' ' ' MET . 46.0 t -74.89 -37.06 41.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.146 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.896 ' CE ' HD12 ' A' ' 72' ' ' LEU . 57.8 mtm -70.24 -62.52 1.36 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.419 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.634 ' HE2' ' O ' ' A' ' 13' ' ' ALA . 40.6 mtm -63.1 -51.49 66.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.397 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.686 ' O ' HG23 ' A' ' 22' ' ' ILE . . . -54.6 -37.08 60.07 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.583 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.694 HD23 ' HA3' ' B' ' 18' ' ' GLY . 24.7 tp -79.6 -38.47 33.86 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.843 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -85.64 -35.94 20.63 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.514 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . . . -62.57 -43.71 98.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.939 HD12 ' N ' ' A' ' 23' ' ' GLY . 2.6 pp -65.26 -40.53 88.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.939 ' N ' HD12 ' A' ' 22' ' ' ILE . . . -60.98 -29.35 70.58 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 119.859 -1.162 . . . . 0.0 110.22 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 58' ' ' GLY . . . -73.21 -56.62 4.84 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.005 -0.598 . . . . 0.0 110.07 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.53 -54.4 18.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.227 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.12 -56.4 8.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.747 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 31' ' ' LEU . . . -47.97 -54.08 12.79 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.898 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.752 HD11 ' HA ' ' A' ' 59' ' ' LEU . 68.2 mt -49.86 -34.38 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.66 -34.36 28.33 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.356 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mm -77.17 -62.06 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.0 0.429 . . . . 0.0 110.42 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.672 HD22 ' CG ' ' A' ' 54' ' ' PHE . 0.5 OUTLIER -60.95 -43.13 99.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.781 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.98 -50.42 67.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.882 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.33 -51.97 24.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.786 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -58.78 -42.18 88.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.594 0.235 . . . . 0.0 111.402 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.67 ' CD1' HD22 ' B' ' 36' ' ' LEU . 59.9 t80 -58.68 -47.36 84.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.786 0.327 . . . . 0.0 110.889 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.1 tp -55.25 -44.3 75.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.0 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.28 -31.46 67.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.99 24.17 27.83 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.656 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.27 31.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.297 . . . . 0.0 111.333 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.32 -34.29 21.89 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.908 0.385 . . . . 0.0 111.078 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -67.85 -47.3 69.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.117 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.411 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 84.8 mt-30 -58.17 163.55 4.4 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.079 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.475 ' O ' ' CG ' ' A' ' 47' ' ' PRO . 52.0 Cg_exo -53.16 161.3 3.68 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.553 2.169 . . . . 0.0 111.98 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.56 30.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.84 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.0 tp -97.73 -60.66 1.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.332 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.615 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -76.27 -54.63 1.91 Allowed Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.91 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 28.9 Cg_endo -63.26 -32.51 73.25 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.862 1.708 . . . . 0.0 112.358 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 48' ' ' LEU . 5.5 tt -61.14 -34.38 74.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -75.33 -42.13 55.14 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.359 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.495 ' HD2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -73.45 -35.89 65.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.911 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.455 ' HA ' ' CD2' ' A' ' 35' ' ' PHE . 53.6 m -59.37 -46.57 88.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.592 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.655 ' O ' HG23 ' A' ' 56' ' ' VAL . 15.3 pt20 -61.78 -45.14 95.14 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.269 0.557 . . . . 0.0 109.836 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 1.2 t80 -49.25 -36.96 21.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.502 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.672 ' CG ' HD22 ' A' ' 31' ' ' LEU . 8.8 m-85 -77.66 -69.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.056 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.491 HG12 ' HA ' ' A' ' 52' ' ' GLN . 28.9 pt -44.55 -33.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.825 0.345 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 52' ' ' GLN . 92.8 t -76.83 -46.05 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 49.3 ttm -50.61 -29.54 11.15 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.571 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -84.59 -33.63 18.67 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.752 ' HA ' HD11 ' A' ' 28' ' ' ILE . 45.2 tp -73.07 -7.51 51.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.199 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 60' ' ' VAL . 65.0 t -109.56 -1.33 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.877 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.446 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 38.6 t70 -81.47 -23.5 37.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.912 0.387 . . . . 0.0 110.609 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . . . -88.7 -42.08 12.19 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.559 0.695 . . . . 0.0 110.026 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.567 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 2.4 mm -47.11 -34.42 4.28 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.799 -1.091 . . . . 0.0 113.613 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.83 ' O ' HG23 ' A' ' 68' ' ' VAL . 3.6 Cg_exo -78.37 -54.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.936 1.757 . . . . 0.0 111.616 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.843 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 2.0 tpt -52.85 -37.36 60.14 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.512 ' HA ' ' HG2' ' A' ' 17' ' ' MET . 75.5 mt -66.22 -54.46 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.638 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.32 -31.4 61.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 64' ' ' PRO . 56.2 t -75.7 -43.98 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.891 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.437 ' HA2' ' HE1' ' A' ' 16' ' ' MET . . . -65.69 -35.73 91.43 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.907 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -67.25 -38.12 84.66 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.762 -0.719 . . . . 0.0 109.703 178.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 75' ' ' MET . . . -64.91 -60.77 6.48 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.271 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.916 HD22 ' CZ ' ' B' ' 73' ' ' TYR . 58.4 mt -52.2 -34.51 45.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.494 0.664 . . . . 0.0 109.624 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.578 ' CE2' ' CE2' ' A' ' 10' ' ' TYR . 10.7 t80 -71.18 -47.05 59.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.48 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 70' ' ' LEU . 93.2 t -62.31 -26.28 39.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.852 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 71' ' ' GLY . 89.3 mtp -63.73 -49.97 70.96 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.815 ' HB2' HD13 ' A' ' 9' ' ' LEU . 2.4 t80 -53.03 -35.88 59.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 74' ' ' VAL . . . -58.24 -32.64 68.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.058 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.13 -32.74 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.973 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.087 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.571 0.224 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.68 -29.45 0.76 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.371 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.11 -62.84 1.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.029 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.522 HD22 ' N ' ' B' ' 4' ' ' LEU . 3.0 mm? -65.53 -17.88 64.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 109.98 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.74 -71.66 0.17 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.508 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 23.4 ptp -59.23 -21.98 60.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.624 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.17 -44.92 28.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.281 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.751 HD22 ' CE ' ' B' ' 11' ' ' MET . 0.7 OUTLIER -75.05 -39.98 60.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.964 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.803 HD13 ' HB2' ' B' ' 76' ' ' PHE . 6.8 tt -56.15 -59.13 5.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . 0.747 ' HB3' HD12 ' A' ' 8' ' ' LEU . 15.0 m-85 -56.13 -54.21 47.77 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.207 0.527 . . . . 0.0 110.146 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' MET . . . . . 0.751 ' CE ' HD22 ' B' ' 8' ' ' LEU . 57.2 ttp -54.44 -20.1 6.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.124 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' B' ' 9' ' ' LEU . . . -70.57 -54.22 12.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.055 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.57 ' O ' ' HG3' ' B' ' 17' ' ' MET . . . -62.94 -19.17 64.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.794 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.67 -39.26 11.95 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.396 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 11' ' ' MET . 46.3 t -74.85 -37.1 41.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.167 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.893 ' CE ' HD12 ' B' ' 72' ' ' LEU . 57.6 mtm -70.16 -62.57 1.34 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.44 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' MET . . . . . 0.57 ' HG3' ' O ' ' B' ' 13' ' ' ALA . 40.6 mtm -63.1 -51.42 66.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.412 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.698 ' O ' HG23 ' B' ' 22' ' ' ILE . . . -54.69 -37.02 60.3 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.582 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.714 HD23 ' HA3' ' C' ' 18' ' ' GLY . 24.5 tp -79.61 -38.45 33.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.817 ' HB3' ' HG2' ' B' ' 65' ' ' MET . . . -85.65 -35.97 20.6 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.484 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.59 ' HA ' ' CB ' ' B' ' 62' ' ' ALA . . . -62.53 -43.68 98.23 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.919 HD12 ' N ' ' B' ' 23' ' ' GLY . 2.6 pp -65.28 -40.54 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.919 ' N ' HD12 ' B' ' 22' ' ' ILE . . . -60.97 -29.28 70.37 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.237 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' B' ' 58' ' ' GLY . . . -73.31 -56.59 4.86 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.023 -0.589 . . . . 0.0 110.01 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.56 -54.37 18.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.187 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.14 -56.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.727 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 31' ' ' LEU . . . -47.99 -54.01 13.04 Favored Glycine 0 CA--C 1.508 -0.388 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.895 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.744 HD11 ' HA ' ' B' ' 59' ' ' LEU . 68.5 mt -49.93 -34.27 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.285 0.564 . . . . 0.0 109.489 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.46 ' HA2' ' HG ' ' A' ' 31' ' ' LEU . . . -80.67 -34.42 28.13 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.356 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.15 -62.07 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.027 0.441 . . . . 0.0 110.454 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . 0.658 HD22 ' CG ' ' B' ' 54' ' ' PHE . 0.5 OUTLIER -60.91 -43.2 98.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.811 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.94 -50.46 67.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.844 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.28 -52.03 24.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.789 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.8 -42.12 88.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.558 0.218 . . . . 0.0 111.409 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' PHE . . . . . 0.722 ' CD1' HD22 ' C' ' 36' ' ' LEU . 59.9 t80 -58.68 -47.42 84.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.93 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.67 HD22 ' CD1' ' A' ' 35' ' ' PHE . 64.2 tp -55.2 -44.26 75.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.035 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.38 -31.39 67.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.04 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.99 24.17 27.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.704 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.25 31.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.75 0.31 . . . . 0.0 111.305 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.38 -34.27 21.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.911 0.386 . . . . 0.0 111.093 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' B' ' 41' ' ' ARG . 0.3 OUTLIER -67.79 -47.29 69.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.186 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.42 ' HB3' ' HD2' ' B' ' 43' ' ' PRO . 85.0 mt-30 -58.14 163.56 4.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.124 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . 0.475 ' O ' ' CG ' ' B' ' 47' ' ' PRO . 51.8 Cg_exo -53.18 161.29 3.73 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.518 2.145 . . . . 0.0 112.041 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.55 30.9 1.88 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.807 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.74 -60.57 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.391 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.615 HD12 ' N ' ' B' ' 46' ' ' ILE . 1.7 mp -76.37 -54.6 1.86 Allowed Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.857 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' B' ' 46' ' ' ILE . 28.8 Cg_endo -63.26 -32.57 73.16 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.888 1.725 . . . . 0.0 112.34 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.811 HD23 ' O ' ' B' ' 48' ' ' LEU . 5.6 tt -61.08 -34.48 74.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.723 HD12 ' O ' ' B' ' 49' ' ' LEU . 0.3 OUTLIER -75.28 -42.09 55.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.425 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.488 ' HD2' ' CZ ' ' B' ' 35' ' ' PHE . 0.0 OUTLIER -73.48 -35.92 65.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.908 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.455 ' HA ' ' CD2' ' B' ' 35' ' ' PHE . 54.2 m -59.31 -46.61 88.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.607 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.653 ' O ' HG23 ' B' ' 56' ' ' VAL . 15.4 pt20 -61.73 -45.19 95.01 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.203 0.525 . . . . 0.0 109.793 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.3 -36.91 22.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.452 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . 0.658 ' CG ' HD22 ' B' ' 31' ' ' LEU . 8.7 m-85 -77.64 -69.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.071 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.574 HG21 ' CE1' ' A' ' 54' ' ' PHE . 29.0 pt -44.65 -33.92 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.743 0.306 . . . . 0.0 110.901 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.653 HG23 ' O ' ' B' ' 52' ' ' GLN . 91.2 t -76.72 -46.18 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 49.3 ttm -50.6 -29.47 10.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' B' ' 24' ' ' ALA . . . -84.61 -33.64 18.61 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.744 ' HA ' HD11 ' B' ' 28' ' ' ILE . 45.4 tp -73.1 -7.51 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 110.183 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.586 HG12 ' O ' ' B' ' 60' ' ' VAL . 65.0 t -109.54 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.884 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.446 ' O ' ' HD2' ' B' ' 64' ' ' PRO . 38.6 t70 -81.38 -23.59 37.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.912 0.387 . . . . 0.0 110.58 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' B' ' 21' ' ' ALA . . . -88.66 -42.11 12.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.54 0.686 . . . . 0.0 110.001 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.562 ' N ' ' CD ' ' B' ' 64' ' ' PRO . 2.4 mm -47.16 -34.42 4.37 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.527 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.826 ' O ' HG23 ' B' ' 68' ' ' VAL . 3.6 Cg_exo -78.36 -54.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.923 1.748 . . . . 0.0 111.623 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' MET . . . . . 0.817 ' HG2' ' HB3' ' B' ' 20' ' ' ALA . 2.0 tpt -52.83 -37.39 59.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.507 ' HA ' ' HG2' ' B' ' 17' ' ' MET . 75.6 mt -66.22 -54.47 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.596 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.23 -31.49 61.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.826 HG23 ' O ' ' B' ' 64' ' ' PRO . 56.4 t -75.69 -43.92 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.963 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' B' ' 16' ' ' MET . . . -65.79 -35.62 91.16 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.896 ' O ' HG23 ' B' ' 74' ' ' VAL . 0.5 OUTLIER -67.33 -38.04 84.25 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.781 -0.71 . . . . 0.0 109.672 178.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' B' ' 75' ' ' MET . . . -65.0 -60.68 6.56 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.26 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.893 HD12 ' CE ' ' B' ' 16' ' ' MET . 58.8 mt -52.22 -34.48 45.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.484 0.659 . . . . 0.0 109.63 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.916 ' CZ ' HD22 ' A' ' 72' ' ' LEU . 10.7 t80 -71.25 -47.0 59.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.484 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.896 HG23 ' O ' ' B' ' 70' ' ' LEU . 92.9 t -62.31 -26.33 40.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.813 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' B' ' 71' ' ' GLY . 89.2 mtp -63.65 -50.03 70.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' PHE . . . . . 0.803 ' HB2' HD13 ' B' ' 9' ' ' LEU . 2.4 t80 -53.0 -35.94 59.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 74' ' ' VAL . . . -58.3 -32.5 68.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.126 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.17 -32.75 55.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.974 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.12 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.596 0.236 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.6 -29.53 0.75 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.407 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.07 -62.82 1.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.04 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . 0.524 HD22 ' N ' ' C' ' 4' ' ' LEU . 3.0 mm? -65.52 -17.93 64.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 0.0 109.925 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.65 -71.79 0.17 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.476 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' MET . . . . . . . . . . . . . 23.3 ptp -59.13 -22.0 60.21 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.638 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.25 -44.86 28.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.809 HD21 ' HB2' ' D' ' 11' ' ' MET . 0.7 OUTLIER -75.0 -40.12 60.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.958 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' C' ' 76' ' ' PHE . 6.8 tt -56.08 -59.13 5.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.557 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' TYR . . . . . 0.737 ' HB3' HD12 ' B' ' 8' ' ' LEU . 14.9 m-85 -56.15 -54.16 48.48 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 110.147 178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' MET . . . . . 0.756 ' CE ' HD22 ' C' ' 8' ' ' LEU . 57.2 ttp -54.4 -20.2 6.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.152 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' C' ' 9' ' ' LEU . . . -70.56 -54.2 13.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.042 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.567 ' O ' ' HG3' ' C' ' 17' ' ' MET . . . -62.9 -19.22 63.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.761 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.67 -39.24 11.96 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.506 0.67 . . . . 0.0 109.454 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' VAL . . . . . 0.531 HG23 ' O ' ' C' ' 11' ' ' MET . 46.2 t -74.88 -37.03 41.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.168 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' MET . . . . . 0.908 ' CE ' HD12 ' C' ' 72' ' ' LEU . 57.5 mtm -70.28 -62.46 1.38 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.411 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' MET . . . . . 0.567 ' HG3' ' O ' ' C' ' 13' ' ' ALA . 40.7 mtm -63.13 -51.52 66.17 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.376 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.714 ' HA3' HD23 ' B' ' 19' ' ' LEU . . . -54.58 -37.06 59.94 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.585 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.714 HD23 ' HA3' ' D' ' 18' ' ' GLY . 24.0 tp -79.64 -38.42 33.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . 0.818 ' HB3' ' HG2' ' C' ' 65' ' ' MET . . . -85.7 -35.94 20.54 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.533 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.593 ' HA ' ' CB ' ' C' ' 62' ' ' ALA . . . -62.53 -43.7 98.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.932 HD12 ' N ' ' C' ' 23' ' ' GLY . 2.6 pp -65.33 -40.56 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . 0.932 ' N ' HD12 ' C' ' 22' ' ' ILE . . . -60.94 -29.32 70.38 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' C' ' 58' ' ' GLY . . . -73.29 -56.57 4.9 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.045 -0.578 . . . . 0.0 110.069 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.55 -54.38 18.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.259 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 49.1 mm -53.12 -56.42 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.719 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' C' ' 31' ' ' LEU . . . -48.0 -54.06 12.95 Favored Glycine 0 CA--C 1.509 -0.324 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.864 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ILE . . . . . 0.741 HD11 ' HA ' ' C' ' 59' ' ' LEU . 68.3 mt -49.81 -34.38 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.299 0.571 . . . . 0.0 109.496 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.69 -34.41 28.08 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.32 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.16 -62.04 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.102 0 CA-C-O 121.009 0.433 . . . . 0.0 110.433 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' LEU . . . . . 0.657 HD22 ' CG ' ' C' ' 54' ' ' PHE . 0.5 OUTLIER -60.9 -43.18 98.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.817 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.95 -50.42 67.7 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.855 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.34 -51.99 24.31 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.761 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.81 -42.14 88.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.568 0.223 . . . . 0.0 111.416 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' PHE . . . . . 0.772 ' CD1' HD22 ' D' ' 36' ' ' LEU . 60.0 t80 -58.73 -47.32 85.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.722 HD22 ' CD1' ' B' ' 35' ' ' PHE . 64.1 tp -55.27 -44.3 75.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.023 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.33 -31.37 67.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.97 24.12 28.03 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.711 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.2 31.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 111.331 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.32 -34.3 21.89 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 120.955 0.407 . . . . 0.0 111.064 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.478 ' N ' ' HD2' ' C' ' 41' ' ' ARG . 0.4 OUTLIER -67.82 -47.3 69.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.116 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' GLN . . . . . 0.419 ' HB3' ' HD2' ' C' ' 43' ' ' PRO . 84.8 mt-30 -58.14 163.61 4.32 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.115 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' C' ' 47' ' ' PRO . 52.1 Cg_exo -53.22 161.29 3.79 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.566 2.178 . . . . 0.0 111.957 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.51 30.84 1.89 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.86 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 59.0 tp -97.71 -60.61 1.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.359 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' ILE . . . . . 0.616 HD12 ' N ' ' C' ' 46' ' ' ILE . 1.7 mp -76.33 -54.57 1.89 Allowed Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.905 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' C' ' 46' ' ' ILE . 28.9 Cg_endo -63.29 -32.47 72.92 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.848 1.699 . . . . 0.0 112.378 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.803 HD23 ' O ' ' C' ' 48' ' ' LEU . 5.5 tt -61.17 -34.45 75.05 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.704 HD12 ' O ' ' C' ' 49' ' ' LEU . 0.3 OUTLIER -75.22 -42.2 55.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.403 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' ARG . . . . . 0.505 ' HD2' ' CZ ' ' C' ' 35' ' ' PHE . 0.0 OUTLIER -73.36 -36.02 66.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.922 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.455 ' HA ' ' CD2' ' C' ' 35' ' ' PHE . 53.8 m -59.28 -46.6 88.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.558 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . 0.649 ' O ' HG23 ' C' ' 56' ' ' VAL . 15.3 pt20 -61.8 -45.14 95.12 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.234 0.54 . . . . 0.0 109.824 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.28 -36.95 22.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.488 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.657 ' CG ' HD22 ' C' ' 31' ' ' LEU . 8.7 m-85 -77.66 -69.58 0.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.051 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' ILE . . . . . 0.639 HG21 ' CE1' ' B' ' 54' ' ' PHE . 29.1 pt -44.5 -34.0 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.779 0.323 . . . . 0.0 110.941 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.649 HG23 ' O ' ' C' ' 52' ' ' GLN . 89.8 t -76.69 -46.14 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.63 -29.48 11.09 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' C' ' 24' ' ' ALA . . . -84.64 -33.61 18.6 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.741 ' HA ' HD11 ' C' ' 28' ' ' ILE . 45.0 tp -73.11 -7.49 51.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 110.202 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.573 HG12 ' O ' ' C' ' 60' ' ' VAL . 64.8 t -109.55 -1.33 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.85 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . 0.444 ' O ' ' HD2' ' C' ' 64' ' ' PRO . 38.6 t70 -81.48 -23.57 37.32 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.922 0.392 . . . . 0.0 110.601 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' ALA . . . . . 0.593 ' CB ' ' HA ' ' C' ' 21' ' ' ALA . . . -88.6 -42.06 12.27 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.551 0.691 . . . . 0.0 110.089 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' ILE . . . . . 0.576 ' N ' ' CD ' ' C' ' 64' ' ' PRO . 2.4 mm -47.17 -34.45 4.42 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.569 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . 0.802 ' O ' HG23 ' C' ' 68' ' ' VAL . 3.6 Cg_exo -78.38 -54.47 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.948 1.766 . . . . 0.0 111.599 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' MET . . . . . 0.818 ' HG2' ' HB3' ' C' ' 20' ' ' ALA . 2.0 tpt -52.87 -37.37 60.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . 0.511 ' HA ' ' HG2' ' C' ' 17' ' ' MET . 75.4 mt -66.13 -54.47 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.653 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.29 -31.43 61.61 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' C' ' 64' ' ' PRO . 56.7 t -75.72 -43.98 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.901 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . 0.513 ' HA2' ' HE1' ' C' ' 16' ' ' MET . . . -65.67 -35.74 91.46 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' LEU . . . . . 0.913 ' O ' HG23 ' C' ' 74' ' ' VAL . 0.5 OUTLIER -67.28 -38.03 84.4 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.801 -0.7 . . . . 0.0 109.726 178.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' C' ' 75' ' ' MET . . . -64.96 -60.74 6.51 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.269 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.909 HD22 ' CZ ' ' D' ' 73' ' ' TYR . 58.3 mt -52.19 -34.53 45.78 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.5 0.667 . . . . 0.0 109.648 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.892 ' CZ ' HD22 ' B' ' 72' ' ' LEU . 10.6 t80 -71.18 -46.96 60.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.537 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.913 HG23 ' O ' ' C' ' 70' ' ' LEU . 92.9 t -62.42 -26.22 39.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.819 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' C' ' 71' ' ' GLY . 89.2 mtp -63.71 -50.0 70.89 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' PHE . . . . . 0.8 ' HB2' HD13 ' C' ' 9' ' ' LEU . 2.4 t80 -53.03 -35.91 59.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' C' ' 74' ' ' VAL . . . -58.3 -32.54 68.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.105 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.19 -32.73 55.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.09 179.937 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.579 0.228 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.69 -29.41 0.75 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.438 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.08 -62.83 1.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.067 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . 0.534 HD22 ' N ' ' D' ' 4' ' ' LEU . 3.0 mm? -65.59 -17.87 64.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.087 0.47 . . . . 0.0 109.979 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.68 -71.75 0.17 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.473 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.17 -21.98 60.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.622 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.22 -44.91 28.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.272 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.936 HD21 ' HB2' ' E' ' 11' ' ' MET . 0.7 OUTLIER -75.02 -40.08 60.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.959 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . 0.811 HD13 ' HB2' ' D' ' 76' ' ' PHE . 6.8 tt -56.08 -59.09 5.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.568 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.739 ' HB3' HD12 ' C' ' 8' ' ' LEU . 14.8 m-85 -56.17 -54.1 49.2 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.166 0.508 . . . . 0.0 110.148 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' MET . . . . . 0.809 ' HB2' HD21 ' C' ' 8' ' ' LEU . 57.2 ttp -54.49 -20.19 7.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.128 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' D' ' 9' ' ' LEU . . . -70.56 -54.16 13.19 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.075 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' D' ' 17' ' ' MET . . . -62.96 -19.19 64.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.804 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.64 -39.21 11.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.523 0.677 . . . . 0.0 109.49 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' VAL . . . . . 0.531 HG23 ' O ' ' D' ' 11' ' ' MET . 46.2 t -74.86 -37.11 41.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.805 -1.088 . . . . 0.0 109.182 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' MET . . . . . 0.906 ' CE ' HD12 ' D' ' 72' ' ' LEU . 57.7 mtm -70.23 -62.51 1.36 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.425 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' D' ' 13' ' ' ALA . 40.6 mtm -63.09 -51.49 66.38 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.434 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . 0.714 ' HA3' HD23 ' C' ' 19' ' ' LEU . . . -54.62 -37.07 60.15 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.557 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.721 HD23 ' HA3' ' E' ' 18' ' ' GLY . 24.0 tp -79.64 -38.41 33.81 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.841 ' HB3' ' HG2' ' D' ' 65' ' ' MET . . . -85.65 -35.93 20.62 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.536 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . 0.592 ' HA ' ' CB ' ' D' ' 62' ' ' ALA . . . -62.63 -43.69 98.18 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.931 HD12 ' N ' ' D' ' 23' ' ' GLY . 2.6 pp -65.29 -40.59 89.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . 0.931 ' N ' HD12 ' D' ' 22' ' ' ILE . . . -60.94 -29.34 70.44 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.216 177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' D' ' 58' ' ' GLY . . . -73.17 -56.6 4.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.039 -0.581 . . . . 0.0 110.104 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.57 -54.29 19.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.26 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.23 -56.39 8.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.737 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' D' ' 31' ' ' LEU . . . -47.96 -54.1 12.71 Favored Glycine 0 CA--C 1.508 -0.352 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.902 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' ILE . . . . . 0.727 HD11 ' HA ' ' D' ' 59' ' ' LEU . 68.1 mt -49.86 -34.32 9.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . 0.438 ' HA2' ' HG ' ' C' ' 31' ' ' LEU . . . -80.62 -34.5 28.05 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.327 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.14 -62.04 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.987 0.422 . . . . 0.0 110.443 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . 0.677 HD22 ' CG ' ' D' ' 54' ' ' PHE . 0.5 OUTLIER -60.93 -43.18 98.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.787 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.99 -50.43 67.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.811 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.29 -51.97 24.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.862 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.8 -42.17 88.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.608 0.242 . . . . 0.0 111.402 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' PHE . . . . . 0.772 ' CD1' HD22 ' E' ' 36' ' ' LEU . 60.0 t80 -58.65 -47.39 84.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.799 0.333 . . . . 0.0 110.931 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.772 HD22 ' CD1' ' C' ' 35' ' ' PHE . 64.4 tp -55.24 -44.23 75.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.31 -31.47 67.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.047 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.92 24.07 28.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.695 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.23 31.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.746 0.308 . . . . 0.0 111.324 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.4 -34.35 21.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.043 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . 0.477 ' N ' ' HD2' ' D' ' 41' ' ' ARG . 0.4 OUTLIER -67.72 -47.29 69.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.172 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' GLN . . . . . 0.427 ' HB3' ' HD2' ' D' ' 43' ' ' PRO . 84.9 mt-30 -58.15 163.6 4.34 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.122 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' PRO . . . . . 0.475 ' O ' ' CG ' ' D' ' 47' ' ' PRO . 52.1 Cg_exo -53.2 161.33 3.73 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.504 2.136 . . . . 0.0 111.998 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.6 30.91 1.89 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.7 -60.67 1.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.366 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' ILE . . . . . 0.622 HD12 ' N ' ' D' ' 46' ' ' ILE . 1.7 mp -76.32 -54.58 1.89 Allowed Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.909 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' D' ' 46' ' ' ILE . 28.8 Cg_endo -63.16 -32.61 74.22 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 121.873 1.715 . . . . 0.0 112.404 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . 0.817 HD23 ' O ' ' D' ' 48' ' ' LEU . 5.5 tt -61.11 -34.43 74.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.209 0.528 . . . . 0.0 109.611 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . 0.723 HD12 ' O ' ' D' ' 49' ' ' LEU . 0.3 OUTLIER -75.28 -42.14 55.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.384 179.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' ARG . . . . . 0.503 ' HD2' ' CZ ' ' D' ' 35' ' ' PHE . 0.0 OUTLIER -73.41 -35.94 65.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.917 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.446 ' HA ' ' CD2' ' D' ' 35' ' ' PHE . 53.9 m -59.34 -46.55 88.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.595 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . 0.646 ' O ' HG23 ' D' ' 56' ' ' VAL . 15.3 pt20 -61.86 -45.05 95.45 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.187 0.518 . . . . 0.0 109.8 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.28 -36.98 22.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.429 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.677 ' CG ' HD22 ' D' ' 31' ' ' LEU . 8.8 m-85 -77.65 -69.55 0.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.069 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' ILE . . . . . 0.646 HG21 ' CE1' ' C' ' 54' ' ' PHE . 29.0 pt -44.57 -33.96 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.785 0.326 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' VAL . . . . . 0.646 HG23 ' O ' ' D' ' 52' ' ' GLN . 90.4 t -76.73 -46.17 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.56 -29.55 11.0 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.56 ' O ' ' HB1' ' D' ' 24' ' ' ALA . . . -84.64 -33.58 18.68 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . 0.727 ' HA ' HD11 ' D' ' 28' ' ' ILE . 45.1 tp -73.1 -7.53 51.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.188 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . 0.589 HG12 ' O ' ' D' ' 60' ' ' VAL . 65.7 t -109.53 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.849 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . 0.452 ' O ' ' HD2' ' D' ' 64' ' ' PRO . 38.6 t70 -81.43 -23.54 37.46 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 110.627 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . 0.592 ' CB ' ' HA ' ' D' ' 21' ' ' ALA . . . -88.66 -42.06 12.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.533 0.682 . . . . 0.0 110.045 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' ILE . . . . . 0.575 ' N ' ' CD ' ' D' ' 64' ' ' PRO . 2.4 mm -47.17 -34.47 4.44 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.532 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' PRO . . . . . 0.819 ' O ' HG23 ' D' ' 68' ' ' VAL . 3.6 Cg_exo -78.33 -54.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.021 1.814 . . . . 0.0 111.631 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' MET . . . . . 0.841 ' HG2' ' HB3' ' D' ' 20' ' ' ALA . 2.0 tpt -52.89 -37.36 60.48 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . 0.508 ' HA ' ' HG2' ' D' ' 17' ' ' MET . 75.6 mt -66.14 -54.46 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.658 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.26 -31.43 61.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' VAL . . . . . 0.819 HG23 ' O ' ' D' ' 64' ' ' PRO . 56.2 t -75.7 -44.0 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.931 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.72 -35.65 91.28 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' LEU . . . . . 0.91 ' O ' HG23 ' D' ' 74' ' ' VAL . 0.5 OUTLIER -67.34 -38.02 84.19 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.779 -0.71 . . . . 0.0 109.708 178.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' D' ' 75' ' ' MET . . . -64.97 -60.7 6.55 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.277 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' LEU . . . . . 0.908 HD22 ' CZ ' ' E' ' 73' ' ' TYR . 58.1 mt -52.24 -34.46 46.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.529 0.68 . . . . 0.0 109.675 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' TYR . . . . . 0.909 ' CZ ' HD22 ' C' ' 72' ' ' LEU . 10.7 t80 -71.22 -46.95 60.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.523 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.91 HG23 ' O ' ' D' ' 70' ' ' LEU . 92.9 t -62.4 -26.26 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.791 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' D' ' 71' ' ' GLY . 89.2 mtp -63.64 -50.06 70.79 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' PHE . . . . . 0.811 ' HB2' HD13 ' D' ' 9' ' ' LEU . 2.4 t80 -52.99 -35.92 59.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.439 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' D' ' 74' ' ' VAL . . . -58.32 -32.51 68.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.125 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.16 -32.71 55.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.134 -179.976 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.609 0.242 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.6 -29.52 0.75 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.421 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -71.11 -62.79 1.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.043 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . 0.527 HD22 ' N ' ' E' ' 4' ' ' LEU . 3.0 mm? -65.57 -17.91 64.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.116 0.484 . . . . 0.0 109.97 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.66 -71.75 0.17 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.512 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.13 -21.99 60.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.3 -44.85 28.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.244 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.899 HD21 ' HB2' ' F' ' 11' ' ' MET . 0.7 OUTLIER -75.08 -40.0 60.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.972 179.621 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . 0.805 HD13 ' HB2' ' E' ' 76' ' ' PHE . 6.8 tt -56.13 -59.12 5.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.568 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.788 ' HB3' HD12 ' D' ' 8' ' ' LEU . 14.8 m-85 -56.17 -54.03 50.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.139 0.495 . . . . 0.0 110.107 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' MET . . . . . 0.936 ' HB2' HD21 ' D' ' 8' ' ' LEU . 56.5 ttp -54.49 -20.23 7.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.124 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' E' ' 9' ' ' LEU . . . -70.54 -54.26 12.87 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.048 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' E' ' 17' ' ' MET . . . -62.87 -19.19 63.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.811 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.72 -39.23 11.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.483 0.658 . . . . 0.0 109.392 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' VAL . . . . . 0.527 HG23 ' O ' ' E' ' 11' ' ' MET . 45.9 t -74.9 -37.06 40.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.163 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' MET . . . . . 0.902 ' CE ' HD12 ' E' ' 72' ' ' LEU . 57.7 mtm -70.23 -62.5 1.36 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.424 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' MET . . . . . 0.571 ' HG3' ' O ' ' E' ' 13' ' ' ALA . 40.5 mtm -63.06 -51.51 66.38 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.471 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.721 ' HA3' HD23 ' D' ' 19' ' ' LEU . . . -54.63 -37.08 60.21 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.562 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' LEU . . . . . 0.767 HD23 ' HA3' ' F' ' 18' ' ' GLY . 23.8 tp -79.61 -38.37 34.02 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.832 ' HB3' ' HG2' ' E' ' 65' ' ' MET . . . -85.73 -35.89 20.52 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.542 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . 0.588 ' HA ' ' CB ' ' E' ' 62' ' ' ALA . . . -62.63 -43.63 98.33 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.916 HD12 ' N ' ' E' ' 23' ' ' GLY . 2.6 pp -65.29 -40.57 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 23' ' ' GLY . . . . . 0.916 ' N ' HD12 ' E' ' 22' ' ' ILE . . . -60.88 -29.41 70.46 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.237 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 24' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' E' ' 58' ' ' GLY . . . -73.2 -56.65 4.81 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.05 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.49 -54.39 18.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.277 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.12 -56.46 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.715 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 27' ' ' GLY . . . . . 0.452 ' O ' ' N ' ' E' ' 31' ' ' LEU . . . -47.92 -54.13 12.53 Favored Glycine 0 CA--C 1.509 -0.329 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.894 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 28' ' ' ILE . . . . . 0.742 HD11 ' HA ' ' E' ' 59' ' ' LEU . 68.3 mt -49.85 -34.3 9.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 29' ' ' GLY . . . . . 0.545 ' HA2' ' HG ' ' D' ' 31' ' ' LEU . . . -80.58 -34.54 28.09 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.358 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.13 -62.04 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 121.011 0.434 . . . . 0.0 110.439 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 31' ' ' LEU . . . . . 0.669 HD22 ' CG ' ' E' ' 54' ' ' PHE . 0.5 OUTLIER -60.98 -43.15 99.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.765 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.96 -50.45 67.44 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.871 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.31 -51.97 24.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.794 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.83 -42.13 88.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.56 0.219 . . . . 0.0 111.357 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 35' ' ' PHE . . . . . 0.774 ' CD1' HD22 ' F' ' 36' ' ' LEU . 60.0 t80 -58.73 -47.34 84.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.803 0.335 . . . . 0.0 110.891 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.772 HD22 ' CD1' ' D' ' 35' ' ' PHE . 64.5 tp -55.24 -44.26 75.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.046 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -58.32 -31.45 67.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.043 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.98 24.17 27.8 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.673 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.28 31.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.734 0.302 . . . . 0.0 111.322 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.32 -34.33 21.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.984 0.421 . . . . 0.0 111.089 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' E' ' 41' ' ' ARG . 0.4 OUTLIER -67.86 -47.25 69.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.169 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 42' ' ' GLN . . . . . 0.427 ' HB3' ' HD2' ' E' ' 43' ' ' PRO . 84.8 mt-30 -58.13 163.59 4.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 43' ' ' PRO . . . . . 0.473 ' O ' ' CG ' ' E' ' 47' ' ' PRO . 52.2 Cg_exo -53.2 161.32 3.74 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.541 2.16 . . . . 0.0 111.963 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.54 30.87 1.89 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.838 0.351 . . . . 0.0 110.864 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.76 -60.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.334 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 46' ' ' ILE . . . . . 0.619 HD12 ' N ' ' E' ' 46' ' ' ILE . 1.7 mp -76.26 -54.61 1.91 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.889 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 47' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' E' ' 46' ' ' ILE . 28.9 Cg_endo -63.26 -32.53 73.23 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.815 1.676 . . . . 0.0 112.391 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 48' ' ' LEU . . . . . 0.805 HD23 ' O ' ' E' ' 48' ' ' LEU . 5.5 tt -61.15 -34.44 75.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 49' ' ' LEU . . . . . 0.716 HD12 ' O ' ' E' ' 49' ' ' LEU . 0.3 OUTLIER -75.29 -42.03 55.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.445 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 50' ' ' ARG . . . . . 0.504 ' HD2' ' CZ ' ' E' ' 35' ' ' PHE . 0.0 OUTLIER -73.54 -35.92 65.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.858 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 51' ' ' THR . . . . . 0.45 ' HA ' ' CD2' ' E' ' 35' ' ' PHE . 53.6 m -59.35 -46.56 88.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.601 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . 0.654 ' O ' HG23 ' E' ' 56' ' ' VAL . 15.4 pt20 -61.76 -45.17 95.07 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.238 0.542 . . . . 0.0 109.796 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.26 -36.96 21.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.486 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 54' ' ' PHE . . . . . 0.669 ' CG ' HD22 ' E' ' 31' ' ' LEU . 8.8 m-85 -77.6 -69.58 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 55' ' ' ILE . . . . . 0.589 HG21 ' CE1' ' D' ' 54' ' ' PHE . 29.0 pt -44.58 -33.97 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.789 0.328 . . . . 0.0 110.883 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 56' ' ' VAL . . . . . 0.654 HG23 ' O ' ' E' ' 52' ' ' GLN . 91.3 t -76.74 -46.11 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.63 -29.46 11.04 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 58' ' ' GLY . . . . . 0.562 ' O ' ' HB1' ' E' ' 24' ' ' ALA . . . -84.64 -33.63 18.53 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 59' ' ' LEU . . . . . 0.742 ' HA ' HD11 ' E' ' 28' ' ' ILE . 45.4 tp -73.08 -7.51 51.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.96 0.409 . . . . 0.0 110.218 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . 0.586 HG12 ' O ' ' E' ' 60' ' ' VAL . 64.9 t -109.52 -1.29 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.892 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . 0.447 ' O ' ' HD2' ' E' ' 64' ' ' PRO . 38.6 t70 -81.45 -23.6 37.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.579 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 62' ' ' ALA . . . . . 0.588 ' CB ' ' HA ' ' E' ' 21' ' ' ALA . . . -88.61 -42.13 12.22 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.565 0.697 . . . . 0.0 110.046 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 63' ' ' ILE . . . . . 0.563 ' N ' ' CD ' ' E' ' 64' ' ' PRO . 2.4 mm -47.09 -34.44 4.27 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.611 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 64' ' ' PRO . . . . . 0.807 ' O ' HG23 ' E' ' 68' ' ' VAL . 3.6 Cg_exo -78.32 -54.54 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.981 1.787 . . . . 0.0 111.624 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 65' ' ' MET . . . . . 0.832 ' HG2' ' HB3' ' E' ' 20' ' ' ALA . 2.0 tpt -52.8 -37.41 59.79 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . 0.518 ' HA ' ' HG2' ' E' ' 17' ' ' MET . 75.6 mt -66.22 -54.47 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.608 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.26 -31.46 61.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' E' ' 64' ' ' PRO . 56.5 t -75.66 -43.99 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.93 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 69' ' ' GLY . . . . . 0.425 ' HA2' ' HE3' ' E' ' 16' ' ' MET . . . -65.76 -35.6 91.16 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 70' ' ' LEU . . . . . 0.894 ' O ' HG23 ' E' ' 74' ' ' VAL . 0.5 OUTLIER -67.33 -38.06 84.3 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.755 -0.723 . . . . 0.0 109.717 178.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 71' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' E' ' 75' ' ' MET . . . -65.0 -60.66 6.59 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.256 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 72' ' ' LEU . . . . . 0.905 HD22 ' CZ ' ' F' ' 73' ' ' TYR . 58.2 mt -52.27 -34.47 46.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.524 0.678 . . . . 0.0 109.645 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 73' ' ' TYR . . . . . 0.908 ' CZ ' HD22 ' D' ' 72' ' ' LEU . 10.6 t80 -71.2 -47.03 59.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.498 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 74' ' ' VAL . . . . . 0.894 HG23 ' O ' ' E' ' 70' ' ' LEU . 92.9 t -62.34 -26.2 39.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.804 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 75' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' E' ' 71' ' ' GLY . 89.3 mtp -63.71 -50.04 70.73 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 76' ' ' PHE . . . . . 0.805 ' HB2' HD13 ' E' ' 9' ' ' LEU . 2.4 t80 -53.01 -35.94 59.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 77' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' E' ' 74' ' ' VAL . . . -58.28 -32.57 68.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.123 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 78' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.16 -32.74 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.996 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.104 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . 0.455 ' HG3' ' OD1' ' G' ' 3' ' ' ASN . 68.2 mtm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.651 0.262 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.56 -29.57 0.75 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.05 -62.8 1.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . 0.532 HD22 ' N ' ' F' ' 4' ' ' LEU . 3.0 mm? -65.58 -17.88 64.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.091 0.472 . . . . 0.0 109.967 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.7 -71.71 0.17 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.487 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 6' ' ' MET . . . . . . . . . . . . . 23.1 ptp -59.19 -22.0 60.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.635 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.23 -44.89 28.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.267 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.85 HD21 ' HB2' ' G' ' 11' ' ' MET . 0.7 OUTLIER -75.02 -40.06 60.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.954 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . 0.812 HD13 ' HB2' ' F' ' 76' ' ' PHE . 6.8 tt -56.14 -59.11 5.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.548 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 10' ' ' TYR . . . . . 0.759 ' HB3' HD12 ' E' ' 8' ' ' LEU . 14.8 m-85 -56.16 -53.98 50.59 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.175 0.512 . . . . 0.0 110.146 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 11' ' ' MET . . . . . 0.899 ' HB2' HD21 ' E' ' 8' ' ' LEU . 56.4 ttp -54.55 -20.22 7.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.085 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 12' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' F' ' 9' ' ' LEU . . . -70.53 -54.24 12.95 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.042 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' F' ' 17' ' ' MET . . . -62.95 -19.11 63.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.823 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.67 -39.25 11.95 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.523 0.678 . . . . 0.0 109.455 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 15' ' ' VAL . . . . . 0.53 HG23 ' O ' ' F' ' 11' ' ' MET . 46.1 t -74.85 -37.09 41.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.152 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 16' ' ' MET . . . . . 0.905 ' CE ' HD12 ' F' ' 72' ' ' LEU . 57.5 mtm -70.26 -62.54 1.35 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.387 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 17' ' ' MET . . . . . 0.572 ' HG3' ' O ' ' F' ' 13' ' ' ALA . 40.6 mtm -63.08 -51.48 66.49 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.433 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . 0.767 ' HA3' HD23 ' E' ' 19' ' ' LEU . . . -54.66 -37.07 60.3 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.592 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 19' ' ' LEU . . . . . 0.835 HD23 ' HA3' ' G' ' 18' ' ' GLY . 23.6 tp -79.54 -38.4 34.27 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . 0.825 ' HB3' ' HG2' ' F' ' 65' ' ' MET . . . -85.73 -35.91 20.51 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.497 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . 0.584 ' HA ' ' CB ' ' F' ' 62' ' ' ALA . . . -62.57 -43.64 98.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.92 HD12 ' N ' ' F' ' 23' ' ' GLY . 2.6 pp -65.29 -40.55 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . 0.92 ' N ' HD12 ' F' ' 22' ' ' ILE . . . -60.92 -29.33 70.35 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.257 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 24' ' ' ALA . . . . . 0.565 ' HB1' ' O ' ' F' ' 58' ' ' GLY . . . -73.25 -56.63 4.83 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 114.965 -0.618 . . . . 0.0 110.08 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.46 -54.45 17.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.235 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.06 -56.48 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.747 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 27' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' F' ' 31' ' ' LEU . . . -48.03 -54.0 13.19 Favored Glycine 0 CA--C 1.509 -0.324 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.91 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 28' ' ' ILE . . . . . 0.75 HD11 ' HA ' ' F' ' 59' ' ' LEU . 68.6 mt -49.87 -34.32 9.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 29' ' ' GLY . . . . . 0.455 ' HA2' ' HG ' ' E' ' 31' ' ' LEU . . . -80.65 -34.43 28.14 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.364 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.15 -62.1 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.993 0.425 . . . . 0.0 110.446 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 31' ' ' LEU . . . . . 0.671 HD22 ' CG ' ' F' ' 54' ' ' PHE . 0.5 OUTLIER -60.89 -43.21 98.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.778 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.97 -50.39 68.11 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.882 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.3 -52.03 24.33 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.806 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.68 -42.24 88.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.619 0.247 . . . . 0.0 111.43 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 35' ' ' PHE . . . . . 0.495 ' CZ ' ' HD2' ' F' ' 50' ' ' ARG . 59.8 t80 -58.66 -47.46 84.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.802 0.334 . . . . 0.0 110.859 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.774 HD22 ' CD1' ' E' ' 35' ' ' PHE . 64.2 tp -55.25 -44.19 75.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -58.41 -31.36 67.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.015 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.95 24.12 27.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.719 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.28 31.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.763 0.316 . . . . 0.0 111.357 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.33 -34.3 21.87 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.114 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 41' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' F' ' 41' ' ' ARG . 0.4 OUTLIER -67.85 -47.29 69.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 42' ' ' GLN . . . . . 0.415 ' HB3' ' HD2' ' F' ' 43' ' ' PRO . 84.9 mt-30 -58.1 163.6 4.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 43' ' ' PRO . . . . . 0.465 ' O ' ' CG ' ' F' ' 47' ' ' PRO . 52.3 Cg_exo -53.22 161.36 3.74 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.505 2.137 . . . . 0.0 111.973 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.63 30.93 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.836 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.71 -60.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.089 0.471 . . . . 0.0 111.333 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 46' ' ' ILE . . . . . 0.608 HD12 ' N ' ' F' ' 46' ' ' ILE . 1.7 mp -76.34 -54.58 1.88 Allowed Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.857 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 47' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' F' ' 46' ' ' ILE . 28.8 Cg_endo -63.28 -32.49 72.98 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.85 1.7 . . . . 0.0 112.374 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 48' ' ' LEU . . . . . 0.812 HD23 ' O ' ' F' ' 48' ' ' LEU . 5.5 tt -61.16 -34.43 75.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.205 0.526 . . . . 0.0 109.594 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 49' ' ' LEU . . . . . 0.722 HD12 ' O ' ' F' ' 49' ' ' LEU . 0.3 OUTLIER -75.27 -42.1 55.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.438 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 50' ' ' ARG . . . . . 0.495 ' HD2' ' CZ ' ' F' ' 35' ' ' PHE . 0.0 OUTLIER -73.49 -35.96 65.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.857 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 51' ' ' THR . . . . . 0.449 ' HA ' ' CD2' ' F' ' 35' ' ' PHE . 53.4 m -59.36 -46.53 88.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.601 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . 0.646 ' O ' HG23 ' F' ' 56' ' ' VAL . 15.3 pt20 -61.8 -45.12 95.23 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.247 0.546 . . . . 0.0 109.83 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.31 -36.9 22.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.464 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 54' ' ' PHE . . . . . 0.671 ' CG ' HD22 ' F' ' 31' ' ' LEU . 8.9 m-85 -77.63 -69.57 0.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.095 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 55' ' ' ILE . . . . . 0.62 HG21 ' CE1' ' E' ' 54' ' ' PHE . 29.0 pt -44.62 -33.97 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.76 0.314 . . . . 0.0 110.883 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 56' ' ' VAL . . . . . 0.646 HG23 ' O ' ' F' ' 52' ' ' GLN . 92.1 t -76.72 -46.15 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 57' ' ' MET . . . . . . . . . . . . . 49.3 ttm -50.58 -29.45 10.84 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 58' ' ' GLY . . . . . 0.565 ' O ' ' HB1' ' F' ' 24' ' ' ALA . . . -84.66 -33.61 18.53 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 59' ' ' LEU . . . . . 0.75 ' HA ' HD11 ' F' ' 28' ' ' ILE . 45.5 tp -73.06 -7.55 51.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.964 0.412 . . . . 0.0 110.227 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . 0.57 HG12 ' O ' ' F' ' 60' ' ' VAL . 64.5 t -109.48 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.893 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 61' ' ' ASP . . . . . 0.454 ' O ' ' HD2' ' F' ' 64' ' ' PRO . 38.6 t70 -81.45 -23.6 37.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.926 0.393 . . . . 0.0 110.552 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 62' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' F' ' 21' ' ' ALA . . . -88.63 -42.04 12.27 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.572 0.701 . . . . 0.0 110.099 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 63' ' ' ILE . . . . . 0.574 ' N ' ' CD ' ' F' ' 64' ' ' PRO . 2.4 mm -47.1 -34.52 4.37 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.774 -1.103 . . . . 0.0 113.509 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 64' ' ' PRO . . . . . 0.812 ' O ' HG23 ' F' ' 68' ' ' VAL . 3.5 Cg_exo -78.34 -54.54 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.994 1.796 . . . . 0.0 111.593 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 65' ' ' MET . . . . . 0.825 ' HG2' ' HB3' ' F' ' 20' ' ' ALA . 2.0 tpt -52.79 -37.4 59.69 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . 0.521 ' HA ' ' HG2' ' F' ' 17' ' ' MET . 75.7 mt -66.18 -54.46 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.684 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.24 -31.44 61.51 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 68' ' ' VAL . . . . . 0.812 HG23 ' O ' ' F' ' 64' ' ' PRO . 56.6 t -75.68 -44.04 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.86 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.73 -35.65 91.27 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 70' ' ' LEU . . . . . 0.909 ' O ' HG23 ' F' ' 74' ' ' VAL . 0.5 OUTLIER -67.33 -38.05 84.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.696 178.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 71' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' F' ' 75' ' ' MET . . . -64.96 -60.7 6.55 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.278 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 72' ' ' LEU . . . . . 0.905 HD12 ' CE ' ' F' ' 16' ' ' MET . 58.2 mt -52.18 -34.52 45.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.514 0.674 . . . . 0.0 109.623 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 73' ' ' TYR . . . . . 0.905 ' CZ ' HD22 ' E' ' 72' ' ' LEU . 10.7 t80 -71.24 -47.02 59.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.469 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 74' ' ' VAL . . . . . 0.909 HG23 ' O ' ' F' ' 70' ' ' LEU . 92.8 t -62.33 -26.19 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.807 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 75' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' F' ' 71' ' ' GLY . 89.3 mtp -63.75 -50.0 70.8 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 76' ' ' PHE . . . . . 0.812 ' HB2' HD13 ' F' ' 9' ' ' LEU . 2.4 t80 -52.96 -35.98 59.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 77' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' F' ' 74' ' ' VAL . . . -58.23 -32.58 68.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.151 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.16 -32.77 55.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.122 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . 0.417 ' HG3' ' OD1' ' H' ' 3' ' ' ASN . 68.1 mtm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.6 0.238 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.67 -29.5 0.77 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.395 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 3' ' ' ASN . . . . . 0.455 ' OD1' ' HG3' ' F' ' 1' ' ' MET . 75.3 m-20 -70.96 -62.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.088 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 4' ' ' LEU . . . . . 0.529 HD22 ' N ' ' G' ' 4' ' ' LEU . 3.0 mm? -65.54 -17.98 64.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.47 . . . . 0.0 109.97 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 5' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' G' ' 1' ' ' MET . 11.9 t-20 -64.62 -71.78 0.17 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.518 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.11 -22.02 60.2 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.657 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.2 -44.94 28.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.261 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.757 HD12 ' HB3' ' H' ' 10' ' ' TYR . 0.7 OUTLIER -75.0 -40.0 60.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.009 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 9' ' ' LEU . . . . . 0.784 HD13 ' HB2' ' G' ' 76' ' ' PHE . 6.8 tt -56.11 -59.2 5.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.528 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 10' ' ' TYR . . . . . 0.774 ' HB3' HD12 ' F' ' 8' ' ' LEU . 14.9 m-85 -56.12 -54.06 49.6 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.19 0.519 . . . . 0.0 110.182 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 11' ' ' MET . . . . . 0.85 ' HB2' HD21 ' F' ' 8' ' ' LEU . 57.1 ttp -54.48 -20.19 7.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.129 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 12' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' G' ' 9' ' ' LEU . . . -70.56 -54.22 12.96 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.052 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 13' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' G' ' 17' ' ' MET . . . -62.87 -19.22 63.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.784 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.7 -39.24 11.94 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.491 0.662 . . . . 0.0 109.456 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 15' ' ' VAL . . . . . 0.528 HG23 ' O ' ' G' ' 11' ' ' MET . 46.1 t -74.88 -37.03 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.195 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 16' ' ' MET . . . . . 0.903 ' CE ' HD12 ' G' ' 72' ' ' LEU . 57.7 mtm -70.29 -62.54 1.35 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.407 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 17' ' ' MET . . . . . 0.561 ' HG3' ' O ' ' G' ' 13' ' ' ALA . 40.6 mtm -63.05 -51.5 66.44 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.434 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 18' ' ' GLY . . . . . 0.835 ' HA3' HD23 ' F' ' 19' ' ' LEU . . . -54.61 -37.13 60.25 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.591 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 19' ' ' LEU . . . . . 0.776 HD23 ' HA3' ' H' ' 18' ' ' GLY . 23.9 tp -79.55 -38.38 34.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 20' ' ' ALA . . . . . 0.812 ' HB3' ' HG2' ' G' ' 65' ' ' MET . . . -85.72 -35.94 20.51 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.558 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.588 ' HA ' ' CB ' ' G' ' 62' ' ' ALA . . . -62.54 -43.64 98.31 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 22' ' ' ILE . . . . . 0.928 HD12 ' N ' ' G' ' 23' ' ' GLY . 2.6 pp -65.36 -40.57 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 23' ' ' GLY . . . . . 0.928 ' N ' HD12 ' G' ' 22' ' ' ILE . . . -60.9 -29.35 70.36 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.21 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 24' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' G' ' 58' ' ' GLY . . . -73.26 -56.58 4.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.101 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.49 -54.42 17.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.236 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.12 -56.43 8.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.71 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 27' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' G' ' 31' ' ' LEU . . . -47.95 -54.07 12.75 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.908 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 28' ' ' ILE . . . . . 0.753 HD11 ' HA ' ' G' ' 59' ' ' LEU . 68.7 mt -49.87 -34.34 9.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.74 -34.34 28.08 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.297 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.19 -62.04 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 CA-C-O 121.026 0.441 . . . . 0.0 110.454 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 31' ' ' LEU . . . . . 0.673 HD22 ' CG ' ' G' ' 54' ' ' PHE . 0.5 OUTLIER -60.91 -43.15 98.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.831 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.95 -50.44 67.46 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.878 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.3 -51.99 24.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.827 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.77 -42.22 88.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.58 0.229 . . . . 0.0 111.406 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 35' ' ' PHE . . . . . 0.502 ' CZ ' ' HD2' ' G' ' 50' ' ' ARG . 59.9 t80 -58.67 -47.41 84.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.736 0.303 . . . . 0.0 110.916 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 36' ' ' LEU . . . . . 0.404 HD22 ' CD1' ' F' ' 35' ' ' PHE . 64.0 tp -55.21 -44.23 75.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.037 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.39 -31.38 67.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.039 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.02 24.17 27.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.662 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.27 31.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.75 0.31 . . . . 0.0 111.306 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.34 -34.34 21.85 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.937 0.399 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 41' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' G' ' 41' ' ' ARG . 0.4 OUTLIER -67.8 -47.28 69.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.163 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 42' ' ' GLN . . . . . 0.427 ' HB3' ' HD2' ' G' ' 43' ' ' PRO . 84.9 mt-30 -58.15 163.57 4.36 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 43' ' ' PRO . . . . . 0.47 ' O ' ' CG ' ' G' ' 47' ' ' PRO . 52.0 Cg_exo -53.16 161.29 3.69 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.536 2.157 . . . . 0.0 111.982 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.52 30.82 1.89 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 45' ' ' LEU . . . . . . . . . . . . . 58.8 tp -97.67 -60.6 1.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.378 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 46' ' ' ILE . . . . . 0.618 HD12 ' N ' ' G' ' 46' ' ' ILE . 1.7 mp -76.36 -54.59 1.87 Allowed Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.891 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 47' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' G' ' 46' ' ' ILE . 29.0 Cg_endo -63.29 -32.47 72.94 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.8 1.667 . . . . 0.0 112.41 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 48' ' ' LEU . . . . . 0.819 HD23 ' O ' ' G' ' 48' ' ' LEU . 5.5 tt -61.12 -34.46 75.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 49' ' ' LEU . . . . . 0.716 HD12 ' O ' ' G' ' 49' ' ' LEU . 0.3 OUTLIER -75.31 -42.06 55.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.419 179.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 50' ' ' ARG . . . . . 0.502 ' HD2' ' CZ ' ' G' ' 35' ' ' PHE . 0.0 OUTLIER -73.49 -35.95 65.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.869 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 51' ' ' THR . . . . . 0.455 ' HA ' ' CD2' ' G' ' 35' ' ' PHE . 55.4 m -59.41 -46.52 88.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.557 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 52' ' ' GLN . . . . . 0.65 ' O ' HG23 ' G' ' 56' ' ' VAL . 15.3 pt20 -61.8 -45.18 94.96 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.268 0.556 . . . . 0.0 109.802 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.23 -36.98 21.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.512 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 54' ' ' PHE . . . . . 0.673 ' CG ' HD22 ' G' ' 31' ' ' LEU . 8.9 m-85 -77.58 -69.58 0.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.112 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 55' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' G' ' 52' ' ' GLN . 28.9 pt -44.6 -33.9 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.802 0.335 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 56' ' ' VAL . . . . . 0.65 HG23 ' O ' ' G' ' 52' ' ' GLN . 91.6 t -76.76 -46.13 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 57' ' ' MET . . . . . . . . . . . . . 49.3 ttm -50.6 -29.52 11.09 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 58' ' ' GLY . . . . . 0.571 ' O ' ' HB1' ' G' ' 24' ' ' ALA . . . -84.6 -33.62 18.68 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 59' ' ' LEU . . . . . 0.753 ' HA ' HD11 ' G' ' 28' ' ' ILE . 45.4 tp -73.09 -7.54 51.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.915 0.388 . . . . 0.0 110.191 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 60' ' ' VAL . . . . . 0.576 HG12 ' O ' ' G' ' 60' ' ' VAL . 64.8 t -109.52 -1.32 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.894 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 61' ' ' ASP . . . . . 0.454 ' O ' ' HD2' ' G' ' 64' ' ' PRO . 38.6 t70 -81.43 -23.55 37.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.972 0.415 . . . . 0.0 110.625 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 62' ' ' ALA . . . . . 0.588 ' CB ' ' HA ' ' G' ' 21' ' ' ALA . . . -88.66 -42.1 12.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.578 0.704 . . . . 0.0 110.043 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 63' ' ' ILE . . . . . 0.57 ' N ' ' CD ' ' G' ' 64' ' ' PRO . 2.4 mm -47.12 -34.42 4.29 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.572 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 64' ' ' PRO . . . . . 0.815 ' O ' HG23 ' G' ' 68' ' ' VAL . 3.6 Cg_exo -78.35 -54.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.975 1.783 . . . . 0.0 111.629 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 65' ' ' MET . . . . . 0.812 ' HG2' ' HB3' ' G' ' 20' ' ' ALA . 2.0 tpt -52.86 -37.35 60.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 66' ' ' ILE . . . . . 0.523 ' HA ' ' HG2' ' G' ' 17' ' ' MET . 75.4 mt -66.23 -54.41 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.643 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.44 61.58 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 68' ' ' VAL . . . . . 0.815 HG23 ' O ' ' G' ' 64' ' ' PRO . 56.2 t -75.68 -43.97 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.9 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.75 -35.66 91.26 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 70' ' ' LEU . . . . . 0.917 ' O ' HG23 ' G' ' 74' ' ' VAL . 0.5 OUTLIER -67.3 -38.0 84.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.716 178.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 71' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' G' ' 75' ' ' MET . . . -65.03 -60.7 6.52 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.252 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 72' ' ' LEU . . . . . 0.903 HD12 ' CE ' ' G' ' 16' ' ' MET . 58.2 mt -52.19 -34.5 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.521 0.677 . . . . 0.0 109.628 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 73' ' ' TYR . . . . . 0.895 ' CZ ' HD22 ' F' ' 72' ' ' LEU . 10.7 t80 -71.19 -47.0 60.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.513 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 74' ' ' VAL . . . . . 0.917 HG23 ' O ' ' G' ' 70' ' ' LEU . 92.7 t -62.4 -26.2 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.784 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 75' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' G' ' 71' ' ' GLY . 89.3 mtp -63.76 -49.97 70.9 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 76' ' ' PHE . . . . . 0.784 ' HB2' HD13 ' G' ' 9' ' ' LEU . 2.4 t80 -52.97 -35.95 59.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 77' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' G' ' 74' ' ' VAL . . . -58.33 -32.52 68.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.108 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.13 -32.77 55.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.966 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.141 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . 0.496 ' HG3' ' OD1' ' I' ' 3' ' ' ASN . 68.0 mtm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.643 0.259 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.72 -29.49 0.77 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.362 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . 0.417 ' OD1' ' HG3' ' G' ' 1' ' ' MET . 75.3 m-20 -71.02 -62.85 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.047 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 4' ' ' LEU . . . . . 0.517 HD22 ' N ' ' H' ' 4' ' ' LEU . 3.0 mm? -65.61 -17.82 64.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.111 0.481 . . . . 0.0 109.978 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.74 -71.77 0.17 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.454 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.12 -22.0 60.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.67 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.22 -44.89 28.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.255 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . 0.761 HD22 ' CE ' ' H' ' 11' ' ' MET . 0.7 OUTLIER -75.02 -40.01 60.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.946 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 9' ' ' LEU . . . . . 0.778 HD13 ' HB2' ' H' ' 76' ' ' PHE . 6.8 tt -56.19 -59.11 5.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.521 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 10' ' ' TYR . . . . . 0.757 ' HB3' HD12 ' G' ' 8' ' ' LEU . 14.9 m-85 -56.12 -54.17 48.33 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.225 0.535 . . . . 0.0 110.163 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 11' ' ' MET . . . . . 0.761 ' CE ' HD22 ' H' ' 8' ' ' LEU . 57.2 ttp -54.46 -20.13 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.145 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 12' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' H' ' 9' ' ' LEU . . . -70.55 -54.26 12.83 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.013 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 13' ' ' ALA . . . . . 0.559 ' O ' ' HG3' ' H' ' 17' ' ' MET . . . -62.92 -19.16 63.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.768 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.68 -39.27 11.93 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.478 0.656 . . . . 0.0 109.454 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 15' ' ' VAL . . . . . 0.531 HG23 ' O ' ' H' ' 11' ' ' MET . 46.0 t -74.89 -37.03 40.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.163 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 16' ' ' MET . . . . . 0.896 ' CE ' HD12 ' H' ' 72' ' ' LEU . 57.7 mtm -70.24 -62.56 1.34 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.404 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 17' ' ' MET . . . . . 0.559 ' HG3' ' O ' ' H' ' 13' ' ' ALA . 40.6 mtm -63.08 -51.44 66.62 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.436 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 18' ' ' GLY . . . . . 0.776 ' HA3' HD23 ' G' ' 19' ' ' LEU . . . -54.62 -37.1 60.21 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 119.573 -1.299 . . . . 0.0 111.597 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 19' ' ' LEU . . . . . 0.709 HD23 ' HA3' ' I' ' 18' ' ' GLY . 24.5 tp -79.59 -38.4 34.1 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 20' ' ' ALA . . . . . 0.821 ' HB3' ' HG2' ' H' ' 65' ' ' MET . . . -85.68 -35.93 20.58 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.567 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.597 ' HA ' ' CB ' ' H' ' 62' ' ' ALA . . . -62.59 -43.66 98.26 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 22' ' ' ILE . . . . . 0.928 HD12 ' N ' ' H' ' 23' ' ' GLY . 2.6 pp -65.34 -40.54 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.928 ' N ' HD12 ' H' ' 22' ' ' ILE . . . -60.9 -29.34 70.33 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 24' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' H' ' 58' ' ' GLY . . . -73.29 -56.6 4.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.038 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.53 -54.36 18.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.195 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 26' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' H' ' 30' ' ' ILE . 49.1 mm -53.23 -56.36 8.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.732 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 27' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' H' ' 31' ' ' LEU . . . -47.95 -54.07 12.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.935 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 28' ' ' ILE . . . . . 0.748 HD11 ' HA ' ' H' ' 59' ' ' LEU . 68.8 mt -49.91 -34.34 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.73 -34.32 28.17 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.333 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 30' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' H' ' 26' ' ' ILE . 49.4 mm -77.19 -62.07 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.974 0.416 . . . . 0.0 110.407 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 31' ' ' LEU . . . . . 0.666 HD22 ' CG ' ' H' ' 54' ' ' PHE . 0.5 OUTLIER -60.91 -43.16 98.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.83 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.99 -50.39 68.02 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.888 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.27 -52.01 24.54 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.822 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.82 -42.15 88.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.563 0.221 . . . . 0.0 111.368 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 35' ' ' PHE . . . . . 0.499 ' CZ ' ' HD2' ' H' ' 50' ' ' ARG . 59.9 t80 -58.7 -47.39 84.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.896 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 36' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' G' ' 35' ' ' PHE . 64.2 tp -55.25 -44.25 75.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 37' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -58.39 -31.35 67.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.013 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.02 24.14 28.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.688 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.24 31.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 111.313 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.28 -34.32 21.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.942 0.401 . . . . 0.0 111.112 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 41' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' H' ' 41' ' ' ARG . 0.4 OUTLIER -67.83 -47.29 69.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.15 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 42' ' ' GLN . . . . . 0.429 ' HB3' ' HD2' ' H' ' 43' ' ' PRO . 84.8 mt-30 -58.09 163.58 4.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.092 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 43' ' ' PRO . . . . . 0.471 ' O ' ' CG ' ' H' ' 47' ' ' PRO . 52.2 Cg_exo -53.26 161.29 3.85 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.496 2.13 . . . . 0.0 111.968 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.49 30.84 1.88 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.834 0.349 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.68 -60.62 1.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.053 0.454 . . . . 0.0 111.343 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 46' ' ' ILE . . . . . 0.607 HD12 ' N ' ' H' ' 46' ' ' ILE . 1.7 mp -76.29 -54.65 1.89 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.908 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 47' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' H' ' 46' ' ' ILE . 29.0 Cg_endo -63.21 -32.55 73.73 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.835 1.69 . . . . 0.0 112.401 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 48' ' ' LEU . . . . . 0.805 HD23 ' O ' ' H' ' 48' ' ' LEU . 5.5 tt -61.08 -34.49 74.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 109.594 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 49' ' ' LEU . . . . . 0.721 HD12 ' O ' ' H' ' 49' ' ' LEU . 0.3 OUTLIER -75.29 -42.09 55.55 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.423 179.204 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 50' ' ' ARG . . . . . 0.499 ' HD2' ' CZ ' ' H' ' 35' ' ' PHE . 0.0 OUTLIER -73.5 -35.87 65.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.899 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 51' ' ' THR . . . . . 0.45 ' HA ' ' CD2' ' H' ' 35' ' ' PHE . 53.3 m -59.38 -46.58 88.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.548 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 52' ' ' GLN . . . . . 0.643 ' O ' HG23 ' H' ' 56' ' ' VAL . 15.4 pt20 -61.78 -45.12 95.27 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.233 0.539 . . . . 0.0 109.851 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 53' ' ' PHE . . . . . 0.4 ' N ' ' HG3' ' H' ' 52' ' ' GLN . 1.2 t80 -49.3 -36.88 22.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.484 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 54' ' ' PHE . . . . . 0.666 ' CG ' HD22 ' H' ' 31' ' ' LEU . 8.9 m-85 -77.74 -69.54 0.54 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.034 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 55' ' ' ILE . . . . . 0.506 HG12 ' HA ' ' H' ' 52' ' ' GLN . 28.8 pt -44.6 -33.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.81 0.338 . . . . 0.0 110.878 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 56' ' ' VAL . . . . . 0.643 HG23 ' O ' ' H' ' 52' ' ' GLN . 91.7 t -76.74 -46.1 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.67 -29.43 11.12 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 58' ' ' GLY . . . . . 0.564 ' O ' ' HB1' ' H' ' 24' ' ' ALA . . . -84.64 -33.65 18.47 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 59' ' ' LEU . . . . . 0.748 ' HA ' HD11 ' H' ' 28' ' ' ILE . 45.4 tp -73.09 -7.54 51.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.958 0.408 . . . . 0.0 110.194 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 60' ' ' VAL . . . . . 0.591 HG12 ' O ' ' H' ' 60' ' ' VAL . 64.8 t -109.53 -1.33 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.873 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 61' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' H' ' 64' ' ' PRO . 38.6 t70 -81.46 -23.53 37.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.916 0.389 . . . . 0.0 110.593 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 62' ' ' ALA . . . . . 0.597 ' CB ' ' HA ' ' H' ' 21' ' ' ALA . . . -88.67 -42.07 12.22 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.589 0.709 . . . . 0.0 110.048 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 63' ' ' ILE . . . . . 0.574 ' N ' ' CD ' ' H' ' 64' ' ' PRO . 2.4 mm -47.18 -34.42 4.41 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.525 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 64' ' ' PRO . . . . . 0.825 ' O ' HG23 ' H' ' 68' ' ' VAL . 3.6 Cg_exo -78.34 -54.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.968 1.778 . . . . 0.0 111.616 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 65' ' ' MET . . . . . 0.821 ' HG2' ' HB3' ' H' ' 20' ' ' ALA . 2.0 tpt -52.84 -37.37 60.04 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 66' ' ' ILE . . . . . 0.513 ' HA ' ' HG2' ' H' ' 17' ' ' MET . 75.6 mt -66.18 -54.44 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.646 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.3 -31.39 61.59 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 68' ' ' VAL . . . . . 0.825 HG23 ' O ' ' H' ' 64' ' ' PRO . 55.8 t -75.64 -44.02 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.894 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 69' ' ' GLY . . . . . 0.442 ' HA2' ' HE1' ' H' ' 16' ' ' MET . . . -65.76 -35.66 91.24 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 70' ' ' LEU . . . . . 0.907 ' O ' HG23 ' H' ' 74' ' ' VAL . 0.5 OUTLIER -67.31 -38.1 84.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.664 178.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 71' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' H' ' 75' ' ' MET . . . -64.98 -60.73 6.5 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.235 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 72' ' ' LEU . . . . . 0.971 HD22 ' CZ ' ' I' ' 73' ' ' TYR . 58.5 mt -52.16 -34.5 45.2 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.508 0.67 . . . . 0.0 109.646 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 73' ' ' TYR . . . . . 0.877 ' CZ ' HD22 ' G' ' 72' ' ' LEU . 10.7 t80 -71.21 -46.99 60.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.497 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 74' ' ' VAL . . . . . 0.907 HG23 ' O ' ' H' ' 70' ' ' LEU . 92.6 t -62.41 -26.22 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.822 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 75' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' H' ' 71' ' ' GLY . 89.3 mtp -63.72 -49.93 71.12 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 76' ' ' PHE . . . . . 0.778 ' HB2' HD13 ' H' ' 9' ' ' LEU . 2.4 t80 -52.97 -35.99 59.66 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 77' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' H' ' 74' ' ' VAL . . . -58.28 -32.53 68.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.1 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.18 -32.69 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.114 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.635 0.255 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.74 -29.42 0.77 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.398 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 3' ' ' ASN . . . . . 0.496 ' OD1' ' HG3' ' H' ' 1' ' ' MET . 75.3 m-20 -71.08 -62.83 1.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.046 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 4' ' ' LEU . . . . . 0.532 HD22 ' N ' ' I' ' 4' ' ' LEU . 3.0 mm? -65.57 -17.92 64.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 0.0 109.944 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.73 -71.67 0.17 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.516 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 6' ' ' MET . . . . . . . . . . . . . 23.3 ptp -59.15 -22.0 60.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.688 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.24 -44.84 28.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.274 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 8' ' ' LEU . . . . . 0.761 HD22 ' CE ' ' I' ' 11' ' ' MET . 0.7 OUTLIER -75.02 -40.09 60.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.962 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 9' ' ' LEU . . . . . 0.807 HD13 ' HB2' ' I' ' 76' ' ' PHE . 6.8 tt -56.06 -59.2 5.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.545 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 10' ' ' TYR . . . . . 0.719 ' HB3' HD12 ' H' ' 8' ' ' LEU . 14.9 m-85 -56.1 -54.15 48.56 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.202 0.525 . . . . 0.0 110.192 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 11' ' ' MET . . . . . 0.761 ' CE ' HD22 ' I' ' 8' ' ' LEU . 57.3 ttp -54.44 -20.16 7.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.131 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 12' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' I' ' 9' ' ' LEU . . . -70.5 -54.21 13.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 13' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' I' ' 17' ' ' MET . . . -62.89 -19.24 63.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.723 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.67 -39.26 11.94 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.503 0.668 . . . . 0.0 109.493 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 15' ' ' VAL . . . . . 0.535 HG23 ' O ' ' I' ' 11' ' ' MET . 46.1 t -74.89 -37.04 40.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.171 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 16' ' ' MET . . . . . 0.894 ' CE ' HD12 ' I' ' 72' ' ' LEU . 57.8 mtm -70.22 -62.55 1.34 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.451 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 17' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' I' ' 13' ' ' ALA . 40.6 mtm -63.07 -51.47 66.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.409 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 18' ' ' GLY . . . . . 0.709 ' HA3' HD23 ' H' ' 19' ' ' LEU . . . -54.61 -37.08 60.13 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.614 -1.279 . . . . 0.0 111.622 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 19' ' ' LEU . . . . . 0.625 HD23 ' HA3' ' J' ' 18' ' ' GLY . 24.5 tp -79.57 -38.48 34.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 20' ' ' ALA . . . . . 0.842 ' HB3' ' HG2' ' I' ' 65' ' ' MET . . . -85.65 -35.97 20.6 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.504 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 21' ' ' ALA . . . . . 0.594 ' HA ' ' CB ' ' I' ' 62' ' ' ALA . . . -62.55 -43.69 98.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 22' ' ' ILE . . . . . 0.92 HD12 ' N ' ' I' ' 23' ' ' GLY . 2.6 pp -65.27 -40.58 89.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 23' ' ' GLY . . . . . 0.92 ' N ' HD12 ' I' ' 22' ' ' ILE . . . -60.91 -29.38 70.45 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.847 -1.168 . . . . 0.0 110.203 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 24' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' I' ' 58' ' ' GLY . . . -73.22 -56.63 4.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.054 -0.573 . . . . 0.0 110.065 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.49 -54.35 18.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.226 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.23 -56.4 8.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.684 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 27' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' I' ' 31' ' ' LEU . . . -47.95 -54.11 12.66 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.875 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 28' ' ' ILE . . . . . 0.734 HD11 ' HA ' ' I' ' 59' ' ' LEU . 68.6 mt -49.83 -34.38 9.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.68 -34.35 28.29 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.345 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.24 -62.05 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.938 0.399 . . . . 0.0 110.389 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 31' ' ' LEU . . . . . 0.667 HD22 ' CG ' ' I' ' 54' ' ' PHE . 0.5 OUTLIER -60.92 -43.18 98.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.781 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.99 -50.45 67.41 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.841 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.23 -52.06 24.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.818 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.78 -42.12 88.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.595 0.236 . . . . 0.0 111.429 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 35' ' ' PHE . . . . . 0.597 ' CD1' HD22 ' J' ' 36' ' ' LEU . 60.0 t80 -58.72 -47.41 84.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 36' ' ' LEU . . . . . . . . . . . . . 64.1 tp -55.2 -44.27 75.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 37' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -58.37 -31.4 67.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.061 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.99 24.16 27.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.675 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.25 31.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.762 0.315 . . . . 0.0 111.313 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.3 -34.34 21.91 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.064 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 41' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' I' ' 41' ' ' ARG . 0.4 OUTLIER -67.81 -47.29 69.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.147 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 42' ' ' GLN . . . . . 0.425 ' HB3' ' HD2' ' I' ' 43' ' ' PRO . 84.8 mt-30 -58.16 163.51 4.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.143 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 43' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' I' ' 47' ' ' PRO . 52.2 Cg_exo -53.2 161.34 3.72 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.507 2.138 . . . . 0.0 111.987 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.55 30.92 1.87 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.78 -60.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.323 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 46' ' ' ILE . . . . . 0.615 HD12 ' N ' ' I' ' 46' ' ' ILE . 1.7 mp -76.26 -54.64 1.91 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.891 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 47' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' I' ' 46' ' ' ILE . 29.0 Cg_endo -63.19 -32.58 73.94 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 121.83 1.686 . . . . 0.0 112.407 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 48' ' ' LEU . . . . . 0.815 HD23 ' O ' ' I' ' 48' ' ' LEU . 5.5 tt -61.1 -34.45 74.96 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 49' ' ' LEU . . . . . 0.716 ' O ' HD12 ' I' ' 49' ' ' LEU . 0.3 OUTLIER -75.29 -42.09 55.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.416 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 50' ' ' ARG . . . . . 0.498 ' HD2' ' CZ ' ' I' ' 35' ' ' PHE . 0.0 OUTLIER -73.49 -35.89 65.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.93 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 51' ' ' THR . . . . . 0.454 ' HA ' ' CD2' ' I' ' 35' ' ' PHE . 53.6 m -59.39 -46.54 88.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.556 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 52' ' ' GLN . . . . . 0.653 ' O ' HG23 ' I' ' 56' ' ' VAL . 15.3 pt20 -61.84 -45.14 95.1 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.215 0.531 . . . . 0.0 109.802 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 53' ' ' PHE . . . . . 0.401 ' N ' ' HG3' ' I' ' 52' ' ' GLN . 1.2 t80 -49.29 -36.89 22.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.478 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 54' ' ' PHE . . . . . 0.667 ' CG ' HD22 ' I' ' 31' ' ' LEU . 8.7 m-85 -77.67 -69.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.053 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 55' ' ' ILE . . . . . 0.505 HG12 ' HA ' ' I' ' 52' ' ' GLN . 29.0 pt -44.54 -33.94 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.754 0.312 . . . . 0.0 110.932 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 56' ' ' VAL . . . . . 0.653 HG23 ' O ' ' I' ' 52' ' ' GLN . 91.3 t -76.75 -46.17 30.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 57' ' ' MET . . . . . . . . . . . . . 49.2 ttm -50.59 -29.47 10.94 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 58' ' ' GLY . . . . . 0.559 ' C ' HD11 ' I' ' 28' ' ' ILE . . . -84.62 -33.59 18.71 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 59' ' ' LEU . . . . . 0.734 ' HA ' HD11 ' I' ' 28' ' ' ILE . 44.9 tp -73.1 -7.53 51.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.939 0.4 . . . . 0.0 110.178 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 60' ' ' VAL . . . . . 0.59 HG12 ' O ' ' I' ' 60' ' ' VAL . 64.7 t -109.54 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.84 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 61' ' ' ASP . . . . . 0.455 ' O ' ' HD2' ' I' ' 64' ' ' PRO . 38.6 t70 -81.44 -23.56 37.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.949 0.404 . . . . 0.0 110.61 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 62' ' ' ALA . . . . . 0.594 ' CB ' ' HA ' ' I' ' 21' ' ' ALA . . . -88.69 -42.08 12.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.524 0.678 . . . . 0.0 109.994 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 63' ' ' ILE . . . . . 0.579 ' N ' ' CD ' ' I' ' 64' ' ' PRO . 2.4 mm -47.04 -34.55 4.28 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.548 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 64' ' ' PRO . . . . . 0.827 ' O ' HG23 ' I' ' 68' ' ' VAL . 3.6 Cg_exo -78.33 -54.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.934 1.756 . . . . 0.0 111.618 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 65' ' ' MET . . . . . 0.842 ' HG2' ' HB3' ' I' ' 20' ' ' ALA . 2.0 tpt -52.83 -37.36 59.95 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 66' ' ' ILE . . . . . 0.511 ' HA ' ' HG2' ' I' ' 17' ' ' MET . 75.6 mt -66.25 -54.46 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.638 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.26 -31.4 61.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 68' ' ' VAL . . . . . 0.827 HG23 ' O ' ' I' ' 64' ' ' PRO . 56.6 t -75.73 -44.02 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.888 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' HE1' ' I' ' 16' ' ' MET . . . -65.71 -35.67 91.32 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 70' ' ' LEU . . . . . 0.911 ' O ' HG23 ' I' ' 74' ' ' VAL . 0.5 OUTLIER -67.24 -38.06 84.59 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.795 -0.702 . . . . 0.0 109.699 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 71' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' I' ' 75' ' ' MET . . . -65.0 -60.69 6.55 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 72' ' ' LEU . . . . . 0.944 HD22 ' CZ ' ' J' ' 73' ' ' TYR . 58.6 mt -52.22 -34.5 46.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.503 0.668 . . . . 0.0 109.63 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 73' ' ' TYR . . . . . 0.971 ' CZ ' HD22 ' H' ' 72' ' ' LEU . 10.6 t80 -71.18 -47.05 59.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.491 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 74' ' ' VAL . . . . . 0.911 HG23 ' O ' ' I' ' 70' ' ' LEU . 93.0 t -62.35 -26.22 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.83 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 75' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' I' ' 71' ' ' GLY . 89.2 mtp -63.78 -49.91 71.06 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 76' ' ' PHE . . . . . 0.807 ' HB2' HD13 ' I' ' 9' ' ' LEU . 2.4 t80 -53.03 -35.92 59.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 77' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' I' ' 74' ' ' VAL . . . -58.33 -32.5 68.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.08 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 78' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.19 -32.78 55.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.101 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' J' J ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.622 0.249 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' J' J ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.62 -29.45 0.74 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.436 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.12 -62.81 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.07 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 4' ' ' LEU . . . . . 0.518 HD22 ' N ' ' J' ' 4' ' ' LEU . 3.0 mm? -65.52 -17.97 64.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.164 0.507 . . . . 0.0 109.973 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -64.65 -71.71 0.17 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.517 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 6' ' ' MET . . . . . . . . . . . . . 23.2 ptp -59.22 -21.95 60.31 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.624 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -77.23 -44.94 28.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.225 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 8' ' ' LEU . . . . . 0.748 HD22 ' CE ' ' J' ' 11' ' ' MET . 0.7 OUTLIER -74.98 -40.08 60.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.958 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 9' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' J' ' 76' ' ' PHE . 6.8 tt -56.13 -59.13 5.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.548 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 10' ' ' TYR . . . . . 0.707 ' HB3' HD12 ' I' ' 8' ' ' LEU . 14.8 m-85 -56.15 -54.17 48.28 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 110.114 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 11' ' ' MET . . . . . 0.748 ' CE ' HD22 ' J' ' 8' ' ' LEU . 57.2 ttp -54.42 -20.19 7.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.145 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 12' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' J' ' 9' ' ' LEU . . . -70.51 -54.2 13.17 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.066 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 13' ' ' ALA . . . . . 0.558 ' O ' ' HG3' ' J' ' 17' ' ' MET . . . -62.95 -19.13 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.815 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.74 -39.18 11.95 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.505 0.669 . . . . 0.0 109.45 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 15' ' ' VAL . . . . . 0.531 HG23 ' O ' ' J' ' 11' ' ' MET . 46.1 t -74.89 -37.08 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.161 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 16' ' ' MET . . . . . 0.908 ' CE ' HD12 ' J' ' 72' ' ' LEU . 57.6 mtm -70.24 -62.52 1.36 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.379 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 17' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' J' ' 13' ' ' ALA . 40.5 mtm -63.11 -51.43 66.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.429 -178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 18' ' ' GLY . . . . . 0.693 ' O ' HG23 ' J' ' 22' ' ' ILE . . . -54.63 -37.08 60.19 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.569 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 19' ' ' LEU . . . . . 0.733 HD23 ' HA3' ' K' ' 18' ' ' GLY . 24.2 tp -79.63 -38.42 33.81 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 20' ' ' ALA . . . . . 0.829 ' HB3' ' HG2' ' J' ' 65' ' ' MET . . . -85.63 -35.98 20.63 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.478 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 21' ' ' ALA . . . . . 0.588 ' HA ' ' CB ' ' J' ' 62' ' ' ALA . . . -62.55 -43.69 98.19 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 22' ' ' ILE . . . . . 0.92 HD12 ' N ' ' J' ' 23' ' ' GLY . 2.6 pp -65.32 -40.51 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . 0.92 ' N ' HD12 ' J' ' 22' ' ' ILE . . . -61.0 -29.3 70.52 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 24' ' ' ALA . . . . . 0.556 ' HB1' ' O ' ' J' ' 58' ' ' GLY . . . -73.23 -56.66 4.79 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.044 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.52 -54.38 18.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.15 -56.41 8.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.741 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 27' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' J' ' 31' ' ' LEU . . . -47.95 -54.09 12.71 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.89 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 28' ' ' ILE . . . . . 0.736 HD11 ' HA ' ' J' ' 59' ' ' LEU . 68.4 mt -49.86 -34.32 9.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.73 -34.32 28.16 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.353 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.19 -62.05 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 120.981 0.419 . . . . 0.0 110.446 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 31' ' ' LEU . . . . . 0.672 HD22 ' CG ' ' J' ' 54' ' ' PHE . 0.5 OUTLIER -60.9 -43.17 98.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.837 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.96 -50.47 67.2 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.861 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.27 -51.99 24.65 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.845 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 34' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -58.81 -42.11 88.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.586 0.232 . . . . 0.0 111.403 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 35' ' ' PHE . . . . . 0.7 ' CD1' HD22 ' K' ' 36' ' ' LEU . 59.7 t80 -58.69 -47.47 84.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.894 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 36' ' ' LEU . . . . . 0.597 HD22 ' CD1' ' I' ' 35' ' ' PHE . 64.1 tp -55.13 -44.32 74.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.39 -31.35 67.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.045 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.01 24.17 27.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.693 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.25 31.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.768 0.318 . . . . 0.0 111.362 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.3 -34.36 21.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 41' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' J' ' 41' ' ' ARG . 0.4 OUTLIER -67.8 -47.32 69.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.149 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 42' ' ' GLN . . . . . 0.417 ' HB3' ' HD2' ' J' ' 43' ' ' PRO . 84.8 mt-30 -58.1 163.55 4.32 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 43' ' ' PRO . . . . . 0.477 ' O ' ' CG ' ' J' ' 47' ' ' PRO . 52.1 Cg_exo -53.17 161.36 3.66 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.52 2.147 . . . . 0.0 111.934 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.59 30.86 1.9 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.7 -60.62 1.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.343 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 46' ' ' ILE . . . . . 0.619 HD12 ' N ' ' J' ' 46' ' ' ILE . 1.7 mp -76.37 -54.57 1.87 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.891 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 47' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' J' ' 46' ' ' ILE . 29.0 Cg_endo -63.28 -32.48 72.97 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.837 1.692 . . . . 0.0 112.385 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 48' ' ' LEU . . . . . 0.815 HD23 ' O ' ' J' ' 48' ' ' LEU . 5.5 tt -61.13 -34.46 75.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 49' ' ' LEU . . . . . 0.722 ' O ' HD12 ' J' ' 49' ' ' LEU . 0.3 OUTLIER -75.25 -42.16 55.79 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.378 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 50' ' ' ARG . . . . . 0.498 ' HD2' ' CZ ' ' J' ' 35' ' ' PHE . 0.0 OUTLIER -73.44 -35.88 65.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.969 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 51' ' ' THR . . . . . 0.45 ' HA ' ' CD2' ' J' ' 35' ' ' PHE . 54.1 m -59.35 -46.58 88.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.573 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 52' ' ' GLN . . . . . 0.653 ' O ' HG23 ' J' ' 56' ' ' VAL . 15.3 pt20 -61.82 -45.13 95.17 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.197 0.523 . . . . 0.0 109.807 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.24 -36.95 21.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.509 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 54' ' ' PHE . . . . . 0.672 ' CG ' HD22 ' J' ' 31' ' ' LEU . 8.8 m-85 -77.62 -69.6 0.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.089 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 55' ' ' ILE . . . . . 0.595 HG21 ' CE1' ' I' ' 54' ' ' PHE . 28.9 pt -44.57 -33.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.828 0.346 . . . . 0.0 110.971 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 56' ' ' VAL . . . . . 0.653 HG23 ' O ' ' J' ' 52' ' ' GLN . 92.1 t -76.81 -46.07 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 57' ' ' MET . . . . . . . . . . . . . 49.1 ttm -50.6 -29.52 11.1 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 58' ' ' GLY . . . . . 0.556 ' O ' ' HB1' ' J' ' 24' ' ' ALA . . . -84.57 -33.69 18.57 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 59' ' ' LEU . . . . . 0.736 ' HA ' HD11 ' J' ' 28' ' ' ILE . 45.4 tp -73.13 -7.44 51.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.941 0.401 . . . . 0.0 110.182 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 60' ' ' VAL . . . . . 0.59 HG12 ' O ' ' J' ' 60' ' ' VAL . 64.9 t -109.56 -1.34 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.884 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 61' ' ' ASP . . . . . 0.456 ' O ' ' HD2' ' J' ' 64' ' ' PRO . 38.6 t70 -81.47 -23.55 37.35 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.935 0.398 . . . . 0.0 110.591 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 62' ' ' ALA . . . . . 0.588 ' CB ' ' HA ' ' J' ' 21' ' ' ALA . . . -88.67 -42.05 12.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.532 0.682 . . . . 0.0 110.041 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 63' ' ' ILE . . . . . 0.574 ' N ' ' CD ' ' J' ' 64' ' ' PRO . 2.4 mm -47.13 -34.5 4.41 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.507 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 64' ' ' PRO . . . . . 0.832 ' O ' HG23 ' J' ' 68' ' ' VAL . 3.5 Cg_exo -78.34 -54.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.973 1.782 . . . . 0.0 111.634 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 65' ' ' MET . . . . . 0.829 ' HG2' ' HB3' ' J' ' 20' ' ' ALA . 2.0 tpt -52.86 -37.39 60.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 66' ' ' ILE . . . . . 0.517 ' HA ' ' HG2' ' J' ' 17' ' ' MET . 75.4 mt -66.22 -54.42 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.601 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.26 -31.5 61.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 68' ' ' VAL . . . . . 0.832 HG23 ' O ' ' J' ' 64' ' ' PRO . 56.5 t -75.66 -43.96 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.941 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' HE1' ' J' ' 16' ' ' MET . . . -65.75 -35.64 91.23 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 70' ' ' LEU . . . . . 0.908 ' O ' HG23 ' J' ' 74' ' ' VAL . 0.5 OUTLIER -67.28 -38.07 84.46 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.774 -0.713 . . . . 0.0 109.694 178.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 71' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' J' ' 75' ' ' MET . . . -64.96 -60.75 6.49 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 72' ' ' LEU . . . . . 0.908 HD12 ' CE ' ' J' ' 16' ' ' MET . 58.7 mt -52.18 -34.48 45.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.522 0.677 . . . . 0.0 109.636 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 73' ' ' TYR . . . . . 0.944 ' CZ ' HD22 ' I' ' 72' ' ' LEU . 10.7 t80 -71.22 -47.0 59.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.488 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 74' ' ' VAL . . . . . 0.908 HG23 ' O ' ' J' ' 70' ' ' LEU . 92.9 t -62.39 -26.24 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.838 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 75' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' J' ' 71' ' ' GLY . 89.3 mtp -63.74 -49.99 70.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 76' ' ' PHE . . . . . 0.81 ' HB2' HD13 ' J' ' 9' ' ' LEU . 2.4 t80 -53.0 -35.91 59.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 77' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' J' ' 74' ' ' VAL . . . -58.35 -32.51 68.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.137 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.21 -32.67 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.993 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.126 179.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.593 0.235 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.63 -29.47 0.75 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.414 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 3' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.06 -62.76 1.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.106 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 4' ' ' LEU . . . . . 0.522 HD22 ' N ' ' K' ' 4' ' ' LEU . 3.0 mm? -65.6 -17.93 64.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.109 0.481 . . . . 0.0 109.939 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -64.72 -71.69 0.17 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.5 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 6' ' ' MET . . . . . . . . . . . . . 23.4 ptp -59.22 -21.93 60.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.673 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.27 -44.88 28.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.238 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 8' ' ' LEU . . . . . 0.753 HD22 ' CE ' ' K' ' 11' ' ' MET . 0.7 OUTLIER -75.06 -40.01 60.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.969 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 9' ' ' LEU . . . . . 0.799 HD13 ' HB2' ' K' ' 76' ' ' PHE . 6.8 tt -56.16 -59.11 5.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.514 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 10' ' ' TYR . . . . . 0.746 ' HB3' HD12 ' J' ' 8' ' ' LEU . 14.9 m-85 -56.13 -54.2 47.91 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.256 0.55 . . . . 0.0 110.167 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 11' ' ' MET . . . . . 0.753 ' CE ' HD22 ' K' ' 8' ' ' LEU . 57.2 ttp -54.37 -20.2 6.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.118 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 12' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' K' ' 9' ' ' LEU . . . -70.55 -54.23 12.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.032 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 13' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' K' ' 17' ' ' MET . . . -62.94 -19.15 63.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.752 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.7 -39.23 11.95 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.493 0.663 . . . . 0.0 109.43 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 15' ' ' VAL . . . . . 0.532 HG23 ' O ' ' K' ' 11' ' ' MET . 46.1 t -74.92 -37.07 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.148 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 16' ' ' MET . . . . . 0.892 ' CE ' HD12 ' K' ' 72' ' ' LEU . 57.8 mtm -70.14 -62.58 1.33 Allowed 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.444 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 17' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' K' ' 13' ' ' ALA . 40.6 mtm -63.09 -51.47 66.45 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.405 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 18' ' ' GLY . . . . . 0.733 ' HA3' HD23 ' J' ' 19' ' ' LEU . . . -54.63 -37.06 60.18 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.587 -1.292 . . . . 0.0 111.595 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 19' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' K' ' 15' ' ' VAL . 24.5 tp -79.56 -38.43 34.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 20' ' ' ALA . . . . . 0.84 ' HB3' ' HG2' ' K' ' 65' ' ' MET . . . -85.68 -35.95 20.57 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.609 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 21' ' ' ALA . . . . . 0.589 ' HA ' ' CB ' ' K' ' 62' ' ' ALA . . . -62.54 -43.7 98.16 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 22' ' ' ILE . . . . . 0.937 HD12 ' N ' ' K' ' 23' ' ' GLY . 2.6 pp -65.27 -40.56 88.97 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 23' ' ' GLY . . . . . 0.937 ' N ' HD12 ' K' ' 22' ' ' ILE . . . -61.05 -29.27 70.5 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 177.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 24' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' K' ' 58' ' ' GLY . . . -73.26 -56.63 4.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.052 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.5 -54.4 18.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.216 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.11 -56.42 8.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.717 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 27' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' K' ' 31' ' ' LEU . . . -48.0 -54.03 13.01 Favored Glycine 0 CA--C 1.509 -0.322 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.922 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 28' ' ' ILE . . . . . 0.756 HD11 ' HA ' ' K' ' 59' ' ' LEU . 68.5 mt -49.92 -34.31 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.301 0.572 . . . . 0.0 109.461 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.72 -34.4 28.02 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.32 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mm -77.16 -62.02 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.981 0.419 . . . . 0.0 110.439 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 31' ' ' LEU . . . . . 0.675 HD22 ' CG ' ' K' ' 54' ' ' PHE . 0.5 OUTLIER -61.0 -43.12 99.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.808 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.97 -50.44 67.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.837 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.28 -52.0 24.53 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.838 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 34' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -58.81 -42.16 88.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.636 0.255 . . . . 0.0 111.392 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 35' ' ' PHE . . . . . 0.495 ' CZ ' ' HD2' ' K' ' 50' ' ' ARG . 60.0 t80 -58.7 -47.39 84.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.802 0.334 . . . . 0.0 110.908 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 36' ' ' LEU . . . . . 0.7 HD22 ' CD1' ' J' ' 35' ' ' PHE . 64.2 tp -55.23 -44.26 75.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.049 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -58.33 -31.42 67.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.022 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.0 24.17 27.86 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.717 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.28 31.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.764 0.316 . . . . 0.0 111.328 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.34 -34.35 21.85 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.024 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 41' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' K' ' 41' ' ' ARG . 0.4 OUTLIER -67.83 -47.3 69.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 42' ' ' GLN . . . . . 0.409 ' HB3' ' HD2' ' K' ' 43' ' ' PRO . 84.8 mt-30 -58.09 163.56 4.3 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 43' ' ' PRO . . . . . 0.474 ' O ' ' CG ' ' K' ' 47' ' ' PRO . 52.3 Cg_exo -53.23 161.39 3.74 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.498 2.132 . . . . 0.0 111.972 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.65 30.92 1.9 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.853 0.359 . . . . 0.0 110.813 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -97.71 -60.59 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.354 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 46' ' ' ILE . . . . . 0.622 HD12 ' N ' ' K' ' 46' ' ' ILE . 1.7 mp -76.38 -54.57 1.86 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.891 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 47' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' K' ' 46' ' ' ILE . 29.0 Cg_endo -63.22 -32.57 73.62 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 121.866 1.711 . . . . 0.0 112.391 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 48' ' ' LEU . . . . . 0.805 HD23 ' O ' ' K' ' 48' ' ' LEU . 5.5 tt -61.15 -34.39 74.94 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 49' ' ' LEU . . . . . 0.712 ' O ' HD12 ' K' ' 49' ' ' LEU . 0.3 OUTLIER -75.33 -42.11 55.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.401 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 50' ' ' ARG . . . . . 0.495 ' HD2' ' CZ ' ' K' ' 35' ' ' PHE . 0.0 OUTLIER -73.42 -35.92 65.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.937 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 51' ' ' THR . . . . . 0.448 ' HA ' ' CD2' ' K' ' 35' ' ' PHE . 53.6 m -59.35 -46.61 88.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.562 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 52' ' ' GLN . . . . . 0.642 ' O ' HG23 ' K' ' 56' ' ' VAL . 15.4 pt20 -61.76 -45.15 95.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.184 0.516 . . . . 0.0 109.809 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.29 -36.95 22.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.454 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 54' ' ' PHE . . . . . 0.675 ' CG ' HD22 ' K' ' 31' ' ' LEU . 8.8 m-85 -77.7 -69.55 0.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.018 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 55' ' ' ILE . . . . . 0.598 HG21 ' CE1' ' J' ' 54' ' ' PHE . 29.0 pt -44.62 -33.9 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.768 0.318 . . . . 0.0 110.914 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 56' ' ' VAL . . . . . 0.642 HG23 ' O ' ' K' ' 52' ' ' GLN . 93.0 t -76.78 -46.09 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 57' ' ' MET . . . . . 0.562 ' HE1' ' CE2' ' L' ' 53' ' ' PHE . 49.3 ttm -50.63 -29.51 11.18 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 58' ' ' GLY . . . . . 0.57 ' O ' ' HB1' ' K' ' 24' ' ' ALA . . . -84.61 -33.63 18.61 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 59' ' ' LEU . . . . . 0.756 ' HA ' HD11 ' K' ' 28' ' ' ILE . 45.4 tp -73.05 -7.55 51.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.979 0.418 . . . . 0.0 110.237 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 60' ' ' VAL . . . . . 0.593 HG12 ' O ' ' K' ' 60' ' ' VAL . 65.3 t -109.51 -1.38 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.854 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 61' ' ' ASP . . . . . 0.452 ' O ' ' HD2' ' K' ' 64' ' ' PRO . 38.6 t70 -81.45 -23.5 37.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.929 0.395 . . . . 0.0 110.615 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 62' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' K' ' 21' ' ' ALA . . . -88.66 -42.1 12.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.549 0.69 . . . . 0.0 110.032 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 63' ' ' ILE . . . . . 0.576 ' N ' ' CD ' ' K' ' 64' ' ' PRO . 2.4 mm -47.13 -34.5 4.41 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.788 -1.096 . . . . 0.0 113.526 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 64' ' ' PRO . . . . . 0.829 ' O ' HG23 ' K' ' 68' ' ' VAL . 3.6 Cg_exo -78.35 -54.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.948 1.765 . . . . 0.0 111.619 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 65' ' ' MET . . . . . 0.84 ' HG2' ' HB3' ' K' ' 20' ' ' ALA . 2.0 tpt -52.81 -37.39 59.85 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 66' ' ' ILE . . . . . 0.506 ' HA ' ' HG2' ' K' ' 17' ' ' MET . 75.4 mt -66.18 -54.46 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.58 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.24 -31.48 61.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 68' ' ' VAL . . . . . 0.829 HG23 ' O ' ' K' ' 64' ' ' PRO . 55.5 t -75.61 -44.02 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.866 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 69' ' ' GLY . . . . . 0.414 ' HA2' ' HE3' ' K' ' 16' ' ' MET . . . -65.72 -35.76 91.42 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 70' ' ' LEU . . . . . 0.911 ' O ' HG23 ' K' ' 74' ' ' VAL . 0.5 OUTLIER -67.29 -38.04 84.38 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.695 178.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 71' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' K' ' 75' ' ' MET . . . -64.96 -60.7 6.55 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 72' ' ' LEU . . . . . 0.892 HD12 ' CE ' ' K' ' 16' ' ' MET . 58.9 mt -52.23 -34.5 46.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.481 0.658 . . . . 0.0 109.605 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 73' ' ' TYR . . . . . 0.892 ' CZ ' HD22 ' J' ' 72' ' ' LEU . 10.7 t80 -71.23 -46.95 60.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.526 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 74' ' ' VAL . . . . . 0.911 HG23 ' O ' ' K' ' 70' ' ' LEU . 92.7 t -62.42 -26.19 39.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.846 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 75' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' K' ' 71' ' ' GLY . 89.3 mtp -63.73 -50.02 70.75 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 76' ' ' PHE . . . . . 0.799 ' HB2' HD13 ' K' ' 9' ' ' LEU . 2.4 t80 -52.97 -35.96 59.55 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 77' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' K' ' 74' ' ' VAL . . . -58.29 -32.53 68.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.09 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 78' ' ' VAL . . . . . 0.447 HG11 ' HG ' ' M' ' 229' ' ' LEU . 48.3 t -69.24 -32.68 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.102 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' L' L ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.664 0.269 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' L' L ' 2' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -43.17 -37.69 2.18 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -64.07 -66.28 0.56 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.412 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 4' ' ' LEU . . . . . 0.536 ' HA ' ' OD1' ' L' ' 7' ' ' ASP . 85.7 mt -62.52 -19.82 64.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.985 0.422 . . . . 0.0 110.403 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 5' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -66.92 -65.15 0.72 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.158 0.504 . . . . 0.0 110.299 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 6' ' ' MET . . . . . . . . . . . . . 21.4 ptp -58.51 -33.92 70.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.465 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 7' ' ' ASP . . . . . 0.536 ' OD1' ' HA ' ' L' ' 4' ' ' LEU . 0.0 OUTLIER -72.24 -47.73 48.05 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.738 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 8' ' ' LEU . . . . . 0.459 HD11 ' OD1' ' A' ' 7' ' ' ASP . 57.2 mt -64.07 -42.28 97.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.89 0.376 . . . . 0.0 110.6 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 9' ' ' LEU . . . . . 0.876 HD11 ' HG3' ' L' ' 75' ' ' MET . 53.5 tp -56.93 -59.3 5.26 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.955 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 10' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -52.98 -56.9 12.6 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.563 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 11' ' ' MET . . . . . 0.742 ' O ' HG23 ' L' ' 15' ' ' VAL . 21.1 ttt -52.72 -27.17 16.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.423 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 12' ' ' ALA . . . . . 0.763 ' O ' ' HB2' ' L' ' 16' ' ' MET . . . -65.2 -50.77 64.59 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 13' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' L' ' 17' ' ' MET . . . -56.32 -38.56 71.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.447 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.42 ' HB1' ' CG ' ' K' ' 16' ' ' MET . . . -75.99 -44.56 39.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.413 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 15' ' ' VAL . . . . . 0.742 HG23 ' O ' ' L' ' 11' ' ' MET . 60.3 t -70.41 -44.38 77.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.072 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 16' ' ' MET . . . . . 0.763 ' HB2' ' O ' ' L' ' 12' ' ' ALA . 1.3 tmm? -66.49 -53.29 36.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.531 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 17' ' ' MET . . . . . 0.767 ' HE2' ' HA ' ' L' ' 17' ' ' MET . 11.3 mmt -68.31 -44.61 75.03 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.589 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 18' ' ' GLY . . . . . 0.897 ' O ' HD13 ' L' ' 22' ' ' ILE . . . -68.94 -33.41 74.79 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 118.395 -1.86 . . . . 0.0 111.555 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 19' ' ' LEU . . . . . 0.786 HD12 ' N ' ' L' ' 20' ' ' ALA . 2.1 pp -74.34 -45.29 48.14 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.456 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 20' ' ' ALA . . . . . 0.786 ' N ' HD12 ' L' ' 19' ' ' LEU . . . -76.1 -36.07 59.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 120.885 0.374 . . . . 0.0 110.745 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 21' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' L' ' 17' ' ' MET . . . -64.43 -41.93 96.31 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.878 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 22' ' ' ILE . . . . . 0.897 HD13 ' O ' ' L' ' 18' ' ' GLY . 1.5 mp -65.96 -46.83 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.76 68.47 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 24' ' ' ALA . . . . . 1.019 ' HB1' HG12 ' L' ' 60' ' ' VAL . . . -59.85 -65.59 0.65 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.462 -0.869 . . . . 0.0 110.44 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 25' ' ' ALA . . . . . 0.924 ' O ' HG22 ' L' ' 28' ' ' ILE . . . -46.64 -53.5 11.45 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.035 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 26' ' ' ILE . . . . . . . . . . . . . 73.9 mt -51.02 -55.75 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 121.079 -0.249 . . . . 0.0 110.857 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 27' ' ' GLY . . . . . 0.423 ' HA2' ' HB ' ' L' ' 30' ' ' ILE . . . -53.05 -49.45 55.52 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.599 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 28' ' ' ILE . . . . . 0.924 HG22 ' O ' ' L' ' 25' ' ' ALA . 4.6 tp -50.13 -42.28 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.34 -42.87 81.29 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.588 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 30' ' ' ILE . . . . . 0.423 ' HB ' ' HA2' ' L' ' 27' ' ' GLY . 35.8 mm -66.1 -70.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 122.966 0.506 . . . . 0.0 111.161 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 31' ' ' LEU . . . . . 0.554 HD12 ' HD2' ' L' ' 34' ' ' LYS . 52.0 tp -61.3 -38.06 85.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.988 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.73 -46.27 93.66 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.396 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.65 -58.98 11.46 Favored Glycine 0 C--O 1.241 0.569 0 C-N-CA 119.733 -1.222 . . . . 0.0 111.862 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 34' ' ' LYS . . . . . 0.554 ' HD2' HD12 ' L' ' 31' ' ' LEU . 17.8 ptpt -55.96 -50.9 69.52 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.44 0.638 . . . . 0.0 110.936 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 35' ' ' PHE . . . . . 0.435 ' N ' ' HG3' ' L' ' 34' ' ' LYS . 28.9 t80 -52.4 -54.82 27.02 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.858 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 36' ' ' LEU . . . . . 0.847 HD12 HD22 ' L' ' 49' ' ' LEU . 18.6 tp -45.61 -53.07 9.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.135 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 37' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' L' ' 41' ' ' ARG . 65.8 mm-40 -52.03 -45.23 64.55 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.39 -64.87 2.38 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.186 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 39' ' ' ALA . . . . . 0.543 ' HB1' HD23 ' L' ' 48' ' ' LEU . . . -50.28 -29.11 8.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.795 -0.202 . . . . 0.0 111.537 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 40' ' ' ALA . . . . . 0.968 ' HB2' HD11 ' L' ' 49' ' ' LEU . . . -87.39 -38.53 16.08 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.721 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 41' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' L' ' 37' ' ' GLU . 48.9 ttm-85 -56.17 -32.88 64.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.37 0.605 . . . . 0.0 109.606 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 42' ' ' GLN . . . . . 0.854 ' OE1' HD22 ' L' ' 45' ' ' LEU . 81.0 mt-30 -52.25 164.96 0.55 Allowed Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.738 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 43' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' L' ' 42' ' ' GLN . 80.8 Cg_exo -44.13 -67.4 0.12 Allowed 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 124.296 3.331 . . . . 0.0 114.219 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 44' ' ' ASP . . . . . 0.51 ' C ' HD12 ' L' ' 45' ' ' LEU . 9.9 t70 -146.74 55.54 1.13 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.729 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 45' ' ' LEU . . . . . 0.854 HD22 ' OE1' ' L' ' 42' ' ' GLN . 6.5 mp -110.78 12.16 22.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.299 0.571 . . . . 0.0 110.664 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 46' ' ' ILE . . . . . 0.702 ' H ' HD12 ' L' ' 46' ' ' ILE . 1.8 mp -47.71 -50.22 52.83 Favored Pre-proline 0 C--O 1.226 -0.145 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 47' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' L' ' 46' ' ' ILE . 19.1 Cg_endo -60.77 -32.09 92.56 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.607 1.538 . . . . 0.0 110.374 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 48' ' ' LEU . . . . . 0.83 HD11 ' OE1' ' L' ' 52' ' ' GLN . 11.0 tp -55.31 -39.82 70.38 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 49' ' ' LEU . . . . . 0.968 HD11 ' HB2' ' L' ' 40' ' ' ALA . 90.5 mt -44.81 -66.76 0.35 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.345 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 50' ' ' ARG . . . . . 0.444 ' O ' ' CD2' ' L' ' 54' ' ' PHE . 99.4 mtt180 -64.08 -54.52 32.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.791 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 51' ' ' THR . . . . . . . . . . . . . 85.3 m -46.65 -42.27 16.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.566 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 52' ' ' GLN . . . . . 0.83 ' OE1' HD11 ' L' ' 48' ' ' LEU . 26.7 mt-30 -90.01 -17.21 28.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.836 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 53' ' ' PHE . . . . . 0.562 ' CE2' ' HE1' ' K' ' 57' ' ' MET . 40.5 t80 -63.64 -46.39 85.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.332 0.587 . . . . 0.0 109.793 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 54' ' ' PHE . . . . . 0.579 ' CD1' ' HB2' ' M' ' 206' ' ' SER . 37.7 m-85 -63.86 -41.67 97.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.094 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 55' ' ' ILE . . . . . 0.594 HG22 ' HA ' ' L' ' 52' ' ' GLN . 11.0 tt -70.73 -45.53 73.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.859 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 56' ' ' VAL . . . . . 0.935 ' O ' HG23 ' L' ' 60' ' ' VAL . 64.1 t -65.25 -31.03 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.044 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 57' ' ' MET . . . . . 0.423 ' HA ' ' CD1' ' L' ' 28' ' ' ILE . 25.5 ttt -72.76 -56.18 5.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.522 0.677 . . . . 0.0 110.137 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 58' ' ' GLY . . . . . 0.438 ' HA3' ' CD2' ' M' ' 209' ' ' LEU . . . -55.28 -40.16 74.67 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.588 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 59' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' L' ' 55' ' ' ILE . 76.9 mt -65.65 -27.95 68.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.76 0.314 . . . . 0.0 110.862 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 60' ' ' VAL . . . . . 1.019 HG12 ' HB1' ' L' ' 24' ' ' ALA . 81.7 t -77.75 -37.17 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.93 0.395 . . . . 0.0 110.142 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -78.2 -31.39 49.46 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.831 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 62' ' ' ALA . . . . . 0.514 ' O ' HG12 ' L' ' 66' ' ' ILE . . . -50.33 -24.66 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.568 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 63' ' ' ILE . . . . . 0.662 ' HB ' ' HD3' ' L' ' 64' ' ' PRO . 44.0 mt -62.14 -82.88 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.324 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 64' ' ' PRO . . . . . 0.662 ' HD3' ' HB ' ' L' ' 63' ' ' ILE . 75.6 Cg_exo -50.55 -30.13 27.03 Favored 'Trans proline' 0 C--N 1.359 1.118 0 CA-C-N 121.17 1.454 . . . . 0.0 111.643 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 65' ' ' MET . . . . . . . . . . . . . 46.9 tpp -60.66 -37.23 80.85 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.626 0.727 . . . . 0.0 109.493 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 66' ' ' ILE . . . . . 0.514 HG12 ' O ' ' L' ' 62' ' ' ALA . 9.4 mm -74.98 -37.69 41.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.819 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 67' ' ' ALA . . . . . 0.586 ' HB3' ' HE1' ' L' ' 17' ' ' MET . . . -69.52 -29.9 67.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.373 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 68' ' ' VAL . . . . . 0.678 HG23 ' SD ' ' L' ' 17' ' ' MET . 47.2 t -72.48 -55.53 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.35 -51.28 60.06 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 119.855 -1.164 . . . . 0.0 111.586 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 70' ' ' LEU . . . . . 0.765 HD23 ' O ' ' L' ' 70' ' ' LEU . 4.4 tt -67.31 -38.61 85.23 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.109 0.481 . . . . 0.0 110.096 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 71' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' L' ' 75' ' ' MET . . . -62.58 -60.88 7.14 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.444 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 72' ' ' LEU . . . . . 0.773 HD22 ' HB ' ' M' ' 221' ' ' ILE . 3.9 pp -61.69 -31.38 71.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.912 0.387 . . . . 0.0 110.716 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 73' ' ' TYR . . . . . 0.705 ' N ' HD12 ' L' ' 72' ' ' LEU . 80.4 t80 -50.15 -42.17 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.908 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 74' ' ' VAL . . . . . 0.722 HG13 ' SD ' ' L' ' 75' ' ' MET . 14.9 p -111.6 -14.66 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.807 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 75' ' ' MET . . . . . 0.876 ' HG3' HD11 ' L' ' 9' ' ' LEU . 0.1 OUTLIER -84.36 -87.09 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 110.383 179.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 76' ' ' PHE . . . . . 0.409 ' HB3' HD11 ' M' ' 224' ' ' LEU . 46.1 m-85 -54.05 -29.01 42.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.611 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 77' ' ' ALA . . . . . 0.728 ' CA ' HD22 ' M' ' 224' ' ' LEU . . . -77.15 -80.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 111.447 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 78' ' ' VAL . . . . . . . . . . . . . 45.7 t -61.98 -22.29 28.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.336 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 79' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' L' ' 75' ' ' MET . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.053 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 95' ' ' HIS . . . . . . . . . . . . . 17.8 m80 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.762 0.315 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' M' M ' 96' ' ' GLY . . . . . . . . . . . . . . . -113.76 128.83 8.48 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.444 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 97' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' M' ' 97' ' ' LYS . 0.7 OUTLIER -67.82 -79.67 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.72 0.295 . . . . 0.0 110.798 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' M' M ' 98' ' ' SER . . . . . . . . . . . . . 47.7 t -56.87 -22.66 38.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.091 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 99' ' ' LYS . . . . . 0.574 ' O ' ' HD3' ' M' ' 103' ' ' PRO . 1.0 OUTLIER -61.52 -63.81 1.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.596 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' M' M ' 100' ' ' LEU . . . . . 0.755 ' O ' ' HD2' ' M' ' 103' ' ' PRO . 3.6 pp -61.29 -36.94 81.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.886 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 101' ' ' ILE . . . . . 0.73 ' N ' HD12 ' M' ' 100' ' ' LEU . 39.0 mm -61.14 -40.92 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 102' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' M' ' 103' ' ' PRO . . . -60.93 -45.36 96.63 Favored Pre-proline 0 N--CA 1.471 0.598 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 103' ' ' PRO . . . . . 0.755 ' HD2' ' O ' ' M' ' 100' ' ' LEU . 10.1 Cg_exo -72.91 -42.0 1.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.445 2.097 . . . . 0.0 112.375 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 104' ' ' LEU . . . . . 0.601 HD13 ' O ' ' M' ' 100' ' ' LEU . 9.7 mp -62.06 -42.26 99.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.008 0.432 . . . . 0.0 110.595 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 105' ' ' ALA . . . . . 0.478 ' O ' HG12 ' M' ' 108' ' ' ILE . . . -62.2 -41.67 98.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.577 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 106' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.98 -41.31 97.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.394 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 107' ' ' THR . . . . . 0.59 HG22 HG12 ' M' ' 159' ' ' ILE . 74.1 p -61.71 -43.4 98.92 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 108' ' ' ILE . . . . . 0.478 HG12 ' O ' ' M' ' 105' ' ' ALA . 28.8 pt -63.85 -42.98 97.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.747 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 109' ' ' PHE . . . . . 0.552 ' O ' HG12 ' M' ' 112' ' ' VAL . 13.9 m-85 -62.7 -42.84 99.85 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.798 0.332 . . . . 0.0 111.851 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 110' ' ' VAL . . . . . 0.547 HG12 ' O ' ' M' ' 107' ' ' THR . 7.1 p -62.97 -41.05 91.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 111' ' ' TRP . . . . . 0.439 ' HE1' ' HE2' ' M' ' 115' ' ' MET . 2.6 t-105 -61.61 -44.41 97.04 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.39 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 112' ' ' VAL . . . . . 0.552 HG12 ' O ' ' M' ' 109' ' ' PHE . 7.4 p -63.2 -41.35 92.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.362 0.601 . . . . 0.0 109.812 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 113' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -61.69 -38.86 89.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.112 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 114' ' ' LEU . . . . . 0.787 HD21 ' HA ' ' M' ' 152' ' ' SER . 48.8 tp -59.21 -42.07 90.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.13 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 115' ' ' MET . . . . . 0.506 ' SD ' HD13 ' M' ' 249' ' ' ILE . 65.4 mtt -61.88 -43.68 98.34 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.334 0.588 . . . . 0.0 109.835 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 116' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -62.43 -39.24 92.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.881 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 117' ' ' LEU . . . . . . . . . . . . . 63.6 tp -60.47 -40.82 92.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.061 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 118' ' ' MET . . . . . 0.445 ' O ' ' HD3' ' M' ' 122' ' ' PRO . 26.4 ttt -60.89 -44.58 96.92 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.263 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 119' ' ' ASP . . . . . 0.552 ' O ' ' HD2' ' M' ' 122' ' ' PRO . 1.7 m-20 -64.38 -37.87 89.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.559 0.695 . . . . 0.0 110.465 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 120' ' ' LEU . . . . . 0.488 ' HA ' ' CG2' ' M' ' 123' ' ' ILE . 56.8 tp -61.49 -39.32 90.54 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 121' ' ' LEU . . . . . 0.736 HD23 HD21 ' M' ' 148' ' ' ASN . 54.0 tp -59.35 -44.94 98.95 Favored Pre-proline 0 N--CA 1.468 0.457 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 122' ' ' PRO . . . . . 0.552 ' HD2' ' O ' ' M' ' 119' ' ' ASP . 58.1 Cg_endo -72.07 -41.7 1.86 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 121.933 1.756 . . . . 0.0 112.25 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 123' ' ' ILE . . . . . 0.488 ' CG2' ' HA ' ' M' ' 120' ' ' LEU . 6.2 tp -61.07 -42.08 91.77 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.183 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 124' ' ' ASP . . . . . 0.562 ' O ' ' HD2' ' M' ' 127' ' ' PRO . 39.3 m-20 -62.79 -38.63 91.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.026 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 125' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.19 -40.13 95.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 126' ' ' LEU . . . . . 0.56 HD21 ' HA ' ' M' ' 235' ' ' TRP . 60.5 tp -58.59 -44.53 99.16 Favored Pre-proline 0 N--CA 1.47 0.543 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 127' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' M' ' 124' ' ' ASP . 91.0 Cg_exo -40.1 -39.51 2.46 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.79 2.326 . . . . 0.0 112.721 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 128' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -111.16 110.66 21.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.828 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 129' ' ' ILE . . . . . . . . . . . . . 28.6 pt -107.43 166.19 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.231 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 130' ' ' ALA . . . . . . . . . . . . . . . -147.43 -65.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.028 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -123.94 155.15 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.803 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 132' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -162.03 91.95 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.083 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 133' ' ' VAL . . . . . 0.659 HG22 ' O ' ' M' ' 133' ' ' VAL . 12.6 p -104.31 25.12 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 134' ' ' LEU . . . . . . . . . . . . . 84.2 mt 66.57 -64.83 0.22 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.602 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 135' ' ' GLY . . . . . 0.683 ' O ' HD23 ' M' ' 139' ' ' LEU . . . -61.38 -78.22 0.17 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.378 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 136' ' ' LEU . . . . . 0.626 ' HB3' ' HD3' ' M' ' 137' ' ' PRO . 58.8 tp -41.74 -49.6 10.18 Favored Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 137' ' ' PRO . . . . . 0.842 ' O ' HG23 ' M' ' 141' ' ' VAL . 57.1 Cg_exo -51.66 -64.09 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.303 2.002 . . . . 0.0 112.668 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.49 95.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.677 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 139' ' ' LEU . . . . . 0.683 HD23 ' O ' ' M' ' 135' ' ' GLY . 4.3 mm? -60.81 -41.83 96.46 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.747 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 140' ' ' ARG . . . . . 0.742 ' O ' ' HD2' ' M' ' 143' ' ' PRO . 16.9 tpp85 -63.29 -39.24 94.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.25 0.548 . . . . 0.0 111.281 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 141' ' ' VAL . . . . . 0.842 HG23 ' O ' ' M' ' 137' ' ' PRO . 21.2 t -62.83 -41.22 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 142' ' ' VAL . . . . . 0.935 HG13 HD12 ' M' ' 220' ' ' LEU . 48.7 t -59.09 -45.35 99.44 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.328 -177.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 143' ' ' PRO . . . . . 0.742 ' HD2' ' O ' ' M' ' 140' ' ' ARG . 16.7 Cg_exo -66.69 -39.09 16.29 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.468 2.112 . . . . 0.0 110.722 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 144' ' ' SER . . . . . . . . . . . . . 52.8 m -59.23 -41.85 89.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.695 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 145' ' ' ALA . . . . . 0.769 ' HB1' ' CG ' ' M' ' 219' ' ' GLU . . . -61.47 -42.16 98.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.083 0.468 . . . . 0.0 109.978 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 146' ' ' ASP . . . . . 0.657 ' O ' HG12 ' M' ' 149' ' ' VAL . 23.5 m-20 -61.68 -41.18 97.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.448 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 147' ' ' VAL . . . . . 0.694 HG23 ' O ' ' M' ' 143' ' ' PRO . 49.1 t -61.93 -41.4 90.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.407 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 148' ' ' ASN . . . . . 0.736 HD21 HD23 ' M' ' 121' ' ' LEU . 5.2 m120 -61.88 -43.08 99.58 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 149' ' ' VAL . . . . . 0.719 HG22 ' CZ ' ' M' ' 212' ' ' PHE . 7.5 p -62.34 -41.63 92.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.569 -0.453 . . . . 0.0 110.906 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 150' ' ' THR . . . . . . . . . . . . . 80.7 p -62.14 -40.9 97.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.093 0.473 . . . . 0.0 110.317 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 151' ' ' LEU . . . . . 0.749 HD23 ' O ' ' M' ' 151' ' ' LEU . 5.5 tt -61.0 -41.16 95.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.05 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 152' ' ' SER . . . . . 0.787 ' HA ' HD21 ' M' ' 114' ' ' LEU . 90.9 p -60.89 -41.71 96.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.835 0.35 . . . . 0.0 110.602 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 153' ' ' MET . . . . . . . . . . . . . 57.5 ttp -61.35 -41.24 96.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.087 0.47 . . . . 0.0 110.319 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.56 94.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.138 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 155' ' ' LEU . . . . . 0.703 ' O ' HD13 ' M' ' 155' ' ' LEU . 3.0 tm? -60.51 -41.55 94.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.506 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 156' ' ' GLY . . . . . 0.64 ' O ' HG22 ' M' ' 159' ' ' ILE . . . -61.39 -41.6 99.57 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.927 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 157' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.47 -40.71 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.869 0.366 . . . . 0.0 110.879 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 158' ' ' PHE . . . . . 0.659 ' HE1' HD11 ' M' ' 162' ' ' LEU . 3.5 t80 -61.37 -42.45 98.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.78 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 159' ' ' ILE . . . . . 0.64 HG22 ' O ' ' M' ' 156' ' ' GLY . 6.5 tp -63.26 -41.77 93.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.386 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 160' ' ' LEU . . . . . 0.538 HD22 HG23 ' M' ' 159' ' ' ILE . 4.5 mm? -62.41 -42.68 99.62 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 161' ' ' ILE . . . . . 0.503 HG12 ' O ' ' M' ' 158' ' ' PHE . 28.1 pt -61.81 -40.4 86.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.22 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 162' ' ' LEU . . . . . 0.659 HD11 ' HE1' ' M' ' 158' ' ' PHE . 88.1 mt -60.82 -41.17 95.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.889 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 163' ' ' PHE . . . . . 0.665 ' O ' HG22 ' M' ' 166' ' ' ILE . 48.1 t80 -61.17 -42.02 97.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.18 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 164' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -62.67 -41.45 99.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.713 0.292 . . . . 0.0 111.629 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 165' ' ' SER . . . . . . . . . . . . . 83.6 p -61.74 -42.35 98.84 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 166' ' ' ILE . . . . . 0.665 HG22 ' O ' ' M' ' 163' ' ' PHE . 7.1 tp -61.68 -38.85 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.711 0.291 . . . . 0.0 111.146 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 167' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -63.99 109.86 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 168' ' ' MET . . . . . . . . . . . . . 26.5 mmt 60.92 169.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 169' ' ' LYS . . . . . 0.425 ' HD3' ' C ' ' M' ' 169' ' ' LYS . 5.1 tmtm? . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.311 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 199' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.849 0.357 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' M' M ' 200' ' ' LEU . . . . . 0.553 HD22 ' N ' ' M' ' 200' ' ' LEU . 2.8 mm? -69.2 -24.28 64.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.036 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 201' ' ' LEU . . . . . 0.848 ' H ' HD23 ' M' ' 201' ' ' LEU . 2.2 pt? -113.6 -29.14 7.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.582 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 202' ' ' SER . . . . . 0.46 ' HB3' ' CE2' ' L' ' 54' ' ' PHE . 56.4 m -63.14 -42.94 99.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 203' ' ' LYS . . . . . 0.567 ' HB2' ' HD3' ' M' ' 204' ' ' PRO . 63.8 mttp -62.49 -46.09 89.4 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.7 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 204' ' ' PRO . . . . . 0.708 ' HD2' ' C ' ' M' ' 201' ' ' LEU . 41.6 Cg_exo -56.48 -41.76 72.75 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.188 1.926 . . . . 0.0 111.715 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 205' ' ' VAL . . . . . 0.69 HG23 ' O ' ' M' ' 201' ' ' LEU . 48.6 t -61.48 -41.15 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.384 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 206' ' ' SER . . . . . 0.579 ' HB2' ' CD1' ' L' ' 54' ' ' PHE . 37.2 t -61.5 -42.97 99.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.898 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 207' ' ' LEU . . . . . 0.455 HD23 ' O ' ' M' ' 203' ' ' LYS . 3.8 mm? -61.91 -41.46 97.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.118 0.485 . . . . 0.0 110.347 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 208' ' ' GLY . . . . . 0.49 ' O ' ' HG ' ' M' ' 211' ' ' LEU . . . -61.37 -40.69 98.99 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.425 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 209' ' ' LEU . . . . . 0.438 ' CD2' ' HA3' ' L' ' 58' ' ' GLY . 41.1 tp -62.16 -43.51 98.67 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 210' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -63.6 -46.52 85.42 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.545 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 211' ' ' LEU . . . . . 0.949 HD12 ' N ' ' M' ' 212' ' ' PHE . 4.0 pp -65.32 -40.88 94.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.44 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 212' ' ' PHE . . . . . 0.949 ' N ' HD12 ' M' ' 211' ' ' LEU . 7.1 t80 -61.05 -43.55 98.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.639 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.89 -44.6 95.86 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.768 -1.206 . . . . 0.0 112.435 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 214' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -64.48 -42.95 95.58 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 215' ' ' MET . . . . . 0.824 ' HB3' HG22 ' M' ' 249' ' ' ILE . 16.6 ptp -62.33 -42.85 99.72 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 216' ' ' TYR . . . . . 0.503 ' O ' HD23 ' M' ' 220' ' ' LEU . 49.4 t80 -62.35 -44.74 95.78 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.688 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 217' ' ' ALA . . . . . 0.927 ' O ' HG22 ' M' ' 221' ' ' ILE . . . -63.61 -43.28 97.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.133 0.492 . . . . 0.0 110.571 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 218' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' M' ' 222' ' ' PHE . . . -62.92 -42.26 99.71 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.407 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 219' ' ' GLU . . . . . 0.769 ' CG ' ' HB1' ' M' ' 145' ' ' ALA . 7.7 tp10 -62.23 -46.81 87.2 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.276 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 220' ' ' LEU . . . . . 0.935 HD12 HG13 ' M' ' 142' ' ' VAL . 3.4 mm? -68.29 -48.14 65.75 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 221' ' ' ILE . . . . . 0.927 HG22 ' O ' ' M' ' 217' ' ' ALA . 9.7 tt -66.68 -44.17 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 222' ' ' PHE . . . . . 0.809 ' HD1' HG23 ' M' ' 221' ' ' ILE . 5.6 m-85 -64.29 -42.63 96.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 223' ' ' ILE . . . . . 0.602 HD11 HG11 ' M' ' 141' ' ' VAL . 9.2 tt -63.25 -45.05 99.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 224' ' ' LEU . . . . . 0.928 HD12 ' N ' ' M' ' 225' ' ' ILE . 4.4 pp -64.55 -43.66 93.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.798 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 225' ' ' ILE . . . . . 0.928 ' N ' HD12 ' M' ' 224' ' ' LEU . 7.7 tp -63.39 -41.78 93.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.855 0.36 . . . . 0.0 111.694 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 226' ' ' ALA . . . . . 0.546 ' O ' ' CD ' ' M' ' 230' ' ' PRO . . . -60.7 -42.08 96.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.396 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 227' ' ' GLY . . . . . 0.714 ' CA ' HD12 ' M' ' 237' ' ' LEU . . . -63.95 -41.54 98.63 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.422 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 228' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.82 -42.18 97.7 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 229' ' ' LEU . . . . . 0.538 HD23 ' O ' ' M' ' 225' ' ' ILE . 4.4 mm? -61.48 -44.79 93.43 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 230' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' M' ' 227' ' ' GLY . 68.0 Cg_endo -96.93 -178.76 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.122 2.548 . . . . 0.0 113.149 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 231' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -101.24 -41.21 6.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.042 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 232' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -89.23 66.64 7.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.018 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 233' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' M' ' 237' ' ' LEU . 54.7 m -47.83 -25.36 1.26 Allowed 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.903 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 234' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -51.4 -93.52 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.16 -0.337 . . . . 0.0 111.536 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 235' ' ' TRP . . . . . 0.56 ' HA ' HD21 ' M' ' 126' ' ' LEU . 33.4 t90 -69.01 -38.21 79.11 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 236' ' ' ILE . . . . . 0.523 HG21 ' CB ' ' M' ' 230' ' ' PRO . 48.5 mm -61.0 -44.42 98.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.993 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 237' ' ' LEU . . . . . 0.822 HD23 ' O ' ' M' ' 237' ' ' LEU . 5.4 tt -65.83 -41.67 91.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 0.0 111.931 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 238' ' ' ASN . . . . . 0.458 HD21 HD12 ' M' ' 123' ' ' ILE . 51.4 t30 -62.37 -43.0 99.85 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 -176.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 239' ' ' VAL . . . . . 0.613 ' O ' HG22 ' M' ' 243' ' ' ILE . 41.8 t -62.57 -45.62 88.9 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 240' ' ' PRO . . . . . 0.575 ' HD2' ' O ' ' M' ' 237' ' ' LEU . 4.8 Cg_exo -78.82 -41.25 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.7 2.267 . . . . 0.0 112.306 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 241' ' ' TRP . . . . . 0.414 ' NE1' ' HB ' ' M' ' 223' ' ' ILE . 10.8 t90 -62.07 -44.58 96.37 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.082 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 242' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.32 80.32 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 243' ' ' ILE . . . . . 0.801 HG23 ' HD1' ' M' ' 244' ' ' PHE . 5.6 tp -64.82 -42.85 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 244' ' ' PHE . . . . . 0.801 ' HD1' HG23 ' M' ' 243' ' ' ILE . 4.7 m-85 -64.16 -43.62 94.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 245' ' ' HIS . . . . . 0.441 ' O ' HG12 ' M' ' 248' ' ' ILE . 77.2 t60 -62.78 -42.88 99.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.805 0.336 . . . . 0.0 111.42 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 246' ' ' ILE . . . . . 0.867 HD12 HD11 ' M' ' 249' ' ' ILE . 6.8 tp -62.98 -40.79 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.779 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 247' ' ' LEU . . . . . 0.679 HD13 ' O ' ' M' ' 247' ' ' LEU . 3.1 tm? -62.53 -44.21 96.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 248' ' ' ILE . . . . . 0.441 HG12 ' O ' ' M' ' 245' ' ' HIS . 25.5 pt -64.05 -44.82 97.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 249' ' ' ILE . . . . . 0.95 HD12 ' N ' ' M' ' 250' ' ' THR . 2.4 pp -63.32 -39.32 84.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.04 0.448 . . . . 0.0 110.581 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 250' ' ' THR . . . . . 0.95 ' N ' HD12 ' M' ' 249' ' ' ILE . 92.2 m -61.6 -41.15 97.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.385 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 251' ' ' LEU . . . . . 0.678 HD23 ' O ' ' M' ' 251' ' ' LEU . 5.2 tt -61.22 -44.75 96.77 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.101 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 252' ' ' GLN . . . . . 0.484 ' HB3' ' HB3' ' M' ' 211' ' ' LEU . 7.9 mm100 -63.63 -41.57 98.25 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.977 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.37 94.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.946 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 254' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -59.25 -41.18 88.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.333 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 255' ' ' ILE . . . . . 0.633 ' O ' HG22 ' M' ' 258' ' ' VAL . 49.4 mm -61.1 -41.05 87.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.119 0.485 . . . . 0.0 110.145 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 256' ' ' PHE . . . . . 0.404 ' O ' ' CD1' ' M' ' 256' ' ' PHE . 1.5 t80 -61.8 -41.83 98.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.117 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 257' ' ' MET . . . . . 0.541 ' O ' HG22 ' M' ' 260' ' ' THR . 95.2 mmm -61.67 -43.04 99.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 258' ' ' VAL . . . . . 0.633 HG22 ' O ' ' M' ' 255' ' ' ILE . 28.8 m -63.13 -40.89 90.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.569 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 259' ' ' LEU . . . . . 0.735 HD23 ' O ' ' M' ' 259' ' ' LEU . 5.6 tt -62.85 -43.08 99.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.749 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 260' ' ' THR . . . . . 0.541 HG22 ' O ' ' M' ' 257' ' ' MET . 6.3 t -63.59 -42.99 98.21 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 261' ' ' ILE . . . . . 0.447 HG12 ' O ' ' M' ' 258' ' ' VAL . 29.0 pt -63.02 -42.47 96.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 262' ' ' VAL . . . . . 0.593 HG12 ' O ' ' M' ' 259' ' ' LEU . 7.3 p -62.24 -39.41 83.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 111.294 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 263' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -60.83 -40.65 93.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' M' M ' 264' ' ' LEU . . . . . 0.606 HD23 ' C ' ' M' ' 264' ' ' LEU . 5.2 tt -87.04 110.7 20.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.561 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' M' M ' 265' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.889 179.994 . . . . . . . . 0 0 . 1 stop_ save_